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Abstract
Iminium ion organocatalysis is a fast-growing area of contemporary organic chemistry 
in which primary or secondary amines may be used to  accelerate a diverse array of 
stereoselective transformations in the presence of air and water. At the outset of this work, 
three primary limitations were identified with state-of-the-art technology:
High catalyst loadings
Low temperature requirement for conjugate additions
Specificity for aldehyde substrates
Within this thesis chemical and theoretical methods to address these deficiencies 
were undertaken.
In Chapter 3, a direct comparison between the imidazolidinone and the diarylprolinol 
ether scaffold under optimised literature conditions revealed the imidazolidinone 
architecture to  exhibit superior performance in the Diels-Alder cycloaddition between 
cinnamaldehyde and cyclopentadiene.
In Chapter 2, the introduction of an electron withdrawing group onto the 
imidazolidinone scaffold was investigated and its effect on performance on a benchmark 
Diels-Alder cycloaddition determined. The upper limits of electron-withdrawing group 
strength that may be tolerated in a functioning imidazolidinone organocatalyst were 
revealed.
In Chapter 4, twelve novel catalysts were prepared by incorporating electron- 
withdrawing groups into the imidazolidinone scaffold and their effects on both rate and 
enantioselectivity determined.
In Chapter 5, a one-step air- and water-tolerant method for the preparation of the 
MacMillan imidazolidinone catalysts was developed.
In Chapters 6 and 7, efforts to develop a predictive computational model for 
imidazolidinone catalyst activity is described based around the experimental results obtained 
previously in the thesis. The knowledge gained was then used to design structures with the 
potential to  exhibit high turnovers and extremely high levels of stereoselectivity. Expansion 
of this model to encompass C2-symmetric catalysts was further explored in Chapter 8 .
Chapter 9 summarises the work in Chapters 2-8 and highlights avenues of inquiry 
along which this research may be continued.
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Chapter 1: Introduction to Iminium Ion 
Organocatalysis
1 Introduction to Iminium Ion Organocatalysis
1.1 Overview
Building on work previously performed within the group, a project was undertaken to 
design and develop high performance catalysts to address shortcomings within iminium ion 
organocatalysis.
1.2 The Emergence of Organocatalysis
In his review published in 1990 and titled "Organic Synthesis -  Where now?", Seebach 
states that "new synthetic methods are most likely to  be encountered in the fields of 
biological and organometallic chemistry" .1 In the two decades since this review was 
published, the use of organic molecules to catalyse organic reactions has gone from being an 
oft-overlooked curiosity to a rapidly growing and universally recognised field within organic 
chemistry, and also one in which Seebach himself is now a major player.
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Figure 1.1
One of the milestones that led to this explosion of interest occurred when, in 2000, 
MacMillan coined the term "organocatalysis" in his first publication in the field of iminium 
catalysis.2 Since then, the number of publications on the topic has increased every year, 
showing both the increasing number of discoveries being made within the field, as well as 
the growing acceptance of the term "organocatalysis" as a suitable anchor around which to 
unify the many diverse lines of research (Figure l . l ).3
Two of the factors driving the incredible interest in this field of organic synthesis have 
been the increasing interest in asymmetric synthesis and also in the drive towards greener 
chemical processes.
2
With a global revenue stream expected to top $1 trillion USD by 2014 and an interest 
in target compounds of ever increasing stereocomplexity, the pharmaceuticals industry has 
been a strong driving force in the development of asymmetric chemical processes.4 The 
agrochemicals, electronics, food, flavours and fragrances industries also drive the 
development of asymmetric synthetic processes.5
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Figure 1.2
The other major factor that simultaneously drives interest in organocatalysis and also 
guarantees its future relevance is the drive towards "greener" chemical processes. From the 
latter half of the 20 th century onwards, there has been an ever-growing awareness of the 
inseparability of our own biological substrates from the biosphere at large. The resultant 
backlash towards environmentally destructive technology has given rise to  an ever increasing 
amount of legislation designed to encumber polluting processes and drive commercial 
interests towards the development and use of environmentally benign chemical processes. 
This is reflected in the ever increasing number of publications on the topic of "green 
chemistry" and the launch of a journal by the RSC dedicated solely to  the field (Figure 1.2).6,7
As purely organic molecules that are required only in catalytic amounts, and with 
chirality that may frequently be derived from natural amino acids, organocatalysts are 
perfectly positioned to benefit from the drive towards asymmetric synthesis and green 
chemistry.
1.3 Types of Organocatalysis
MacMillan describes 5 modes of activation by organocatalysts in his 2008 review .8 In 
decreasing order of new reactions discovered, he lists iminium catalysis (50), hydrogen- 
bonding catalysis (30), enamine catalysis (25), SOMO catalysis (4), and counterion catalysis 
(2 ).
3
These activation modes may be grouped into two distinct classes, according to 
catalyst functionality. Hydrogen bond donors such as 1 may be used to effect both hydrogen- 
bonding catalysis as well as counterion catalysis (Figure 1.3).9
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Likewise, amines such as 2 may be used to effect iminium catalysis (Scheme 1.4), 
enamine catalysis (Scheme 1.5), or SOMO catalysis (Scheme 1.6), depending on the reaction 
conditions used.
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The seminal paper in the field of iminium ion organocatalysis was published in 2000 
by MacMillan and showed how the use of 7-HCI at 10 mol% could catalyse the Diels-Alder 
reaction of 5 and 6  in 19:1 methanohwater at 23 °C to  achieve 99% conversion in 8 hours, 
with 93% ee for both the endo- and exo- diatereomers, 8  and 9 (Figure 1.7).2
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This activation mode was further explored by the MacMillan group in subsequent 
papers detailing 3+2 cycloadditions, cyclopropanations, conjugate additions with open and 
closed transition states, aminations and hydride reductions (Scheme 1.8).10-16
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While the work done by MacMillan in the field of organocatalysis has almost 
exclusively used catalysts based on the imidazolidinone architecture (e.g 2 and 7), other 
architectures have also shown catalytic ability. In particular, diarylprolinol ether catalysts 
such as 10 and 11 have been used to accelerate a wide variety of transformations with high 
degrees of asymmetry (Figure 1.9).17
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Figure 1.10: Enamine processes catalysed by the imidazolidinone architecture
While not directly relevant to this project, the developments within enamine catalysis 
illustrate the versatility of imidazolidinone organocatalysts and show areas in which insights 
gained through research into iminium organocatalysis may also be utilised. The MacMillan 
group has also shown the use of the enamine activation mode for effecting a-chlorination 
and a-fluorination of aldehydes, a-fluorination of ketones and aldol reactions (Scheme 
1 .1 0 ).18- 21
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The more recently discovered SOMO catalysis has been used by MacMillan to  induce 
allylation, vinylation, carbo-oxidation, epoxidation, and arylation (Scheme l . l l ).22-26
1.4 Mechanistic Insight
Before the development of iminium ion organocatalysis w ithin his group, MacMillan 
postulated that the LUMO-lowering ability and kinetic lability of Lewis acid catalysts "might 
also be available with a carbogenic system that exists as a rapid equilibrium between an 
electron-deficient and electron-rich state" .2
This postulate lead to the idea of iminium ion organocatalysis, in which an 
alkylammonium salt (12 HCI) may reversibly condense with an aldehyde (13) or ketone to 
yield an iminium ion (14) (Scheme 1.12). 14 would then be expected to have a lower LUMO 
energy than 13 and readily react with a diene (15), or other suitable reagent, to  give a 
product iminium ion (16). 16 could then hydrolyse to provide the product (17) and 
regenerate 12HCI.
15
Scheme 1.12
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The concept of iminium organocatalysis was embodied in MacMillan's seminal 
publication.2 In it, he described the use of iminium organocatalysis to allow the Diels-Alder 
reaction of 5 and 6 to proceed to completion within a few hours at room temperature 
(Scheme 1.7). Additionally, by employing a chiral catalyst, MacMillan was able to observe 
substantial stereoselectivity, attaining product ees of 84 -  93%.
18.E 18.Z
Figure 1.13
In explaining the mechanism by which the reaction proceeds, MacMillan implied that 
the Diels-Alder reaction proceeds only through the intermediary of iminium ions and that no 
other active species were present. MacMillan also asserted that 18.E forms exclusively, as 
steric interactions between the geminal dimethyl groups and the proton a- to the iminium 
carbon render 18.Z highly unfavourable (Figure 1.13).
19.E1 19.E2
Figure 1.14
To explain the mechanism by which the benzyl arm extending from the chiral centre 
of 7 imparts stereoinformation into the product, MacMillan used computer-aided 
computational analysis to study the preferred conformations of 19.E. Using a relatively crude 
Molecular Mechanics function, he found that 19.E1 was the preferred conformation and that 
approach of 6 from the top face of the substrate was effectively blocked, leading to only one 
product enantiomer (Figure 1.14). More recently, work by Houk and also work within our 
group has shown that, largely due to a favoured n-hydrogen interaction, 19.E2 is infact the 
preferred conformation.27'28 19.E2 effectively blocks only the carbon a- to the iminium ion, 
but still provides sufficient shielding to allow good enantiocontrol in closed transition state 
reactions, such as the Diels-Alder reaction and conjugate addition of pyrroles.2'12 This finding
explains the inability of 7 to effect good stereocontrol in open transition state reactions, in 
which the G-carbon alone is targeted, such as conjugate addition of indoles.13
20.Z12
Figure 1.15
For open transition state reactions, the MacMillan group first found success with 2 
(Figure 1.15). Modelled iminium ions of 2 were found to preferentially reside in 20.El, as the 
conformation analogous to 19.E2 was disfavoured due to steric interactions between the 
benzyl arm and tert-butyl group.29 Unfortunately, 2 has only been shown to achieve good 
stereocontrol at low temperatures. This was suspected to be due to a lack of iminium 
geometry control.
1.5 Mechanistic Investigations within the Group
c h 3o h
7 13 18HPF6
Scheme 1.16
The mechanisms of iminium catalysis have been extensively studied within our group. 
A breakthrough occurred when 18 HPF6 was obtained as a stable compound that could be 
dried in vacuo (Scheme 1.16).30
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Scheme 1.17
18 HPF6 was found to react with 6 in dry acetonitrile to give 21 and 22 (Scheme 1.17). 
Upon aqueous workup, 8  and 9 could be obtained and were found to have moderate ee's.31 
Allowing 21 and 22 to stand for a period of days resulted in the gradual loss of enantiopurity. 
This result indicated that the Diels-Alder reaction is reversible in dry acetonitrile and that the 
forward reaction is under kinetic control. In both wet acetonitrile and in wet methanol, the 
Diels-Alder reaction appears irreversible, indicating that hydrolysis/methanolysis of 21 and 
22 is more rapid than the retro Diels-Alder reaction.
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Scheme 1.18
Further complexity arose when research performed within our group elucidated the
multitude of species present under reaction conditions (Scheme 1.18).31 It was shown that all 
aldehydes existed in equilibrium with their dimethylacetals and that the presence of water 
drives the equilibrium towards the aldehyde.
In contradicting MacMillan's postulate that cycloaddition was the RDS in the 
benchmark reaction, research within our group has shown that the RDS is 18 formation and 
that the cycloaddition is extremely rapid. The presence of water thus increases the rate of 
the bimolecular iminium formation step by increasing the concentration of 6 , which has been 
shown to  react w ith 7 far more rapidly than 23.31
10
7HCI 7
Scheme 1.19
The finding that the RDS is iminium ion formation indicates that the concentration of 
7, which exists in rapid equilibrium with 7-HCI, is also critical to  attaining high turnover 
(Scheme 1.19).
1.6 Catalyst Development w ith in  the Group
O r
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Scheme 1.20
While conducting a structure activity relationship study, the ability of EWGs to 
enhance catalyst efficacy was observed. The performance difference between 26, 27, and 28 
in the benchmark Diels-Alder reaction between 5 and 6 serves to highlight this effect 
(Scheme 1.20).30 26, lacking any EWG's, was seen to  be a very poor catalyst, attaining less 
than 5% conversion after 24 hours. 27 featured the ethyl ester EWG and was seen to effect 
62% conversion in the same time period, while 28 which featured the much stronger 
trifluoromethyl EWG allowed the reaction to proceed nearly to completion in the same time 
period.
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Seeking to reproduce this rate enhancement in the already high-performing 
imidazolidinone architecture, 29-32 were envisioned (Figure 1.21). Unfortunately, the 
attempted syntheses of these compounds all failed and the catalytic activity of 29-32 
remained unknown .30
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^  c h 3oh, ^ 0  L
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Scheme 1.22
After failing to reach other target structures, 33 was prepared. In the benchmark 
Diels-Alder reaction, it was found able to reach 99% conversion of 5 to 8  and 9 in 3 hours 
when used at 10 mol% in methanol at 25 °C (Scheme 1.22).30 At the same loading, 
MacMillan's seminal catalyst 7 required 8 hours to  attain the same conversion at 23 °C.2
This finding established that the premise of rate enhancement through addition of an 
EWG was applicable to  the imidazolidinone architecture and highlighted a path towards 
lower organocatalyst loadings.
12
1.7 Project Aims
As the most widely published subfield of organocatalysis, iminium catalysis appeared 
a fru itfu l area in which to work. Additionally, there had been a long-running thread of 
research into iminium organocatalysis within the group and many of the initial hurdles to 
gain entry into the field had been overcome. This project aimed to build upon this research 
and to  address the primary shortcomings with iminium catalysis, which were seen to be:
High catalyst loadings
Low temperature requirements for conjugate additions 
- Specificity for aldehyde substrates
As such, research was embarked upon with the goal of increasing catalyst turnover, 
removing low temperature requirements from conjugate addition reactions, and 
investigating the possibility of adapting catalysts for use with enone substrates.
13
Chapter 2: Fluorinated Imidazolidinones
14
2 Fluorinated Imidazolidinones
2.1 Introduction
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Scheme 2.1
In his seminal paper on organocatalysis, MacMillan reported the use of up to 20 mol% 
of 7-HCI to accelerate the Diels-Alder reaction (Scheme 2.1).2 MacMillan has also reported 
the use of up to  20 mol% 7 in conjunction with TFA for catalysing the conjugate additions of 
pyrroles into enals and the use of up to 20 mol% of 7 HCI04 fo r catalysing 1,3-dipolar 
cycloadditions.12,10 These high loadings are prohibitive to  scale-up, as expense would be 
incurred during catalyst synthesis and waste disposal. Informal discussions with industrial 
process chemists raised the requirement for high loadings as the main barrier to using 
organocatalysis on a large scale.32
Previous work within our group had shown that cyclic amines have rate advantages 
over comparable acyclic amines and also that an electron-withdrawing group beta to the 
active nitrogen could improve the turnover of a secondary amine catalyst, as seen in the 
series of catalysts 26, 27, and 28 (Scheme 1.20).30
At the time this work was performed, the RDS in the benchmark Diels-Alder reaction 
was thought to be the cycloaddition itself, as had been shown to  be the case when using
15
28-HCI in the benchmark reaction.33 As such, it was postulated that EWGs raised reaction 
rates by lowering the LUMO energy of the iminium ion. Recent work within the group has 
shown that the RDS in the benchmark Diels-Alder reaction w ith 7-HCl, when conducted in a 
methanokwater mixture, is iminium ion formation and that the cycloaddition is relatively 
rapid.31 Later research used 1H NMR to monitor the complex equilibria occurring under 
reaction conditions and showed the importance of considering all the species in Scheme 
1.18.31 EWGs are now believed to increase rate by increasing the acidity of catalyst salts and 
giving rise to  higher concentrations of free amine under reaction conditions.
The goal of the work performed within this chapter was to increase catalyst 
performance and allow for lower catalyst loadings by synthesising and evaluating EWG- 
containing secondary amine catalysts.
2.2 Piperazine-2,6 -dione work
Q
5 eq.
6
X fn e 
h2 c r
41 HCI 
20 mol%
methanol, 25 °C, 24 h
A Ph
69%
Scheme 2.2
One of the key catalysts discovered during previous investigations within the group, 
41, was found able to achieve 69% conversion in the benchmark reaction at 20 mol% loading 
and 25 °C fo r 24 hours, using 5 equivalents of 6 (Scheme 2.2).30 This architecture was also 
thought to hold promise as the foundation around which a C2-symmetric catalyst capable of 
catalyzing the reactions of ketones as well as aldehydes could be constructed. Further 
investigation was therefore undertaken with the aim of replacing the methyl group at N -l 
position with an EWG to yield a more efficient catalyst.
A - nh2
42
A
43
KHC03
acetonitrile 
reflux, 2 d
A A A -  + Y X '
44
29%
41
Scheme 2.3
The synthetic route taken previously to reach 41 was the reaction of 42 and 43 in the 
presence of potassium hydrogen carbonate in refluxing acetonitrile (Scheme 2.3). An initial
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Sn2 attack of the amine nitrogen upon the a-bromoester 43 was thought to yield the acyclic 
intermediate 44, which could then undergo a 6 -exo-trig cyclisation, favoured under Baldwin's 
rules, to  yield 41 (29%).34
^  H0 0 0 \  .N. .0
a ^ nh, +  ^  . x y
acetonitrile N
reflux, 66 h H
45 43 46
Scheme 2.4
An analogous approach towards 46 using 45 instead of 42 failed to provide the 
desired product upon workup, and the reaction was assumed to have failed (Scheme 2.4).
J U * ™  + ° \ a/ °
acetonitrile kt
reflux, 17 h h
23%
47 48 46
Scheme 2.5
An alternative approach allowed 46 to be obtained from 47 and 48 in 23% yield 
(Scheme 2.5).
V  * —  t y
H rt, 17 h I
Boc
54%
46 49 50
Scheme 2.6
50 was formed from 46 and 49 in 54% yield (Scheme 2.6). Due to the low solubility of 
46, the reaction had to be performed in DMF.
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Boc Boc
50 51-53,41
Reagents Solvent Conditions X Target
Pyridine, Tf20 DCM -50 °C - rt Tf 51
NaH, Ac20 DMF rt, 18 h Ac 52
NaH, TFAA DMF rt, 16 h CF3CO 53
NaH, CH3I DMF rt, 21 h ch 3 41
Scheme 2.7
A solution of 50 was treated with triflic  anhydride at -50  °C and then warmed to  room 
temperature (Scheme 2.7). No product could isolated and only unidentified side products 
could be seen. This was explained when a publication was found describing the reactive 
nature of the complex formed between valerolactam and triflic  anhydride.35
50 was then treated with sodium hydride, followed by acetic anhydride. Analysis of 
the crude reaction mixture by 1H NMR showed the continued presence of the peak 
corresponding to the imidic proton, indicating the reaction had failed to give the desired 
product.
The reaction was then repeated using the more reactive TFAA. Once again, 1H NMR 
showed the presence of an unsubstituted imide.
As the methodology of deprotonation using sodium hydride followed by addition of 
an electrophile was in doubt, a test reaction was performed whereby 50 was stirred in DMF 
with methyl iodide and sodium hydride. *H NMR showed the presence of multiple products 
with signatures indicating that methylation was occurring on the carbon atoms a- to the 
imide. This result was surprising as the relatively acidic imide functionality, estimated to have 
a pKa of around 15, was expected to be readily deprotonated by sodium hydride and the 
resultant anion expected to react with methyl iodide through its nitrogen atom .36
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Scheme 2.8
The reaction of 55 and 49 in THF proceeded to completion (Scheme 2.8). A slight 
excess of 55  was used and the residual amount was removed by twice washing an ethereal 
solution of the crude mixture with citric acid (1 M). Evaporation of the ethereal solution 
provided 56 in 94% yield.
+ r ci Y r°
0  Boc 0  |1 CH3CN, 60 °C, 4.5 h
" H
56 57 58
Scheme 2.9
An attempt at inducing a reaction between allylamine, generated in-situ from 57, and 
triethylamine failed and starting materials were recovered (Scheme 2.9).
+  - nh!
NBoc O EtOH, CH3CN
r.t, 4.5 h, reflux, 20 h j-j
56 59 41
Scheme 2.10
Using 59 also failed to  induce any reaction as only 56 was recovered from the reaction 
mixture (Scheme 2.10). No traces of product or acyclic intermediate were noted. At this 
stage, a lack of results prompted the abandonment of research into the piperazine-2 ,6-dione 
architecture so as to  focus efforts on the more promising imidazolidinone architecture.
19
2.3 Fluorinated Imidazolidinones
° \   ^
y v *
Bn^N  OF,
H
7 30
Figure 2.11
A longstanding goal within the group had been the synthesis of 30 (Figure 2.11). 
Computer modelling had shown that the iminium ion formed upon its condensation with 
acrolein would have a significantly lower energy LUMO (-5.99 eV) than that formed with 
benchmark catalyst 7 (-5.71 eV).30 It was assumed at the time that this would result in a very 
high performance catalyst.
19.E2 60.E1 20.E1
Figure 2.12
Additionally, 30 was thought to hold potential for use in a wider range of reactions. 
When compared to 19.E2, The Ti-hydrogen bond that favours this conformation is replaced 
with a repulsive n-fluorine interaction, rendering 60.E1 the preferred conformation (see 
Chapter 7.3). This conformation offers comparable substrate shielding to 20.E1, the 
preferred conformation of 20.E, and may impart stereocontrol into reactions going via open 
transition states (Figure 2.12).
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2.4 Synthetic attempts towards 30
* EtOH, rt, 96 h I  H
NH2 HCI n h 2
95%
61 62
Scheme 2.13
61 was stirred in 33% (w/w) ethanolic methylamine for 5 days at room temperature, 
and 62 obtained in 95% yield after aqueous workup (Scheme 2.13). The 1H NMR spectra of 62 
showed a doublet (J = 4.99 Hz) at 2.82 ppm, corresponding to  the N-methyl group. The 
splitting arose from coupling to the amidic proton and has been established within the group 
as a reliable diagnostic tool to determine whether the amidic methyl group is part of an 
uncyclised amide or a cyclised imidazolidinone, in which case the peak appears as a singlet.
Bnv V  + X , - VCe*
NH H F3C CF3 DMSOl B n ^ N  CF3
80 °C, 30 min, H
rt. 17 h
62 63 30
Scheme 2.14
As a first synthetic attempt towards 30, a solution of 62 in DMSO at 80 °C was treated 
with gaseous 63, generated by the action of concentrated sulfuric acid on the liquid 
sesquihydrate (Scheme 2.14). After stirring for 17 h at room temperature, an aqueous 
workup was performed. NMR of the organic faction showed a complex mixture of 
products.
^  + X  - V U
NH2 H F3C CF3 DMF, B n ^ '^ N  CF3
80 °C, 24 h H
62 63 30
Scheme 2.15
A second attempt was then made by substituting DMF for DMSO and repeating the 
procedure in the first experiment, stirring for 24 hours at 80 °C instead of room temperature 
(Scheme 2.15). A complex mixture of products was returned, and column chromatography 
failed to isolate any factions with 1H NMR signatures matching those expected of 30.
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Scheme 2.16
To allay fears that the presence of water may be hindering the reaction, dry DMF was 
used and the second attempt was repeated, stirring fo r 4 hours instead of 24 hours (Scheme 
2.16). Once again, the reaction did not proceed cleanly and resulted in a complex mixture of 
products. A crystalline product was isolated by precipitation from the crude mixture and was 
found to be insoluble in almost all organic solvents. Accordingly, the product was purified by 
successive washings w ith chloroform. A doublet of integration 3 and coupling constant 4.87 
Hz at 2.62 ppm matched closely the N-methyl doublet of 62 and indicated this material to be 
uncyclised. Consideration of DEPT, HSQC and HMBC spectra alluded to 65 as a possible 
structure. This was confirmed when 65 was independently synthesized from 62 and TFAA. At 
this stage, it appeared that 64 was forming but, rather than dehydrating to  give an imine, 
was undergoing a fluoroform elimination to  give 65.
To disfavour this elimination and encourage dehydration, the reaction was repeated 
in DMSO and in the presence of catalytic TFA (Scheme 2.17). Once again, the spectrum of the 
crude mixture was ambiguous while column chromatography yielded a complex mixture of 
products, none of which bore the signature of an imidazolidinone.
Fluoroform elimination was a quite unexpected side reaction that presented a barrier 
to further progression with this synthetic methodology. Rather than trying for a one-step 
synthesis of 30, it was decided that isolation of 6 6  followed by a separate cyclisation step 
might be a more profitable approach (Scheme 2.18). A search of the literature fo r the 
preparation of a-polyfluorinated imines showed that almost all methods employed a 
dehydrating agent. This indicated that the intermediate aminols did not readily dehydrate.
DMSO, 80 °C, 67 h
O
62 63 30
Scheme 2.17
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Scheme 2.18
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Scheme 2.19
One notable technique for aminol dehydration was the method of Middleton and 
Krespan.37 In a representative synthesis, 59 and 63 were allowed to combine at low 
temperature to  yield 67. POCI3 was then added, and 68  was isolated by distillation (Scheme 
2.19).
“"tV  + A . Y nU
NH, H FjC ^ C F ,  B n A jj^ C F ,
62 63 30
Scheme 2.20
Using this methodology, 62 was dissolved in anhydrous pyridine, cooled to  -20  °C and 
treated with 63 and then with phosphorus oxychloride. The reaction mixture was stirred at -  
20 °C for 1 hour and then refluxed for 2 hours (Scheme 2.20). Extensive column 
chromatography of the crude reaction mixture failed to  isolate any factions resembling 30.
This experiment was reattempted using 1:1 pyridine:acetonitrile as a solvent, allowing 
the temperature to be lowered to -78  °C before the phosphorus oxychloride was added. 
Extensive column chromatography was performed on the crude reaction mixture, but failed 
to isolate the desired product or shed light on why such a diverse array of side products was 
being formed.
fi F3CVCF3f  h
F3C ^ C F 3 DCM, -78 °C H0 ’ j j
0
100%
63 64
Scheme 2.21
Results so far had been discouraging. While there was indisputable evidence that 62 
and 63 were interacting, the only product that had been isolated in any significant yield was 
65. The wide array of side products observed indicated conditions were too forcing. In order 
to ascertain whether 62 and 63 may form a stable complex under mild conditions, a solution 
of 62 in anhydrous DCM was cooled to  -78  °C and treated with an excess of 63. Upon 
warming to room temperature and evaporation of the solvent and excess 63, pure 64 was 
obtained in quantitative yield (Scheme 2.21). 64 proved to  be a stable compound with a
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structure that could be confirmed by full characterization. Further study showed 64 to  
undergo slow elimination of 63 at room temperature, gradually reverting to 62 over the 
course of a few weeks. The presence of water or protic solvents was found to speed up this 
process dramatically, whereas minimal degradation was observed after storage in the 
absence of air and moisture at low temperature for around a year.
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Scheme 2.22
Having formed one of the desired bonds and overcome the problems of dealing with 
a gas by fixating the trifluoromethyl groups in a stable aminol, attention was focused around 
converting this intermediate into the desired product 30. As the trifluoromethyl groups 
appeared to impart a strong preference for sp3 hybridisation upon their attached carbon 
atom, it was envisaged that if imine 66  could be formed in the absence of strong 
nucleophiles, spontaneous cyclisation should yield 30, potentially a stable product (Scheme 
2.22).
FjC CFj
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64 30
Reagent Solvent Conditions
H2S04 - rt, 4h
CSA cd c i3 rt, 16 h
TFA cd c i3 rt, 16h
BBr3 cdc i3 rt, 5 min
BF3 Et20 chc i3 rt, 5 min
MgS04 cd c i3 rt, 97 h
P4O10 cdc i3 rt, 98 h
FeCI3 THF rt, 16 h, N2
Scheme 2.23
64 was stirred in concentrated sulfuric acid for 4 hours, then basified and extracted 
with ether (Scheme 2.23). Upon evaporation, a mixture of 62 and 64 was returned.
A solution of 64 in deuterated chloroform was treated w ith catalytic CSA. This also 
induced elimination of 63 and reversion to 62.
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A solution of 64 in deuterated chloroform was treated with catalytic TFA. Leaving the 
tube to  stand overnight at room temperature induced partial conversion to an unidentified 
product. *H NMR showed a doublet {J = 4.7 Hz) at 2.50 ppm, indicating the material was 
uncyclised.
A solution of 64 in deuterated chloroform was treated w ith catalytic boron 
tribromide. An immediate reaction occurred and precipitate was formed. Due to the 
presence of precipitate, 1H NMR yielded a poor quality spectrum. It did indicate, however, 
that a mixture of products had been formed and that treatment of 64 with boron tribromide 
was unlikely to provide any single product in good yield.
A solution of 64 in deuterated chloroform was treated w ith catalytic boron trifluoride 
etherate. A precipitate formed immediately and the reaction was discarded. The reaction 
was repeated in regular chloroform, using stoichiometric boron trifluoride etherate. The 
precipitate was filtered, dried, and dissolved in DMSO-d6 fo r *H NMR. The spectrum 
appeared to show a complexing of 64 w ith the boron trifluoride, but did not show any 
chemical conversion.
A solution of 64 in deuterated chloroform was stirred over magnesium sulphate for
97 hours, then filtered and analysed by *H NMR. This showed that the reaction mixture 
consisted mainly of 64 w ith small amounts of 62.
A solution of 64 in deuterated chloroform was stirred over phosphorus pentoxide for
98 hours before being filtered through Celite®. Decomposition or polymerisation appeared to 
have occurred, as the Celite® retained a quantity of insoluble organic matter, while the 
deuterated chloroform appeared to contain no solutes.
64 and 0.3 equivalents iron(lll) chloride were stirred in dry THF under nitrogen. 
Filtration through silica to remove iron complexes and residues returned a small amount of 
an unidentified compound. The reaction was repeated with stoichiometric iron(lll) chloride, 
and the only product that could be isolated was 65.
69 66 64
Scheme 2.24
As dehydration of the aminol followed by in-situ cyclisation appeared to have failed, 
attempts were made to test for the presence of an intermediate by capturing it w ith an 
amine (Scheme 2.24). Isopropylamine was chosen for its availability in the lab and low boiling 
point, allowing any excess reagent to be readily evaporated.
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A solution of 64 in deuterated chloroform was treated w ith TFAA and triethylamine 
then stirred fo r 90 hours at room temperature, before excess isopropylamine was added 
(Scheme 2.25). The solvent and residual isopropylamine were removed by evaporation and 
the residue was found to contain 62 and 64, but no trace of 69.
The previous reaction was repeated using thionyl chloride instead of TFAA. Septuplets 
at 4.73 and 4.53 ppm suggested that the isopropyl moiety had been incorporated, but only in 
trace quantities.
The experiment was then repeated using oxalyl chloride as the dehydrating agent and 
gave rise to a mixture of products. Column chromatography was preformed, yielding a 
significant quantity of a bright yellow solid. The structure of this product was not deduced.
Earlier attempts at dehydrating 64 using phosphorus oxychloride had failed. It was 
proposed that failure could be due to the phosphorus undergoing attack from the amide 
functionality of the aminol, as occurs in the Vilsmeier-Haack reaction. As the hydroxyl group 
of the aminol functionality was acidic, it was conceived that the use of base to  remove this 
proton could lead to  its reaction with a dehydrating agent. A solution of 64 in DME at -78  °C 
was treated w ith butyllithium, followed by diphenyl chlorophosphate (Scheme 2.26). Upon 
workup, a mixture of products was obtained, including one chloroform-insoluble white solid. 
A structure for this compound was not elucidated, but 1H NMR showed it to  be uncyclised 
while 13C NMR showed it to be free of trifluoromethyl groups.
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Scheme 2.26
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Methanol was substituted for diphenyl chlorophosphate and the reaction repeated 
(Scheme 2.27). This resulted in a crude reaction mixture consisting mostly of 62, showing 
that loss of 63 had occurred.
c f 3
TFAA, pyridine
F3C ' 'C F 3
63 70
70%
71
Scheme 2.28
As a testimony to the extreme reactivity of 63, a search of the literature had revealed 
its ability to  condense with amides to  yield N-carbonylimines.38'39 In the example of Burger et 
al, 63 condensed with 70 in the presence of TFAA and pyridine to  furnish 71 (Scheme 2.28). 
Compounds of this nature appear to be stable, as evidenced by the commercial availability of 
71.
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Scheme 2.29
It was envisaged that if the amine functionality of 62 could be protected as compound 
74, condensation with 63 could yield iminium ion 73. Removal of the Boc groups under acidic 
conditions would then yield intermediate 72, which would spontaneously cyclise to  the 
desired compound 30 (Scheme 2.29). As carbamates are more nucleophilic than amides, it 
was deemed necessary to  add two Boc groups such that 74 would condense only with the 
amide.
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A first attempt at preparing 74 involved stirring 62 in the presence of 2 equivalents of 
49 over potassium carbonate in THF for 19 hours at room temperature and 2 hours at reflux 
(Scheme 2.30). Upon workup, the crude reaction mixture was seen only to contain 49 and 75, 
with no trace of 74.
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Scheme 2.31
Refluxing 75 in DCM with DMAP and 49 for 40 hours failed to yield 74; 75 was 
returned unchanged (Scheme 2.31). Due to  the complexity of the route envisaged towards 
30 via 72 and the difficulty in obtaining the initial 74, these synthetic adventures were 
curtailed.
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Scheme 2.32
As an investigation to see whether a stable complex between a less powerful 
nucleophile and 63 could be isolated, a solution of 76 in DCM at -78  °C was treated with an 
excess of 63. Fixation appeared not to occur, as when the solution was warmed slowly to 
room temperature and the DCM and excess 63 evaporated, only 76 was returned (Scheme 
2.32).
At this point, a lo t of synthetic effort had been expended and minimal progress 
towards 30 had been made. It appeared novel synthetic approaches would be required to  
access such a highly fluorinated compound and the development of such approaches was 
beyond the scope of this project. As such, efforts towards 30 were discontinued.
DMAP
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2.5 Trifluoroacetophenone
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Scheme 2.33
Attempts to  incorporate 63 into an imidazolidinone had failed. Accordingly, the less 
fluorinated structure 78 was targeted. 78 was seen as having similarity to 33, a catalyst 
previously developed within the group, as well as theoretically being synthetically accessible 
from 79, a relatively cheap and easily handled ketone (Scheme 2.33).
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AcOH CHCIs reflux, 42 h
Scheme 2.34
An attempt analogous to the synthesis of 33 was made whereby 62, 79 and catalytic 
PTSA in DMF were subjected to  microwave irradiation at 120 °C for 1 hour (Scheme 2.34). 
This resulted in a distribution of uncyclised products, but no imidazolidinone was detected by 
1H NMR analysis.
Under thermal conditions, stirring 62 and 79 in DMF at 120 °C with catalytic PTSA for 
68 hours resulted in extensive side product formation and no trace of the desired product.
62 and 79 were then refluxed in chloroform in the presence of acetic acid for 42 
hours. Upon analysis by 1H NMR, the crude was found to contain mainly starting materials, 
with traces of an unidentified uncyclised product.
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Curious about the apparent unreactivity of 79, a brief assay was performed to see 
whether it would react with powerful electrophiles. Solutions of 79 in deuterated chloroform 
were treated w ith 1 equivalent of either triflic anhydride, phosphorus(lll) bromide, or oxalyl 
chloride (Scheme 2.35). In each case, no reaction was observed after standing overnight at 
room temperature.
Bn
81
N
NH2
Br2 \ / ”  / = \  62 Bn>Y ^ N '
DCM, rt f| Br DCM, rt P h ^ N H
Ph'" I 
Ph
82
Scheme 2.36
The aza-Wittig reaction can be used to  obtain imines from phosphorimines and 
ketones. The reaction is believed to go via a 4-membered intermediate, extruding 
triphenylphosphine oxide in a manner analogous to the W ittig reaction. Publications were 
found describing its use in forming fluoroakylated imines and it was deemed worthy of 
investigation.40,41 A solution of 81 was prepared in-situ by the reaction of 80 with elemental 
bromine. Upon the addition of 62, 82 was formed in qualitative yield (Scheme 2.36). To 
attempt deprotonation, 82 was then stirred overnight in DCM with potassium carbonate and 
a material believed to be the phosphorimine 84 isolated.
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Scheme 2.37
The suspected phosphorimine was then refluxed with 79 for 89 hours in p-xylene, but 
failed to produce 84 (Scheme 2.37).
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Figure 2.38
After the first isolation of suspected iminophosphorane 83, crystals were grown by 
slow evaporation of a DCM solution of the material and submitted for X-ray crystallographic 
structure determination. Results were returned some time later and showed that rather than 
the crystalline material being a phosphimine, it was in fact 82, an aminophosphonium 
bromide (Figure 2.38). This result explained the failing of the aza-Wittig attempt and showed 
that the deprotonation of 83 would require more basic conditions to yield 82.
At this time, and before further attempts at deprotonating the iminophosphonium 
bromide could be made, a paper was found detailing the use of gallium(lll) triflate 86 as a 
catalyst in the formation of benzimidazolines, benzothiazolines, benzoxazolines, and 
dihydrobenzoxazinones.42 In the most relevant procedure, 85, 1.5 equivalents of 79 and 5 
mol% gallium triflate 86  were heated in DCM in a sealed tube at 120 °C for 2 hours (Scheme 
2.39). After workup, the desired product was obtained in 80% yield. While work within the 
group had traditionally used protic acids for the synthesis of imidazolidinones, the use of 
Lewis acids held promise for more facile syntheses. The synthetic challenge of attaining 78 
presented an ideal opportunity to investigate the use of Lewis acids in the formation of 
imidazolidinones.
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Gallium(lll) triflate 86  was not commercially available and initial attempts were made 
with Lewis acids already present in the lab. 62 and 79 were refluxed in toluene for 18 hours 
in the presence of 5 mol% zinc perchlorate, a mild Lewis acid (Scheme 2.40). The reaction 
failed to produce the desired product, and the crude was found to  consist solely of starting 
materials.
DCM, CF3 Bn
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Scheme 2.41
The next attempt was using the more powerful azaphilic Lewis acid ytterbium(lll) 
triflate at 7.5 mol% concentration in refluxing DCM for 19 hours (Scheme 2.41). No reaction 
was observed and starting materials were returned intact. It was noted that the catalyst 
seemed insoluble in the refluxing DCM.
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Scheme 2.42
Another attempt in refluxing chloroform using 9 mol% catalyst achieved quantitative 
conversion to  imine 84 but failed to produce any imidazolidinone (Scheme 2.42). While this 
result was very encouraging, further attempts to discover a one-step condensation and 
cyclisation reaction seemed warranted.
32
0
Bn
+ r V l'cFi Yb<°T,)» 0 ^ nn An \  :_^ ^  ^  ^  'Y  'n ^
n h2 CHCl3, Cf3 In  H
120 “C, 15 h
17%
62 79 84
Scheme 2.43
Increasing the temperature to  120 °C by heating 62, 79, and ytterbium(lll) triflate at 
120 °C in a sealed vessel did not induce cyclisation and also yielded lower quantities of imine 
(Scheme 2.43).
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The reaction was then repeated under microwave irradiation at 150 °C for 60 
minutes, resulting in widespread decomposition (Scheme 2.44).
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Scheme 2.45
Lowering the temperature to 140 °C and changing the solvent to DCE to reduce 
pressure in the reaction vessel did not alleviate the decomposition, and the reaction again 
failed to produce 78 (Scheme 2.45).
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Scheme 2.46
Given the ability of ytterbium(lll) trifla te to cleanly catalyse the formation of 84, the 
investigation into Lewis acids appeared to be bearing fru it. It was deemed worthwhile to 
synthesise gallium(lll) triflate 86  so as to  investigate its catalytic efficacy. Accordingly, the 
synthesis was performed by heating gallium metal in excess triflic  acid at 150 °C for 4 days 
(Scheme 2.46).43 The progress of the reaction could be observed as lustrous beads of gallium 
metal rose atop pillars of the light grey triflate. When the majority of gallium had converted 
to the triflate, the reaction was cooled to room temperature, then poured into water.
X K
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Residual gallium metal was removed by filtration and the filtra te was evaporated and the 
residue dried in vacuo at 240 °C to yield gallium(lll) trifla te 86  in 6 6% yield. None of the usual 
forms of characterization were possible due to  the nature of the compound. A neutral pH 
reading indicated the absence of triflic acid and the compound, a freeflowing gray powder, 
was assumed to be pure.
As gallium(lll) trifla te 86  appeared completely insoluble in chloroform, acetonitrile 
was used as a reaction solvent. 62 and 79 were refluxed over 3A molecular sieves in the 
presence of 5 mol% of the catalyst (Scheme 2.47). This facilitated 44% conversion to 84 but 
did not induce cyclisation to 78.
62 and 79 were then subjected to microwave irradiation in the presence of 15 mol% 
of gallium(lll) trifla te  86  at 120 °C for 60 minutes, which induced clean conversion to 84 as a 
single isomer but again failed to produce any imidazolidinone (Scheme 2.48). Subjectively, in 
the reactions between 62 and 79, gallium(lll) triflate (8 6 ) appeared comparable to 
ytterbium(lll) triflate, if a little less potent.
As a final attempt towards a one-step synthesis of 78, copper(ll) triflate was used to 
catalyse the reaction between 62 and 79. An attempt under thermal conditions using 8 mol% 
catalyst under dry conditions induced conversion to 84, but at a lower rate than 
ytterbium(lll) trifla te (Scheme 2.49).
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It was suspected that water formed during the condensation of 62 and 79 was 
moderating the reactivity of the copper catalyst and surmised that by increasing the catalyst 
loading, the relative effect may be reduced. To investigate this, microwave irradiation of a 
dry acetonitrile solution of 62 and 79 at 120 °C for 60 minutes in the presence of 29 mol% 
catalyst was performed (Scheme 2.50). This resulted in 83% conversion to 84 with no 
detectable cyclisation.
Applying the methodology developed so far, 62 and 79 were refluxed in acetonitrile 
for 62 hours under nitrogen, over molecular sieves and in the presence of 37 mol% copper(ll) 
triflate. After aqueous workup, column chromatography was used to  provide 0.97 g of 84 in 
40% isolated yield (Scheme 2.51).
The comparable reaction using 5 mol% ytterbium(lll) trifla te in refluxing chloroform 
furnished 1.27 g of 84 in 63% yield (Scheme 2.52). 84 was found to be a stable, air- 
insensitive, compound and was fully characterised. Having obtained 84, methodology for its 
cyclisation to imidazolidinone 78 was developed.
Cu(OTf)2,
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c h 3c n , n2,
reflux, 62 h
40%
62 79 84
Scheme 2.51
Yb(OTf)3,
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Scheme 2.52
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Scheme 2.53
For the sake of simplicity, a protic acid, TFA was tried first. 84 and 36 mol% TFA in 
DMF were subjected to microwave irradiation at 120 °C for 60 minutes (Scheme 2.53). The 1H
NMR spectra of the crude showed partial conversion to a single compound that was isolated 
by column chromatography. Full characterisation was not performed, but the 1H NMR 
spectra acquired indicated the structure to be that of 87, which may have arisen via a 1,3- 
hydride shift. A doublet of 5.13 Hz and integration 3 at 2.87 ppm indicated the material to be 
uncyclised, while the benzylic protons originating from the amino amide portion of the 
molecule appeared as two doublets of coupling 14.42 Hz, indicating the absence of the a- 
carbonyl proton with which they normally appeared as an ABX system. The a-carbonyl 
proton, normally present at 4.18 ppm and coupled to  the benzylic system, had been replaced 
by a quartet at 5.01 ppm with a coupling constant of 7.23 Hz, a potential value for a 37fh 
coupling constant.44 An attempt was made to  convert 87 to  known compound 88  by stirring 
in 1:1 4 M hydrochloric acid:THF, but no organic material was recovered upon evaporation 
and extraction with diethyl ether.
A solution of 84 and ytterbium(lll) trifla te (13 mol%) in DMF was subjected to 
microwave irradiation at 120 °C for 60 minutes (Scheme 2.54). Although previous attempts to 
generate 78 directly from 62 and 79 using ytterbium(lll) trifla te under microwave irradiation 
had resulted in decomposition, it was hoped that in the absence of the starting materials and 
in the absence of the water arising from their condensation, there may exist potential for 84 
to cyclise to 78. This potential was not bourne out, as the crude reaction mixture contained 
mainly 84, w ith no traces of 78 appearing.
Yb(OTf)3
84 78
Scheme 2.54
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Scheme 2.55
A solution of 84 and indium(lll) triflate (31 mol%) in DMF were subjected to 
microwave irradiation at 120 °C for 60 minutes (Scheme 2.55). The result was similar to  the 
previous experiment and the crude was almost entirely starting material, with traces of 79.
n A m.
° \  /Cu(OTf)-1/2PhCH3 ' V ' Nv
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84 78
Scheme 2.56
A solution of 84 and copper(l) trifla te toluene complex (23 mol%) in dry acetonitrile 
were subjected to microwave irradiation at 120 °C for 60 minutes (Scheme 2.56). No reaction 
occurred, and the starting material was returned.
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Scheme 2.57
A solution of 84 and copper(ll) trifla te complex (28 mol%) in dry acetonitrile were 
subjected to  microwave irradiation at 120 °C for 60 minutes (Scheme 2.57). This resulted in 
clean conversion of 84 into equal amounts of 78 and 89 (70% combined yield).
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Scheme 2.58
An attempt to lower the catalyst loading by using 14 mol% copper(ll) triflate and 130 
°C reaction temperature failed and 84 was returned unchanged (Scheme 2.58). It was 
suspected that improperly dried acetonitrile was deactivating the catalyst.
Irradiating 84 in bench acetonitrile in the presence of 37 mol% copper(ll) triflate at 
120 °C for 60 minutes also failed to induce any cyclisation and 84 was returned. It was 
observed at this point that if the reagents and reaction solvent were dried, the reaction 
mixture would initially be a pale turquoise colour, while the presence of water would result 
in a deep blue colouration. It was therefore surmised that the attempt to reduce the catalyst 
loading failed due to the presence of water in the reaction mixture.
Noting that the copper(ll) trifla te in the bottle had a pale blue tinge, it was dried by 
heating at 100 °C in vacuo for 30 minutes, during which time the colouration disappeared. 84 
was also dried by heating at 60 °C in vacuo for 1 hour then dissolved in freshly distilled 
acetonitrile. 9 mol% freshly dried catalyst was added and the pale blue solution irradiated at 
130 °C for 60 minutes. Unfortunately, despite the attempts to  keep the reaction anhydrous, 
only traces of product were detected and the bulk of the material remained as 84.
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Scheme 2.59
Repeating the previous reaction using 65 mol% pre-dried catalyst in dry acetonitrile 
resulted in complete conversion of 84 to  78 and 89 (Scheme 2.59). Whereas running the 
reaction at 120 °C had resulted in a 1:1 ratio of the diastereomers, this reaction provided 78 
and 89 in a 2:1 ratio (63% combined yield).
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Having determined the conditions required for the cyclisation of 84 to occur, the 
reaction was scaled up. 0.95 g of 78 and 50 mol% copper(ll) trifla te in 15 mL dry acetonitrile 
were irradiated at 125 °C for 90 minutes (Scheme 2.60). An aqueous workup was performed 
to remove the catalyst, and column chromatography provided clean 78 and 89, in 34% and 
29% yield, respectively.
An unexpected barrier to further progress was stumbled upon when attempting to 
form hydrochloride salts of 78 and 89. In accordance with the standard procedure for 
forming catalyst hydrochloride salts, ethereal solutions of 78 and 89 were treated with 
anhydrous hydrogen chloride gas generated from the reaction of concentrated sulfuric acid 
upon ammonium chloride (Scheme 2.61). In the usual case, upon treatment with hydrogen 
chloride gas, the formerly clear ethereal solution was be seen to  turn cloudy for a few 
seconds, before regaining transparency as a precipitate appears. Precipitate formation is 
usually complete after 10  minutes and the product may be obtained in a pure form by 
filtering and washing with ether. When this procedure was attempted with 78 and 89, 
however, no reaction of the ethereal solution with the hydrogen chloride gas was noted, 
even when the gas was bubbled through for 1 hour. Evaporation of the now-fuming ethereal 
solutions returned 78 and 89 as free amines. While unexpected at the time, literature 
descriptions of similarly fluorinated amines indicate that low basicity and an unwillingness to 
form salts is not unprecedented.45,46
-hci ■HCI
78 78 HCI 89 89 HCI
Scheme 2.61
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2.6 Benchmark Reaction Attempted
19:1 CH30H:H20  
rt, 4 h
Scheme 2.62
Discovery of a synthetic route to 78 and 89 had proved most troublesome and 
required substantially more effort than expected. As such, it was deemed necessary to 
properly test for catalytic activity, rather than assuming their inability to form hydrochloride 
salts would render them catalytically inactive. In a modification to the standard procedure 
for performing Diels-Alder reactions, benzoyl chloride was preadded to methanol, generating 
1 equivalent of hydrogen chloride in situ, after which water and 78 was added, followed by 5 
and 6 (Scheme 2.62). After stirring the homogenous solution for 4 hours, no conversion to 8 
or 9 was observed.
19:1 CH30H:H20  
rt, 4 h
Scheme 2.63
The reaction was repeated with 89, which also resulted in no conversion after 4 hours 
(Scheme 2.63). These results, combined with the lack of basicity observed with 78 and 89, led 
to the conclusion that 78 and 89 were not catalytically active in the Diels-Alder reaction of 5 
and 6 . Further investigations were not performed.
2.7 Trifluoroacetone based catalysts
o. /  ov /
V -N  V -N  o
Br r ^  > ^^C F 3n H
90 91 92
Scheme 2.64
Loath to discard hard won experience in the incorporation of fluoroalkyl groups into 
the imidazolidinone architecture, a final attempt at a functional trifluoromethylated catalyst
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was made. 90 and 91, lacking the phenyl EWG of 78 and 89, were seen to  have the potential 
to be basic and nucleophilic enough to be viable catalysts (Scheme 2.64) (calculated 
basicities: Chapter 7.2).
o n O
Bn
62 92 93
Scheme 2.65
92 proved difficult to handle, due to its low viscosity and low boiling point (22 °C). In 
order to assess the ease with which 62 and 92 may condense to form 93, conveniently 
fixating the trifluoromethyl moiety, 62, 4 equivalents of 92 and a drop of TFA were dissolved 
in deuterated chloroform and reaction progress monitored by 1H NMR (Scheme 2.65). Total 
conversion of 62 to 93 was observed after the NMR tube was allowed to stand overnight at 
room temperature.
62 and 2 equivalents of 92 were stirred with 1 drop of TFA in chloroform for 19 hours. 
Upon evaporation of the solvent and excess 92, 8.1 g of 93 was obtained in qualitative yield 
(Scheme 2.66).
Using the same procedure as was developed for the cyclisation of 84, 93 and 22 mol% 
copper(ll) trifla te in dry acetonitrile were irradiated at 140 °C for 60 minutes. After aqueous 
workup and column chromatography, 90 and 91 were obtained in 14% and 13% yield, 
respectively (Scheme 2.67).
62 92
100%
93
Scheme 2.66
Cu(OTf)2
MW, dry CH3CN, Bn1
140 °C, 60 min
93 90 91
14% 13%
Scheme 2.67
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In line with the normal procedure for forming hydrochloride salts, an ethereal 
solution of 90 was treated with hydrogen chloride gas (Scheme 2.68). Initially, no interaction 
was noted and the hydrogen chloride gas was observed to bubble freely through the 
solution. After around 40 minutes, an abrupt change was noted as precipitate began to form 
and gas absorption began. A further 5 -1 0  minutes later, hydrogen chloride was once again 
seen to be passing freely through the solution and the insoluble product was isolated by 
filtration, yielding 90-HCI (79%). The procedure was repeated using fresh 90 and once again, 
a prolonged period of apparent inactivity occurred before precipitate was seen to form.
o. /  o. /yv ** yy
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Scheme 2.69
An ethereal solution of 91 exhibited the same behaviour when treated with hydrogen 
chloride gas, yielding 91-HCI in 96% yield (Scheme 2.69).
X KBn N CF3
79%
90-HCI
2.8 Benchmark Reaction Re-attempted
5 mol% 90-HCI
19:1 CH30H:H20 
rt, 17 h
5 6 8 9
Scheme 2.70
90-HCI was evaluated in the benchmark reaction, but failed to catalyse any product 
formation even after the reaction had been run for 17 hours at room temperature (Scheme
2.70).
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Scheme 2.71
91-HCI was evaluated in the same manner and found to be w ithout activity (Scheme
of 94.E or 94.Z were observed even after more than 48 hours standing at room temperature.
The experiment was repeated with 91-HCI and showed no sign of iminium ions after 
standing for over 48 hours at room temperature (Scheme 2.73). These experiments indicated 
that the reason for the lack of catalytic activity observed with 90 and 91 is rooted in their 
unwillingness to form iminium ions with 5 under the conditions examined. It appeared that 
while the elimination of the phenyl group of 78 and 89 had allowed hydrochloride salt 
formation to occur, the trifluoromethyl EWG was still too strong to allow 90 and 91 to  exhibit 
iminum ion formation and catalytic activity.
2.71).
Scheme 2.72
A 0.1 M solution of 90-HCI in 19:1 deuterated methanol:deuterated water was 
treated w ith 5 equivalents of 5 and the results observed by *H NMR (Scheme 2.72). No traces
Scheme 2.73
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2.9 Trichloromethyl EWG attempts
Ov /  Ov /'Y -n V - n /
j /^-cci3 1 y - y -
Bn h '
96 2
Figure 2.74
As the trifluoromethyl group had proved too strong an EWG to be incorporated at the 
2-position of an imidazolidinone catalyst, the trichloromethyl group was considered. The 
longer carbon-chlorine bond length and greater van der Waals radius of the chlorine atoms 
renders the trichloromethyl group a closer steric match to a tert-butyl group than a methyl 
group. Accordingly, 96 presented a sensible target structure that could be considered as an 
analogue of 2 and may thus have potential for use in open transition state reactions (Figure 
2.74).
y V  +  I  Y V c a ,
* H CCI3 MW, DMF, B r r ^ N
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Reagents Solvent Conditions
PTSA 
FeCIs, 3A MS 
FeCI3
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dry THF 
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Scheme 2.75
A one-step synthesis of 96 was attempted when 62, 97 and 17 mol% PTSA were 
subjected to  microwave irradiation in DMF at 130 °C for 60 minutes (Scheme 2.75). The 
resultant dark oil was found to contain a large number of unidentified compounds and the 
reaction was deemed to have failed.
In a preparation analogous to  that published for 2, 62, 97 and 23 mol% iron(lll) 
chloride were stirred over 3A molecular sieves in dry THF at room temperature .12 Multiple 
products were observed in the crude mixture, including traces of a possible imine.
As the formation of brown iron(lll) oxide indicated that the reaction was generating 
water, it was hoped that by using a larger amount of catalyst, the water of condensation may 
be absorbed w ithout deactivating all of the iron(lll) chloride. Molecular sieves were omitted 
as they appeared unable to sequester water before it reacted with the iron(lll) chloride. 62,
1.7 equivalents of 97 and 93 mol% iron(lll) chloride were stirred in dry THF for 22 hours.
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Once again, a mixture of products was observed, including a potential imine. As a one-step 
synthesis appeared out of reach, a two-step solution was sought.
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Scheme 2.76
62 and 97 were stirred in DCM with 9 mol% PTSA at room temperature for 66  hours 
(Scheme 2.76). A aqueous workup was performed to remove the PTSA and the crude was 
subjected to  column chromatography, providing 98 in 36% yield.
B n ^ N ^ C C I 3 *yT H F ,N 2, Bn N 
rt, 22 h
98 96
Scheme 2.77
98 and iron(lll) chloride were stirred in dry THF under nitrogen at room temperature 
for 22 hours. The crude was taken up in diethyl ether and washed w ith water and brine.
Upon evaporation, no residue was obtained, indicating the products were lost in the aqueous 
layers (Scheme 2.77).
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Scheme 2.78
98 and 14 mol% PTSA were refluxed in IPA for 16 hours (Scheme 2.78). After aqueous 
workup, the resultant mixture was seen to contain a mixture of products, none of which 
appeared to  be 96. 98 appeared to have a marked propensity fo r decomposing rather than 
cyclising. No further efforts towards 96 were performed.
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2.10 Conclusions
Br
89 78 90 91 30
Figure 2.79
Before the research in this chapter was conducted, an upper lim it to the strength of 
EWGs capable of being incorporated into a functioning imidazolidinone catalyst had not been 
envisaged, and it was imagined that performance might scale linearly w ith EWG strength.
This has now been proven false and the fatal effect of the trifluoromethyl group upon an 
imidazolidinone's catalytic ability has been established by the synthesis and evaluation of 89, 
78, 90, and 91 (Figure 2.79). 30, which was previously seen as a desirable target, is still 
believed to be synthetically accessible yet now believed to be catalytically inactive.
A novel synthetic route capable of furnishing previously unreported imidazolidinones 
in good yields has been developed (Scheme 2.80). Ytterbium(lll) trifla te was found to catalyse 
the condensation of 62 and 79 in refluxing chloroform providing 84 in up to 63% yield. TFA 
was found to  catalyse the condensation of 62 and 92 in chloroform at room temperature, 
giving quantitative conversion to 93. Both 84 and 93 were found to cyclise in the presence of 
copper(ll) trifla te under microwave irradiation to provide 78, 89, 91, and 90, in 34%, 29%,
13% and 14% isolated yield, respectively. A search of the literature revealed that, to  date, 
this work represents the first general purpose route to 2-fluoroalkylated imidazolidinones. 
The experience and knowledge gained in imidazolidinone synthesis should allow for access to 
a wider range of target structures and permit greater freedom in catalyst design.
TFA/Yb(OTf)3 Cu(OTf)2
MW, dry CH3CN
62 79 R = Ph 
92 R = CH3
84 R = Ph (63%)
93 R = CH3 (100%)
78 R1 = Ph, R2 = CF3 (34%)
89 R1 = CF3, R2 = Ph (29%) 
91 R1 = CH3, R2 = CF3 (13%)
90 R1 = CF3, R2 = CH3 (14%)
Scheme 2.80
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2.11 Further Work
Bn >cf3 Bn*' 'N  CH2F BnH H
c h f 2
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7 91 99 100
Figure 2.81
7 is a functioning, albeit slow, catalyst. It has now been established that 91, 
possessing a trifluoromethyl EWG is bereft of catalytic activity in the presence of hydrogen 
chloride as a co-acid (Figure 2.81). An obvious line of research would therefore be to 
synthesise 99 and 100, adapting existing synthetic procedures as necessary.
While unlikely to  possess catalytic activity, 30 is expected to  be a stable compound 
and might be attainable via dehydrating of 64 (Scheme 2.82). This would present the first 
general synthesis of such a heavily fluorinated imidazolidione and could allow the formation 
of differentially substituted 2,2-bis(trifluoromethyl)imidazolidinones, which, being 
deactivated mimics of imidazolidinone rings, may have potential in pharmaceutical design.
o
30 64
Scheme 2.82
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Chapter 3: Direct Comparison of Imidazolidinone 
and Diarylprolinol Ether Reactivity
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3 Direct Comparison of Imidazolidinone and Diarylprolinol Ether 
Reactivity
3.1 Attribution
The experimental work within this chapter was performed largely by Ronan 
Pommereuil, an Erasmus project student working under my supervision.
3.2 Introduction
Ar = 3,5-(CF3)2C6H6
7 11 10
Figure 3.1
For catalysing the Diels-Alder reaction, 7 is the preferred imidazolidinone and 11 is 
the preferred diarylprolinol ether catalyst (Figure 3.1).47'48 The goal of the work documented 
within this chapter was to perform a fair comparison of 7 and 11 and determine which 
architecture holds the most promise for accelerating Diels-Alder reactions. 10 has seen use in 
catalysing asymmetric Michael reactions and was included fo r the sake of comparison 49
3.3 Catalyst Acquisition
4 mol% PTSA
CH3OH, 
reflux, 20 h
62 101 7 7HCI
Scheme 3.2
62 was refluxed in methanol with an excess of acetone and catalytic PTSA for 16 
hours to provide 7 in 95% yield (Scheme 3.2). Treatment of an ethereal solution of 7 with 
hydrogen chloride gas yielded 7-HCI (71%).
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Scheme 3.3
Catalyst 10 was obtained commercially. Upon treatment of an ethereal solution of 10 
with hydrogen chloride gas, a mixture of 10 HCI and 102HCI was obtained (Scheme 3.3).
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11 Ar = 3.5-(CF3)2C6H3 11HCI 103-HCI
Scheme 3.4
Catalyst 11 was also obtained commercially. Upon treatment of an ethereal solution 
of 11 w ith hydrogen chloride gas, partial deprotection of the silyl ether occurred and a 
mixture of 11-HCI and 103 HCI was returned (Scheme 3.4).
3.4 Experiment Design
2.5 eq. 93% ee 93% ee
In his seminal paper on the organocatalysed Diels-Alder reaction, MacMillan showed 
7-HCI to be his catalyst of choice.2 7-HCI was shown to catalyse the reaction between 5 and 6 
at 23 °C in 19:1 methanohwater to yield 8  (93% ee) and 9 (93% ee) in 99% combined yield in 
8 hours (Scheme 3.5).
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Scheme 3.6 86%
As published by Hayashi in 2007,10 mol% 11 and 20 mol% TFA catalysed the reaction 
between 5 and 6  in toluene at room temperature in 20 hours to yield 8 (83% ee) and 9 (95% 
ee) in 86% combined isolated yield (Scheme 3.6).47
The differing conditions used by MacMillan and Hayashi prompted the design of a 
comparison that would be fair to both architectures. The most comprehensive comparison 
would be the use of 7-HCI, 10-HCI and 11-HCI in both 19:1 methanol:water and in toluene, as 
well as the use of 7,10 and 11 in conjunction with 2 equivalents of TFA in 19:1 
methanokwater and in toluene. Unfortunately, the failure of 10 and 11 to  form 
hydrochloride salts w ithout partial loss of the TMS protecting group meant that only 7 could 
be used as its hydrochloride salt.
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3.5 Experimental Results
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Figure 3.7
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Figure 3.9
Ph
♦  7*2TFA in PhCH3 
a 7»2TFA in CH30H/H20  
A7»HCI in CH30H/H20  
+ 11*2TFA in PhCH3
•  11»2TFA in CH30H/H20  
-7*HCI in PhCH3 
O10*2TFA in PhCH3
Catalyst Solvent 9 ee 8  ee
7-2TFA 19:1CH30H:H20 93 96
7-HCI 19:1 CH30H:H20 93 93
11-2TFA 19:1 CH30H:H20 90 95
11-2TFA PhCH3 91 89
7-2TFA PhCH3 86 89
Figure 3.10
All reactions were run at 25 °C for 6 hours, at 0.5 M 5 concentration, with 2.5 
equivalents of 6 and 10 mol% catalyst or catalyst hydrochloride loading (Scheme 3.8). Where 
needed, TFA was used at 20 mol% loading. For the reactions performed in 19:1 
methanokwater, aliquots were taken at periodic intervals and worked up as per the
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benchmark Diels-Alder procedure (see Chapter 10.2 for full details). For reactions performed 
in toluene, the hydrolysis step was omitted and aliquots were subjected directly to a basic 
workup then the diethyl ether evaporated and relative aldehyde concentrations determined 
by *H NMR.
3.6 Analysis
The low performance of 10-2TFA in toluene (O) was surprising, especially when 
compared to the much higher performance of 11-2TFA in the same solvent system (+). It 
appeared that the four trifluoromethyl EWGs had a very pronounced effect on the 
performance of the diarylprolinol architecture. Due to  the low performance shown by 10 in 
this system, no attempts were made to measure product ee's. 10's performance in the 19:1 
methanokwater system was not investigated.
11-2TFA showed higher performance and also greater enantiocontrol when used in 
toluene (+) than when used in 19:1 methanokwater (•). Its turnover in toluene was far higher 
than that achieved by 10-2TFA (O) yet still lower than that achieved by 7-2TFA in toluene (♦ )  
and 19:1 methanokwater (A ) and 7-HCI in 19:1 methanokwater (a ).
The poor performance of 7-HCI in toluene (-) was expected, as it showed very little  
solubility in this medium. Accordingly, no attempt to  determine product ee's was 
undertaken. In 19:1 methanokwater, 7-HCI was readily soluble and demonstrated good 
turnover and good enantiocontrol (A).
7-2TFA in 19:1 methanokwater (A ) showed higher turnover than 7-HCI in the same 
solvent (a ), and also exhibited greater enantiocontrol.
7-2TFA in toluene (♦ )  showed the highest turnover of all systems tested, but also 
exhibited lower levels of enantiocontrol than any of the other systems for which ee's were 
measured.
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3.7 Conclusions
Ar = 3,5-(CF3)2C6H6
7 11 10
Figure 3.11
The results indicated that 7 consistently attained higher turnover and greater 
enantiocontrol than 11, the favoured prolinol-based catalyst (Figure 3.11). This reinforced 
the choice of the imidazolidinone architecture as the main target of investigations carried out 
in this project.
Most interestingly, the conditions published by MacMillan for use of 7 were found to be 
suboptimal for the Diels-Alder reaction used in our investigations. 7-2TFA in 19:1 
methanokwater was seen to exhibit higher turnover and greater enantiocontrol than 7-HCI in 
the same solvent system. As no rationale for the effects of co-acid and solvent system has 
been devised, it is quite possible that a brute force screening of reaction parameters could 
find a still more optimal system for the use of 7 in the reaction between 5 and 6 .
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Chapter 4: High-Performance Imidazolidinones
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4 High-Performance Imidazolidinones
4.1 Introduction
7 91 90
Figure 4.1
The primary goal of this project was to develop a catalyst for iminium-ion catalysed 
reactions that was both fast and selective. Benchmark catalyst 7 displayed high levels of 
enantiocontrol and it was thought that by adding EWGs, a turnover increase could be 
attained (Figure 4.1). In Chapter 2.7, the synthesis of 91 and 90 was described. 91-HCI and 
90-HCI were prepared but were found to be inactive in the benchmark Diels-Alder reaction. It 
was believed that the trifluoromethyl EWG rendered 91 and 90 insufficiently nucleophilic to 
form iminium ions.
Previous work within the group had found 33 to be a powerful catalyst (Figure 4.2). 
10 mol% of 33-HCI was found to catalyse the reaction between 5 and 3 equivalents of 6 in 
19:1 methanokwater at 25 °C, achieving 78% conversion to 8  (6 8 % ee) and 9 (34% ee) in 3 
hours (Scheme 4.3).30 Although this catalyst exhibited poor stereocontrol, the rate of 
conversion was significantly higher than that of 7. Synthesis and re-evaluation of 33 and its 
diastereomer 104 appeared a suitable starting point for the work within this chapter.
33 104
Figure 4.2
10 mol% 33-HCI
19:1
CH3OH:H20,
O
5 6
3 eq.
25 °C, 3 h
8 9
68% ee 32% ee
Scheme 4.3 78%
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4.2 EWG Imidazolidinone Synthesis
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Scheme 4.4
Using the method discovered previously within the group, 62,105 and 12 mol% PTSA 
in DMF were subjected to microwave irradiation at 120 °C for 30 minutes (Scheme 4.4). After 
a basic aqueous workup to remove PTSA and DMF, 1H NMR showed the crude to  contain 
mainly 106. 33 and 104 were present in small amounts, but isolation was not attempted.
62.105 and 12 mol% PTSA in DMF were subjected to  microwave irradiation at 120 °C 
for 60 minutes. 1H NMR of the crude showed that the extended reaction time had increased 
conversion to 33 and 104 but the continued presence of 106 rendered purification by column 
chromatography troublesome.
62.105 and 13 mol% PTSA in DMF were subjected to  microwave irradiation at 150 °C 
for 60 minutes. 1H NMR of the crude showed increased presence of 33 and 104 when 
compared to previous experiments. Column chromatography was attempted using 95:4:1 
DCM:CH3 0 H:Et3N but streaking was observed and neither 33 nor 104 could be obtained pure 
using this eluent system.
C U .N H  \  /o y n y—n
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62 105 106 33 104
2M HCI
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Scheme 4.5
The reaction was repeated when 62, 105 and 10 mol% PTSA in DMF were irradiated 
at 120 °C for 120 minutes (Scheme 4.5). The crude showed relatively clean conversion to 33 
and 104 with 106 present in small amounts. In an attempt to  hydrolyse 106, the crude was 
stirred in 1:1 THF:hydrochloric acid (4 M) for an hour. Unfortunately, 106 remained intact.
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Scheme 4.6
Before further attempts towards a one-step synthesis of 33 were undertaken, it was 
discovered that stirring 62 and 105 over magnesium sulphate in DCM for 24 hours resulted in 
complete conversion to 106 (Scheme 4.6).
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Scheme 4.7
106 and 12 mol% PTSA in DMF were irradiated at 140 °C for 60 minutes (Scheme 4.7). 
1H NMR of the crude showed the presence of 33 and 104 as well as traces of side products. 
After column chromatography, 33 (50%) and 104 (18%) were obtained.
To investigate the effect of raising the temperature, 106 and 11 mol% PTSA in DMF 
were irradiated at 150 °C for 60 minutes. 1H NMR of the crude showed the presence of 33 
and 104 as well as small amounts of side products. After column chromatography, 33 (41%) 
and 104 (24%) were obtained.
It was suspected that the reaction would proceed more cleanly at a lower 
temperature. 4.5 g of 106 and 11 mol% PTSA in DMF were irradiated at 130 °C for 60 minutes. 
1H NMR of the crude showed very clean conversion to 33 and 104. Column chromatography 
yielded 33 (41%) and 104 (35%) in quantities sufficient for evaluation.
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Scheme 4.8
To determine whether the whole reaction was reversible and hence under 
thermodynamic control, 33 was subjected to microwave irradiation at 140 °C for 60 minutes 
in DMF in the presence of 11 mol% PTSA (Scheme 4.8). The 1H NMR spectra of the crude 
showed the presence of 33 and 104 in a 1.2:1 ratio and showed that under these conditions, 
the cyclisation step was reversible.
Having produced sufficient quantities of 33 and 104, the next step was to form the 
hydrochloride salts. A rapidly stirred etheric solution of 33 was treated with hydrogen 
chloride gas for 5 minutes before the precipitate was washed with excess diethyl ether and 
dried in vacuo to yield 33-HCI (85%) as a yellow solid (Scheme 4.9).
33
85%
33HCI
Scheme 4.9
104 104-HCI
85%
Scheme 4.10
An etheric solution of 104 was treated with hydrogen chloride gas for 5 minutes and 
the product isolated in the same manner as used for 33-HCI. 104-HCI was obtained as a white 
solid (85%) (Scheme 4.10).
4.3 Quantifying the Background Reaction
CHztyaq), NaBH3CN
7 107 107-HCI
81%
Scheme 4.11
While it was assumed that Diels-Alder reactions catalysed by imidazolidinone 
hydrochlorides proceed exclusively via iminium ions, this had never been conclusively shown 
and no efforts had been undertaken to  quantify the background reaction. To remedy this 
omission, synthetic efforts were made towards 107, a structural analogue of 7 incapable of 
forming iminium ions yet still capable of effecting acid catalysis and forming aminols. 7-HCI 
was stirred with sodium cyanoborohydride in 37% aqueous formaldehyde for 67 hours at 
room temperature. After basic workup and extraction with diethyl ether, 107 was obtained. 
107 was found to  rapidly turn pink when exposed to  the air, necessitating immediate 
conversion to the more stable 107-HCI (81% overall) via the usual method (Scheme 4.11).
19:1
CH30H:H20,
2.5 eq. 4%
Scheme 4.12
5 mol% of 107-HCI was used in the benchmark Diels-Alder reaction between 5 and 6 
in 19:1 methanokwater at 25 °C. After 6 hours, an aliquot was taken and the standard 
procedure used to determine that the combined conversion to  7 and 8  was 4% (Scheme 
4.12).
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4.4 Catalytic Performance
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Figure 4.15
5 and 2.5 equivalents of 6 in 19:1 methanol:water were stirred with 5 mol% of 7-HCI, 
33-HCI, or 104-HCI for 6 hours at 25 °C (Scheme 4.13). Periodic aliquots were taken, worked 
up according to  the benchmark procedure, and conversion determined by XH NMR (Figure 
4.14). After the 4 hours had elapsed, 8  and 9 were isolated as per the benchmark procedure. 
8  and 9 were converted to their 2,4-DNPH adducts, which were subjected to HPLC to 
determine their enantiopurities (Figure 4.15).
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4.5 Performance Analysis
The results showed that both 33 and 104 achieved higher conversions than 
benchmark catalyst 7. The reactions catalysed by 33-HCI and 104-HCI attained completion in 
approximately 2 hours, whereas 7-HCI effected only 50% conversion after 4 hours. 
Additionally, while experimental errors were not quantified, it may be tentatively asserted 
that 104 is a more efficient catalyst than 33 under the conditions examined.
In terms of enantiocontrol, 7 clearly outperformed 33 and 104. The scale of the 
difference indicated that 33 and 104 must have glaring design flaws.
Interestingly, the background reaction, as quantified using 107-HCI, may be expected 
to play a larger role in lowering the ee's of 7 than 33 and 104, due to the lower reactivity in 
iminium ion catalysed reaction pathways. This suggested that for an imidazolidinone to attain 
higher levels of enantiocontrol than 7 in the benchmark reaction, high turnover would be 
essential.
18.E 18.Z 108.Z 109.Z
Figure 4.16
As first proposed in MacMillan's seminal paper, exclusive formation of 18.E is 
considered to be a critical part of 7's stereocontrol (Figure 4.16).2 Formation of 18.Z was 
thought to be disfavoured by steric hindrance between the proton a- to the iminium carbon 
and the geminal dimethyl groups of the imidazolidinone ring. Lacking the same degree of 
steric differentiation between the 2- and 5-positions, 33 and 104 may be expected to more 
readily form 108.Z and 109.Z, respectively. Upon reaction with 6 ,108.Z would be expected to 
generate undesired enantiomers and lower the overall product ee. 109.Z can be viewed as a 
pseudo C2-symmetric iminium ion and this may explain the higher selectivity observed. The 
precise reasons for the lower selectivity than 7 were not apparent at this stage.
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4.6 Methyl Analogue Synthesis
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Scheme 4.17
If the rationale for the poor stereocontrol exhibited by 33 and 104 was accurate, the 
obvious solution to enhancing the enantiocontrol of these catalysts would be to increase 
steric bulk around the 2-position. This line of thinking gave rise to target structures 110 and 
111, analogues of 33 and 104 that should be obtainable via an analogous synthesis 
employing 112 (Scheme 4.17).
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Scheme 4.18
Using the same methodology as developed to synthesise 106, 62 and 112 were stirred 
over magnesium sulphate in DCM (Scheme 4.18). After 24 hours at room temperature, 
analysis by 1H NMR showed only the presence of starting materials.
b" y v  +
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Scheme 4.19
N02
The use of 3A molecular sieves in DCM had also been observed to catalyse formation 
of 106. 62 and 112 were stirred over 3A molecular sieves in DCM for 169 hours at room 
temperature (Scheme 4.19). 1H NMR showed only the presence of starting materials.
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Scheme 4.20
N02
In Chapter 2.5, the utility of Lewis acids in catalysing imine formation was discovered. 
It was thought that Lewis acids may also assist in formation of 113. To this end, four reactions 
were performed using the Lewis acids gallium(lll) trifla te 86 , ytterbium(lll) triflate, indium(lll)
63
triflate and yttrium (lll) triflate. In each case, 62, 112 and 10 mol% metal(lll) trifla te  were 
stirred over 3A molecular sieves in DCM for 21 hours, after which an aqueous workup was 
performed and reaction progress observed by 1H NMR. In all cases, it was found that only 
traces of 113 had been formed (Scheme 4.20).
10 mol% M(OTf)3. 
3AMS
CH3CN, 
rt, 22 h
M Conversion
Ga 16%
Yb 13%
In 10%
Y 5%
Scheme 4.21
Noting the low solubility of the metal complexes in DCM, 62, 112 and 10 mol% 
metal(lll) trifla te were stirred over 3A molecular sieves in acetonitrile for 22  hours (Scheme 
4.21). Aqueous workups were performed and conversion determined by 1H NMR. The results 
indicated that gallium(lll) trifla te 86  was the most suitable catalyst for 113 formation but that 
its conversion under these conditions was not high enough to  render isolation of 113 an 
attractive option.
Bn +  ^  23 mol% PTSA
NH2 n  DMF,
° 2N 140 °C, 180 min
62 112 110 111
11% 12%
Scheme 4.22
As formation of 113 appeared difficult, a one-step synthesis of 110 and 111 was 
attempted. 62, 112 and 23 mol% PTSA in DMF were subjected to microwave irradiation at 
140 °C for 180 minutes (Scheme 4.22). After column chromatography, 110 (11%) and 111 
(12%) were isolated and converted to 110HCI and 111-HCI by the usual method.
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Figure 4.24
To gain further insight into this transformation, 62, 112 and 10 mol% PTSA in DMF 
were subjected to microwave irradiation at 130 °C fo r 240 minutes (Scheme 4.23). Aliquots 
were taken every 60 minutes, extracted w ith diethyl ether and washed w ith water to remove 
the ytterbium (lll) triflate. 1H NMR was then used to assay the relative proportion of each of 
the four analytes 110-113 (Figure 4.24). 62 was not observed, due to it being lost in the 
aqueous factions.
Results showed that the reaction appeared to  be under thermodynamic control, 
reaching equilibrium after approximately 2 hours. As large amounts of 112 were present at 
equilibrium, it was surmised that the equilibrium could be driven towards the right by 
employing a desiccant such as molecular sieves. Unfortunately, molecular sieves were found 
to be incompatible w ith the microwave reactors used in this project and no investigation of 
alternative desiccants was performed.
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4.7 Acetophenone Analogue Performance
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Figure 4.27
5 and 2.5 equivalents of 6  in 19:1 methanol.water were stirred with 5 mol% of the 
catalyst hydrochloride for 4 hours at 25 °C (Scheme 4.25). Periodic aliquots were taken, 
worked up as per the benchmark procedure, and conversion determined by 1H NMR (Figure 
4.26). After the 4 hours had elapsed, 8  and 9 were isolated as per the benchmark procedure 
and converted to  their 2,4-DNPH adducts for ee determination by HPLC (Figure 4.27).
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4.8 Acetophenone Analogue Analysis
Previously, it was proposed tha t 33 and 104 exhibited poor enantiocontrol due to 
their lack of selectivity in forming iminium ions and that increasing steric bulk around the 2- 
position would lead to improved stereocontrol. This hypothesis appeared to be validated, as 
110 and 111 were seen to exhibit far greater enantiocontrol than 33 and 104.
Pleasingly, while 110 and 111 showed lower performance than 33 and 104, they still 
retained a large performance advantage over 7.
Particularly noteworthy was 110's concurrent exhibition of high performance and 
good enantiocontrol, a previously unseen combination. It was evident that if the 
enantiocontrol could be improved, 1 10  would show comprehensively better catalytic 
performance than 7 in the benchmark Diels-Alder reaction, completing one of the stated 
goals of this project.
4.9 Non-EWG Imidazolidinone Synthesis
During the course of this work, only one non-EWG catalyst, 7, had been evaluated 
(Figure 4.28). It was decided that 114 and 115 should be synthesised and evaluated, to 
ascertain the effect of small structural changes on the turnover and stereoselectivity of the 
Diels-Alder reaction. 2 has been reported by MacMillan fo r use in conjugate additions and 
the performance of this catalyst in the benchmark Diels-Alder reaction was also deemed 
worthy o f investigation.
7 114 115 2
Figure 4.28
6 mol% PTSA
62 116 114
48%
Scheme 4.29
62, 116 and 6 mol% PTSA were refluxed in IPA fo r 18 hours and column 
chromatography used to provide 114 (48%) (Scheme 4.29). The usual procedure for forming 
hydrochloride salts yielded 114-HCI (41% overall).
V Y  + cfc
MM - I------1nh2
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Scheme 4.30
62, 117 and 14 mol% PTSA were stirred in IPA at 75 °C for 18 hours (Scheme 4.30). 
The recovered material consisted largely of 62, with 117 presumed to have evaporated. This 
indicated that more energy would be required to form 115.
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NH2
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24 mol% PTSA
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140 °C, 50 min
117
Scheme 4.31
62, 117 and 24 mol% PTSA in DMF were subjected to microwave irradiation at 140 °C 
for 50 minutes (Scheme 4.31). Aqueous workup and column chromatography yielded 115 
(40%). The standard method for forming hydrochloride salts yielded 115-HCI (76%, 30% 
overall).
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/
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2 eq. 22%, >99% ee
Scheme 4.32
Using conditions developed in Chapter 5.11, 62 and 118 were refluxed with 1 mol% 
ytterbium(lll) trifla te in chloroform for 8 hours (Scheme 4.32). Column chromatography 
yielded 2 (22%, >99% ee), which was converted to 2-HCI by the usual method.
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4.10 Non-EWG Evaluation
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Figure 4.35
5 and 2.5 equivalents of 6 in 19:1 methanokwater were stirred with 5 mol% of the 
catalyst hydrochloride for 6 hours at 25 °C (Scheme 4.33). Periodic aliquots were taken, 
worked up as per the benchmark procedure, and conversion determined by XH NMR (Figure 
4.34). After the 4 hours had elapsed, 8  and 9 were isolated as per the benchmark procedure 
and converted to their 2,4-DNPH adducts for ee determination by HPLC (Figure 4.35).
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4.11 Non-EWG Analysis
114 and 115 exhibited good stereocontrol, attaining ee's very close to those of 7 but 
with exo ee's substantially less than that of 7. 2 exhibited very poor stereocontrol. While the 
reasons for its poor stereocontrol are not understood, the large discrepancy between endo 
and exo ee's indicates that if E/Z selectivity is lacking, it is only part of the problem.
2, 7 and 115 showed similar levels of turnover. 114 showed very low turnover, less 
than half that of 7. This result was very surprising, considering the structural similarity of 114 
to 7 and 115 and its almost identical enantiocontrol to 115.
These results showed an apparent performance ceiling for catalysts lacking EWGs. 
They also showed that subtle changes to a catalyst's structure can have dramatic and 
unforeseen effects on its performance.
4.12 Changing the EWG - Synthesis
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110 119 121 123 125
R1 ch 3 ch 3 ch 3 ch 3 ch 3
R2 p -n o 2c6h4 p-ch 3o c 6h4 C6H5 p-cic6h4 p-(NC)C6H4
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R1 p -n o 2c6h4 p-CH3OC6H4 c6H5 p-cic6h4 p-(NC)C6H4
R2 ch 3 ch 3 ch 3 c h 3 ch 3
Scheme 4.36
At this stage of the project, a catalyst 110 had been discovered that exhibited high 
performance in the benchmark reaction as well as good levels of stereocontrol. Lacking a 
clear understanding of how to produce more selective catalysts that retained the high 
performance of 110 , it was decided to synthesise a range of analogues based on differentially 
para-substituted acetophenones (Scheme 4.36). This would allow for a more detailed 
investigation of the effect of EWGs on catalyst turnover and perhaps also the discovery of a 
high performance catalyst with higher levels of enantiocontrol than benchmark catalyst 7 .
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62,127 and 12 mol% PTSA were stirred in DCM over BA molecular sieves for 26 hours 
at room temperature (Scheme 4.37). This reaction produced only traces of 128 and it was 
decided that 119-126 should be obtained by direct reaction of 62 and the relevant 
acetophenone.
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19 md% PTSA
 * ------------► Bn
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140 °C, 60 min
Scheme 4.38
121 122
62, 127 and 19 mol% PTSA in DMF were irradiated at 140 °C for 60 minutes (Scheme 
4.38). *H NMR showed a large number of unassignable peaks, indicating decomposition to 
have occurred.
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Scheme 4.39
Thermal conditions were then investigated. IPA appeared an obvious choice of 
solvent, due to its high boiling point, hydrogen bonding ability and reluctance to form acetals 
with ketones. In a successful synthesis, 62, 127 and 6 mol% PTSA were refluxed in IPA over 
3A molecular sieves for 88  hours (Scheme 4.39). Basic workup and column chromatography 
yielded 121 (23%) and 122 (30%). Submitting 121 and 122 to  the standard procedure for 
forming hydrochloride salts yielded 121-HCI (89%) and 122-HCI (82%).
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62, 129 and 5 mol% PTSA were refluxed in IPA over 3A molecular sieves for 66  hours 
(Scheme 4.40). NMR of the crude showed 119,120 and 130 to be present in a 14:7:1 ratio 
and an overall 87% yield. Column chromatography was not performed.
Bn A  .  5 mol% PTSA, OCH3 -OCH3
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Scheme 4.41
It appeared that refluxing IPA provided insufficient thermal energy to  completely 
cyclise 130. 62,129 and 5 mol% PTSA were refluxed in toluene over 3k  molecular sieves for 
39 hours (Scheme 4.41). The 1H NMR spectra of the crude appeared to  show higher 
conversion to 119 and 120 than observed in the previous reaction. Column chromatography 
was performed and yielded 119 (19%) and 120 (51%). The usual procedure for forming 
hydrochloride salts was followed, yielding 119 HCI (66%) and 120-HCI (80%).
Rn II . 11 10 mol% PTSA,Yfl + ifj 3AMS
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Scheme 4.42
62,131 and 10 mol% PTSA were refluxed in IPA over 3A molecular sieves for 66  hours 
(Scheme 4.42). *H NMR of the crude showed 123 and 124 to be present. Column 
chromatography was not performed.
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Scheme 4.43
Three reactions were performed whereupon 62, 131 and 20 mol% PTSA in DMF were 
subjected to  microwave irradiation for 60 minutes, with reaction temperatures of 120 °C, 130 
°C and 140 °C (Scheme 4.43). Total conversion of 131 to  123 and 124 was assayed by 1H NMR 
of the crude after aqueous workup to remove the catalytic acid and DMF. 62 was known to  
be partially water soluble and would be lost during aqueous workup. When the reaction was 
performed at 130 °C and 140 °C, 123 and 124 were present in a 1:1.0 ratio.
4.13 Thermal Syntheses
At this point, before further work could be carried out, both the microwave reactors 
used so far in this project became unavailable and alternative facilities could not be sourced. 
The synthesis of 119-126 was a pressing concern and further investigation of thermal 
conditions was necessitated.
Whereas 121 and 122 would form readily in refluxing IPA (Scheme 4.45), the other 
imidazolidinones appeared to require more forcing conditions. 110  and 111  appeared to be 
the hardest to form and their synthesis was used as a worst case scenario in developing a 
universal thermal synthesis that may also be used to prepare 119-126.
Efforts were centered around the potent and commercially available Lewis acid, 
ytterbium(lll) triflate, as it appeared to more effective than PTSA for imidazolidinone 
formation.
n O
CHCI3, 
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62 112
Scheme 4.44
62, 112  and 6 mol% ytterbium(lll) triflate were refluxed in chloroform for 65 hours 
(Scheme 4.44). After aqueous workup to remove the catalyst, 1H NMR showed partial 
conversion of 112 to 113 but not 110 or 111.
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62, 112 and 6 mol% ytterbium(lll) trifla te  were refluxed in acetonitrile for 16 hours 
(Scheme 4.45). 1H NMR showed partial conversion of 112 to 113 but not 110 or 111.
Bn N'' _LH '
n h2
62
o2n
5 mol% Yb(OTf)3
IPA, 
reflux, 16 h
112 110 111
Yb(OTf)3 (mol%) Solvent Conditions 110 (%) 111 (%)
5 IPA reflux, 16 h - -
12 PhCH3 reflux, 22 h, N2, 3A MS 28 26
8 PhCH3 reflux, 40 h, N2, 3A MS 35 35
Scheme 4.46
62, 112 and 5 mol% ytterbium(lll) trifla te were refluxed in IPA for 16 hours (Scheme 
4.46). 1H NMR showed 110 and 111, but in quantities too low to  be useful.
62,112 and 12 mol% ytterbium(lll) trifla te were refluxed in toluene for 22  hours over 
3A molecular sieves and under nitrogen. 1H NMR of the crude showed good conversion. 
Column chromatography then provided 110 (28%) and 111 (26%).
The reaction was scaled up as 62 (2.5 g) and 112 (2.2 g) were refluxed with 8 mol% 
ytterbium(lll) trifla te over 3A molecular sieves and under nitrogen in toluene for 40 hours. 
Column chromatography provided 110 (36%) and 111 (35%).
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It was anticipated that 123 and 124 may present difficulties, due the potential for 62 
and 131 to undergo a SNAr reaction, yielding 132 (Scheme 4.47). 62, 131 and 8 mol% 
ytterbium(lll) triflate were refluxed in toluene for 65 hours over 3A molecular sieves and 
under nitrogen (Scheme 4.48). Column chromatography then provided 123 (36%) and 124 
(36%).
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Scheme 4.49
62, 129 and 8 mol% ytterbium(lll) trifla te were refluxed in toluene for 65 hours over 
3A molecular sieves and under nitrogen (Scheme 4.49). Column chromatography then 
provided 119 (29%) and 120 (39%).
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Scheme 4.50
62, 127 and 8  mol% ytterbium(lll) trifla te were refluxed in toluene for 40 hours over 
3A molecular sieves and under nitrogen (Scheme 4.50). Column chromatography then 
provided 121 (33%) and 122 (28%).
3 mol% Yb(OTf)3
toluene, 
reflux, 18 h
62, 133 and 3 mol% ytterbium(lll) trifla te were refluxed in toluene for 18 hours 
(Scheme 4.51). Column chromatography provided 125 and 126, which were converted to 
125-HCI (21% overall) and 126 HCI (19% overall) by the usual method.
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4.14 Performance Evaluation
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Figure 4.54
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110 125 123 121 119 7
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Figure 4.56
5 and 2.5 equivalents of 6 in 19:1 methanokwater were stirred with 5 mol% of the 
catalyst hydrochloride salts for 6 hours at 25 °C (Scheme 4.52). Periodic aliquots were taken, 
worked up as per the benchmark procedure, and conversion and 8:9 determined by 1H NMR. 
After the 4 hours had elapsed, 8 and 9 were isolated as per the benchmark procedure and 
converted to their 2,4-DNPH adducts for ee determination by HPLC.
4.15 Performance Analysis
The turnover order amongst the (2S,5S) catalysts was 111 = 126 = 124 > 122 > 120, 
showing a correlation between stronger EWGs and higher performance within this data set 
(Figure 4.53).
Turnover amongst the (2R,5S) catalysts was harder to  judge, as all reactions had 
almost attained completion after 2 hours (Figure 4.55). The performance order was 123 « 
125 > 110 ~ 121 > 119, suggesting that in this case EWGs were beneficial up to  a point, 
beyond which performance again decreased.
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The superior enantiocontrol of the (2R,5S) catalysts over the (25,55) catalysts was 
pronounced (Figure 4.54, Figure 4.56). While 111 was an exception, 120, 122, 124 and 126 
attained poor product ee's.
8:9 was seen to be relatively consistent across both series and did not vary 
substantially during the course of each reaction. While the limited data in MacMillan's 
seminal paper suggests that endo.exo ratios may be highly substrate dependant, it is pleasing 
to note that 121  generated a slight predominance of 8 , in which it imparted greater 
enantiocontrol (96%).
Ultimately, while 8 more catalysts, 119-126 had been synthesised and evaluated, 110 
remained the catalyst of choice due to its high performance and good enantiocontrol.
4.16 Catalyst Enantiopurity
The inability of any of the catalysts discovered thus far to  attain the desired level of 
enantiocontrol forced further consideration of the situation. It was noted that no assessment 
of the enantiopurity of the catalysts themselves had been performed and that in light of the 
harsh conditions required for their formation, epimerization of the stereocenter a- to the 
amidic carbonyl was a very real possibility.
Bn
NH2
62
0 2N
112
9 mol% PTSA, 
3AMS
N2, toluene, 
reflux, 64 h
Scheme 4.57
110
32%
Racemic 62, 112 and 9 mol% PTSA were refluxed in toluene over 3A molecular sieves 
and under nitrogen for 64 hours (Scheme 4.57). Column chromatography provided racemic 
110 (32%). The other diastereomer was not isolated. Racemic 110 was found to separate on 
a Chiralcel OJ column using a 9:1 hexanes:IPA mobile phase at a flow rate of 1.5 mL min"1 (t = 
52.0 min, 61.9 min).
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110 HCI 110
94% ee
K2C 0 3(aq)
EtOAc
Scheme 4.58
A sample of the 110 HCI used in the benchmark reaction was converted to 110 by 
shaking with ethyl acetate and 4M potassium carbonate (Scheme 4.58). This was subjected 
to HPLC and its ee found to be 94%. This showed that enantiocontrol in the benchmark 
reaction had the potential to improve markedly if optically pure 110-HCI could be obtained.
4.17 Recrystallisation attempts
recry st.
110-HCI 1 10-HCI
Scheme 4.59
Recrystallisation of 110-HCI appeared an obvious way to improve its enantiopurity. 
110-HCI was found to be highly soluble in methanol, acetonitrile and DCM, yet insoluble in 
hexanes, ethyl acetate, diethyl ether, toluene and water. Slow cooling and slow evaporation 
at room temperature both failed to produce a crystalline product (Scheme 4.59). In every 
case, 110-HCI was obtained as an amorphous residue and was found to have an ee identical 
to that of the starting 110-HCI.
110-HCI 121-HCI 119-HCI
Figure 4.60
After the work in this chapter had been completed, crystals of 110-HCI were seen to 
have formed in one of the vials set up as part of recrystallisation attempts. After careful 
washing of the crystals, X-ray crystallography was used to confirm the structure and
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stereochemistry of 110-HCI (Figure 4.60). *H NMR showed the crystals to be chemically 
identical to a fresh sample of 110-HCI. X-ray crystallography was also used to confirm the 
structures of 121-HCI and 119-HCI, both of which were found to crystallise readily upon 
evaporation of DCM:hexanes solutions.
4.18 Amino Amide Recrystallisation
Nh, o W  Boo. nh
62 49 75
Scheme 4.61
Having failed to directly boost the enantiopurity of 110-HCI, investigations were 
turned towards reducing epimerisation during its synthesis. Accordingly, the first step was 
deemed to be the investigation of the optical purity of 62. Separation of 62 on the HPLC
could not be achieved. As such, racemic 62 and 49 were stirred in DCM for 22 hours and an
aliquot of the solution containing racemic 75 subjected to HPLC (Scheme 4.61). It was found 
to separate on the Chiralcel OJ column using a 39:1 hexanes:IPA mobile phase at a flow rate 
of 1.5 mL min 1 (t = 7.1 min, 11.8 min). Subjecting previously synthesised batches of 62 to  this 
protocol showed them to have ee's of 98-99%.
O 0 0
5eq. CH3NH2 recryst
NH2 HCI rtE^ n ’h NH2 H EtOAc, NH Hrt, 140 h hexanes
61 62 62
52%, >99% ee
Scheme 4.62
It was found that 62 could be recrystallised from ethyl acetate:hexanes. In a 
representative synthesis, 61 was stirred in 5 equivalents of 33% ethanolic methylamine for 
140 hours at room temperature (Scheme 4.62). Evaporation and basic workup yielded 62 
which was recrystallised from ethyl acetate:hexanes to provide optically pure 62 (52%).
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4.19 Minimising Epimerisation
0
Bn m , n 6 mol% Yb(OTf)3
H +  II J  --------- —--------------- -  B n-
NH2 n  toluene, h
0 2N ^  reflux, 16 h
62 112 110
23%, 92% ee
Scheme 4.63
As attempts to  recrystallise 110-HCI had failed, work was undertaken towards 
minimising epimerisation during synthesis o f 1 1 0 . 62, 1 1 2 , and 6 mol% ytterbium(lll) trifla te 
were refluxed in toluene for 16 hours (Scheme 4.63). Column chromatography provided 110 
(23%, 92% ee).
o
BnN
N , n 6 mol% Yb(OTf)3
H +  I  Bn'
NH2 ~ Mw- DMF-
° 2n 130 °C, 60 min
62 112 110
22%, 89% ee
Scheme 4.64
62, 112, and 6 mol% ytterbium (lll) trifla te in DMF were irradiated at 130 °C for 60 
minutes (Scheme 4.64). Column chromatography provided 110 (22%, 89% ee).
o o
Bn' Y ^ N ' /  5 mol% Yb(OTf)3
NH2 toluene, NH2
reflux, 16 h
62 62
28% ee
Scheme 4.65
Curious as to the stage of the reaction at which epimerisation was taking place, 
optically pure 62 was refluxed with 5 mol% ytterbium (lll) trifla te  in toluene fo r 16 hours 
(Scheme 4.65). After aqueous workup to  remove the catalyst, the returned 62 was found to 
have an ee of 28%.
BnY a  5 mol% Yb(OTf)3 ^
NH2 toluene, NH2
80 °C, 15 h
62 62
92% ee
Scheme 4.66
Optically pure 62 was stirred with 5 mol% ytterbium (lll) trifla te  in toluene at 80 °C for 
15 hours (Scheme 4.66). After aqueous workup to remove the catalyst, the returned 62 was 
found to have an ee of 92%. This showed that while lowering the temperature may help, the
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use of ytterbium(lll) triflate in imidazolidinone syntheses may always be expected to induce 
some degree of epimerisation.
Bn
NH2
62
0 2N
112
65 mol% PTSA
MW, DMF, 
140 °C, 60 min
Scheme 4.67
110
6%, >99% ee
To determine whether the use of PTSA may result in less epimerisation, 62, 112, and 
65 mol% PTSA in DMF was irradiated at 140 °C for 60 minutes (Scheme 4.67). Column 
chromatography provided 110 (6%, >99% ee).
Bn
NH2
62
0 2N
MsOH 
MW, DMF
112 110
MsOH 
mol %
Temp
°C
Time
min
110  yield
%
110  ee
%
100 130 60 10 96
94 140 60 10 88
22 140 60 13 >99
22 150 25 19 >99
22 160 10 11 >99
36 160 10 - >99
22 150 60 11 >99
Scheme 4.68
Switching to the more easily measured methanesulfonic acid, the effect of catalyst 
loading, time, and temperature upon the reaction of 62 and 112 in DMF under microwave 
irradiation was studied (Scheme 4.68). It was found that at moderate catalyst loadings, the 
reaction may proceed with very little epimerisation. The final set of conditions in Scheme 
4.76 was used to synthesise 0.72 g of 110 in 11% isolated yield, which was converted to 0.64 
g 110-HCI (9% overall), a sufficient quantity for further investigations.
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MsOH
62 131 123
MsOH 
mol %
Temp
°C
Time
min
123 yield
%
123 ee
%
22 150 60 18 95
22 160 25 - 97
22 170 10 15 98
22 170 20 14 97
21 180 10 15 97
22 180 5 14 96
Scheme 4.69
The effect of catalyst loading, time, and temperature upon the reaction of 62 and 131 
in DMF under microwave irradiation was studied (Scheme 4.69). Under the conditions tested, 
it was not possible to  obtain 123 with >99% ee. These results indicated that epimerisation 
may be strongly substrate-dependant and that differing levels of enantiocontrol in the 
benchmark Diels-Alder reaction amongst differentially-substituted 2-arylimidazolidinones 
may be in part due to differences in catalyst enantiopurity.
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4.20 Improved Enantiocontrol
5 6 8 9
2.5 eq.
Loading 
mol %
Temp
°C
Time
hours
8 ee
%
9 ee
%
5 25 2 97 87
5 20 2 97 88
1 room 16 95 88
Scheme 4.70
Using 110-HCI of >99% ee, the benchmark reaction was re-run according to the 
conditions in Scheme 4.70. When the reaction was run for 2 hours at 25 °C using 5 mol% 
110-HCI, 8 ee was substantially improved over the previous result of 92%. 9 ee was identical 
to the previous result of 87%. Lowering the reaction temperature by 5 °C did little to  improve 
results, only raising 9 ee by 1%. Using 1 mol% 110-HCI and letting the reaction run overnight 
at room temperature resulted in a lower 8 ee but did not affect 9 ee.
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4.21 Iminium Ion Selectivity
19:1
CD30D:D20
19:1
CD30D:D20
1342. 5 134.E
5eq.
R1 R2 [134. E] /  [134.Z]
7 ch 3 ch 3 46.6
110 ch 3 p -n o 2c6h4 7.5
125 ch 3 p-(NC)C6H4 6.9
121 ch 3 c6h 5 6.1
123 ch 3 p-cic6h 4 5.1
119 ch 3 p-ch 3o c 6h4 5.0
111 p -n o 2c 6h4 ch 3 4.4
126 p-(NC)C6H4 ch 3 3.8
124 p-cic6h4 ch 3 3.6
122 c6h 5 ch 3 2.5
33 H p-N0 2CeH4 2.4
120 p-CH3OC6H4 ch 3 2.4
Scheme 4.71
Up until this point, it had been assumed that for imidazolidinone catalysts 
disubstituted at the 2-position, 134.E formed exclusively and that the reaction occurring 
through 134.Z was negligible.
An experiment was devised to assay the thermodynamic ratio 134.E:134.Z present 
under benchmark reaction conditions in the absence of a diene. Solutions of the catalyst 
hydrochloride salt (0.1 M) and cinnamaldehyde (5 equivalents, 0.5 M) in 19:1 deuterated 
methanokdeuterium oxide were allowed to stand at room temperature until equilibrium was 
reached, at which point the ratio 134.E:134.Z was determined by 1H NMR (Scheme 4.71).
As expected, 33 had a low 134.E:134.Z ratio, explaining the low stereocontrol shown 
in the benchmark reaction and validating the rationale that drove investigation of the 
acetophenone-based catalysts.
Despite the good enantiocontrol demonstrated by some of the 2,2-disubstituted 
catalysts in the benchmark reaction, none of these catalysts had 134.E.134.Z ratios 
approaching that of benchmark catalyst 7.
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Using the same formula as to calculate an ee from the ratio of two enantiomers, an 
"isomeric excess" was calculated from the 8:9 ratio of each catalyst. When experimentally- 
attained 8 and 9 ee's were plotted against the catalysts' isomeric excesses, a strong trend 
emerged (Figure 4.72, Figure 4.73). These correlations vindicated the choice of 
thermodynamic iminium ion distribution as a catalyst characterization tool.
4.22 Solvent Screening
In efforts to improve the enantiocontrol of flagship catalyst 110 in the benchmark 
Diels-Alder reaction, catalyst enantiopurity had been improved and the effect of temperature 
upon the reaction had been investigated. The discovery that the thermodynamic 8:9 ratio 
may be rapidly determined with some degree of accuracy suggested that solvent systems 
could be screened to determine whether a more suitable solvent system for the use of 
110-HCI in the Diels-Alder reaction may exist.
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135.Z 5 110HCI 135.E
5 eq.
Expt. Solvent Mixture
[135.E] /  
[135.Z]
[110-HCI] /  
[135.E]
A 89:11 CD3CN:D20 8.2 9.1
B 19:1 CD30D:D20 7.5 2.2
C 9:1 CD30D:D20 7.1 2.7
D 19:6 (CD3)2CD0D:D20 6.7 8.1
E 93:7 (CD3)2C0:D20 6.3 24.9
F 19:1 (CD3)2S0:D20 6.0 25.0
G 67:19:9:5 CDCI3:CD30D:(CD3)2CD0D:D20 5.8 10.7
H 67:17:12:6 CD3N02:(CD3)2CD0D:D20:CD30D 4.4 10.2
Scheme 4.74
110-HCI and 5 equivalents of 5 were dissolved in a solvent system and left to stand at 
room temperature until equilibrium was reached, at which point the relative concentrations 
of 135.E and 135.Z were determined by *H NMR (Scheme 4.74). Due to solubility issues in 
most solvent systems, aliquots of more polar solvents had to  be added until a homogenous 
monophase was attained, at which point the mixture was allowed to reach equilibrium and 
the 135.E:135.Z ratio determined. The effect of dilution upon the 135.E:135.Z ratio is 
unknown.
A regular feature of all spectra was the gradual conversion of the doublets 
corresponding to the aldehyde and iminium protons into singlets of approximately the same 
chemical shift. This process occurred over the period of a few days and indicated slow 
deuteration was occurring at the a-position of 5, 135.E or 135.Z, possibly via the 8 - 
hydroxyenamine or B-alkoxyenamine.
The deuterated acetonitrile:deuterium oxide solvent system had the highest 
135.E:135.Z ratio, showing greater 135.E selectivity than both deuterated 
methanokdeuterium oxide systems.
It was of note that 135.E:135.Z ratios varied markedly across solvent systems. This 
indicated that the deuterated methanokdeuterium oxide solvent systems were proficient in
stabilising 135.E, whereas the deuterated acetoneideuterium oxide and deuterated 
DMSOideuterium oxide solvent systems were not.
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5 mol% 110-HCI
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Figure 4.76
Solvent 8  ee 9 ee
9:1CH3CN:H20 95 82
19:1CH30H:H20 97 87
Figure 4.77
The benchmark Diels-Alder reaction was then performed using 5 mol% 110-HCI at 25 
°C in a 9:1 acetonitrile:water system (Scheme 4.75). It was found that although the 9:1 
acetonitrile:water system allowed for a slightly higher reaction rate than the 19:1 
methanokwater system, it exhibited poorer enantiocontrol (Figure 4.76, Figure 4.77).
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4.23 Reaction Dilution
19:1
CH30H:H20,
2.5 eq. 97% ee 87% ee
Scheme 4.78
A final attempt at attaining improved enantiocontrol from the flagship catalyst 
110-HCI was made when the benchmark reaction was diluted by a factor of 5, being 
performed at 0.1 M with respect to 5, rather than the usual 0.5 M (Scheme 4.78). It was 
envisaged that by diluting the reaction mixture, the effect of the 5, 6 , 8 and 9 upon the bulk 
solvent properties would be reduced, perhaps allowing for better iminium ion selectivity and 
greater enantiocontrol.
This proved not to be the case, as the ee's obtained from this reaction exactly 
matched the ee's obtained from the reaction performed at higher concentration.
4.24 Conclusions
During the course of the research documented within this chapter, 11 new 2-aryl 
imidazolidinone catalysts were synthesised and evaluated. All of these catalysts 
demonstrated higher turnovers than the benchmark catalyst 7.
Bn
NH2
62
OzN
112
22 mol% MsOH
MW, DMF, 
150 °C, 60 min
Scheme 4.79
110
11%, >99% ee
The use of protic acids and Lewis acids in the formation of imidazolidinones under 
thermal and microwave conditions was further investigated. This knowledge was utilised to 
synthesise 110 in >99% ee (Scheme 4.79).
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Scheme 4.80
110  exhibited promise for use in asymmetric synthesis but could not be coerced into 
demonstrating comprehensively better enantiocontrol than benchmark catalyst 7 in the 
Diels-Alder reaction between 5 and 6  (Scheme 4.80). 110 may nonetheless have the potential 
to achieve higher levels of enantiocontrol when used with different substrates and is 
noteworthy among imidazolidinone catalysts for being able to  attain high turnover as well as 
good enantioselectivity.
19:1
CD30D:D20
134.Z 5 134.E
5eq.
Scheme 4.81
The use of NMR to  observe the distribution of catalyst hydrochloride and iminium 
ions in deuterated solvent systems was found to be a useful tool by which to  characterise 
catalysts (Scheme 4.81). This technique strongly suggested that the imperfect enantiocontrol 
of the catalysts developed within this chapter could be attributed to a lack of geometric 
selectivity when forming iminium ions.
Finally, two design premises were firm ly established. Future imidazolidinone catalysts
must:
Possess an EWG to enhance turnover 
Exhibit very high levels of iminium ion selectivity
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Chapter 5: Synthesis of Literature 
Imidazolidinones
5 Synthesis of Literature Imidazolidinones
5.1 Introduction
Although the overarching goal of this project was the development of novel high 
performance, selective catalysts for iminium ion catalysed reactions, the majority of project 
time had, at this point, been spent discovering and developing methodology for the synthesis 
of imidazolidinones.
Although many imidazolidinone catalysts have been described and their use widely 
reported, the literature was lacking in information regarding their preparation. Procedures 
were found to be absent from the primary literature, technically challenging, or of dubious 
efficacy (vide infra).
Adapting synthetic methodology already developed w ithin this project to produce a 
range of prominent imidazolidinone catalysts was seen to  be a much needed contribution to 
the field.
5.2 Target Selection
138 139 140
Figure 5.1
Seven target imidazolidinones 7, 2,136-140 were identified, each of which were first 
described by MacMillan and co-workers (Figure 5.1). 7 is used for cycloaddition and closed 
transition state conjugate addition reactions of a,G-unsaturated aldehydes as well as a 
number of enamine-catalysed processes.2,12,50 2 is effective at catalysing conjugate addition, 
enamine and SOMO reactions and has seen use in iminium/enamine cascade reactions.13,51-62 
136 can facilitate iminium ion catalysed reactions of selected a,G-unsaturated ketones.63137 
and 138 provide similar reactivity profiles to 2 but can provide higher enantiocontrol in some 
reactions.64-66 139 and 140 have recently been shown to be suitable for asymmetric catalysis 
of SOMO reactions.24,25,67
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Scheme 5.4
Literature methods for the preparation of 7, 2,136 are shown in Scheme 5.4. Catalyst 
7 is made by refluxing 62 in 1:4 acetone:methanol in the presence of PTSA. Catalyst 2 is 
described as being obtained from an iron(lll) chloride-catalysed reaction between 62 and 
118, although work within our group had showed that modification of this procedure by pre­
forming the imine by stirring 62 and 118 over magnesium sulphate was required for the 
cyclisation to be effective. When this step was omitted, formation of a brown precipitate, 
presumed to be iron(lll) oxide, was visible and the reaction failed. It was therefore assumed 
that water from the initial condensation was deactivating the iron(lll) chloride catalyst. The 
literature procedure for 136 appeared troublesome, requiring freshly distilled 141, and a 
glove box in which to work with the air-sensitive samarium(lll) triflate. Before this work was 
performed, an exhaustive search of the primary literature failed to  uncover procedures for 
the preparation of 137-140. Since the completion of this work, a preparation of 139 was 
published by the MacMillan group .68
The goal of the work described within this chapter was therefore to develop 
methodology that was robust, reliable, easy to perform, and capable of providing 7, 2, and 
136-140 in good yield and high enantiopurity.
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5.3 Precursor Preparation
o o o
5eq.CH3NH2  ^ recfyst- 8,1
NH2 HCI E10H. NH2 H EtOAc, NH H
rt, 96 h i hexanes
61 62 62
52%, >99% ee
Scheme 5.5
The logical first step towards discovering a universal synthesis for the seven target 
compounds 7, 2, and 136-140 was to synthesise the amino amide precursors. A route to 
optically pure 62 had already been discovered, and this was employed for the work in this 
chapter, providing optically pure 62 in 52% overall yield (Scheme 5.5).
'° - | | ^ n h 2 5 eq. CH3NH2 jj------------------------► H2N>. /
« 3 S L  H
142 42
Scheme 5.6 ^ /o
A literature procedure describing the synthesis of 42 was found to work without 
modification.59 Accordingly, 142 was stirred in ethanolic methylamine at 50 °C for 30 minutes 
and a basic workup was performed to yield pure 42 (77%) (Scheme 5.6).
o 0 0 0
' 0 ' ' ' ^  5eq. CH3NH2| v A n /  HCI(a) 'SV ^ N /  recryst < ^ y ^ N ^
NH2 HCI EtOH NH H Et20  Nh2 H EtOH, NH2 "
•HCI hexanes HCI
143 144 144HCI 144HCI
Scheme 5.7 41%
In a method analogous to  the route used for 62,143 was stirred in ethanolic 
methylamine for 3 days and an aqueous workup performed. An ethereal solution of 144 was 
treated with gaseous hydrogen chloride and the precipitate recrystallised from ethanol and 
hexanes to yield needle-like crystals of 144-HCI, assumed to be optically pure, in 41% overall 
yield (Scheme 5.7). The formation of a hydrochloride salt was a necessary step, as 144 
existed as an oil at room temperature.
o
NH rt, 24 h \  JJ mu EtOH,
HN 2 11 HN 2 HCI rt, 120 h
145 146HCI 147
Scheme 5.8 59
Thionyl chloride was added dropwise to a stirred solution of ethanol. When the 
reaction was complete and hydrogen chloride had been generated, 145 was added and the
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mixture stirred for 24 hours at room temperature. The solvent was evaporated and the 
residue washed with ethyl acetate and petroleum ether to provide 146-HCI. This was then 
stirred in an excess of ethanolic methylamine for 120  hours at room temperature and the 
solvent removed to provide 147 in 59% overall yield (Scheme 5.8).
Q y V 1'
t-4Ki — NH,
EtOH, HCI 
reflux, 63 h V
HN
O' 
NH2 -HCI
145 146HCI 
Scheme 5.9
5 eq. CH3NH2
EtOH, 
rt, 169 h HN NH,
147
76%
Using the methodology devised for 147, racemic 145 was refluxed in ethanolic 
hydrogen chloride for 63 hours and after workup, the resultant racemic 146-HCI stirred in 
ethanolic methylamine for 169 hours at room temperature to give racemic 147 in 76% 
overall yield (Scheme 5.9). Screening of HPLC conditions found that the enantiomers would 
separate on a Chiralcel OD-R column using a 7:3 acetonitrile:water solvent system. Previously 
synthesised batches of 147 were then subjected to analysis using this protocol and found to 
have ee's of 95-98%.
recryst 
— X —
HN NH2
147
Scheme 5.10
An attempt was made to crystallise 147 from toluene, which resulted only in a sludge 
being returned (Scheme 5.10). The dioxane:water solvent system was tried and showed 
ability to dissolve 147 at reflux, but did not reprecipitate the desired product when the 
temperature was lowered. Recrystallisation from THF:water yielded a crystalline product, but 
only with very low recovery of material.
NH, HCI
146-HCI
recryst
CH3CN,
EtOH
0
NH2 HCI
146-HCI 
13% 
Scheme 5.11
5 eq. CH3NH2
EtOH, 
rt, 71 h HN NH,
147
>99% ee
Visually, 146-HCI appeared to have more crystallisation potential than 147 and efforts 
were refocused on boosting its optical purity. A solvent screen showed 146-HCI to dissolve 
well in acetonitrile, less well in water, ethanol, and IPA, and to be virtually insoluble in 
toluene and ethyl acetate. An acetonitrile:ethanol system proved to be best amongst those 
tested and provided recrystallised 146-HCI in 13% yield. This was then free-based and stirred
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with ethanolic methylamine for 71 h, providing 147 of >99% ee (Scheme 5.11). While the 
overall yield of 147 was decidedly low, the quantities obtained proved sufficient for the work 
performed within this chapter and no attempt to  optimise this process was made.
o /==-\ o1.NaNH2
2 B n C ' ■ E t 0 H ' H C ' -OH ------------ *  ' i- <  IT T  0H  ’--  I  0
NH2 NH3 n —  nh2 reflux, 23 h N^J nH2 HCI
r, /  0 /Bn Bn
145 148 149HCI
58%
Scheme 5.12
Neither 148 nor 149-HCI could be sourced commercially, necessitating the synthesis 
of 148 from 145. As published by Magnus et ah, 148 may be prepared by doubly 
deprotonating 145 and reacting the resultant dianion with benzyl chloride .70 Accordingly, a 
solution of sodamide was prepared by dissolving metallic sodium in refluxing ammonia 
containing catalytic iron(lll) nitrate nonahydrate. 145 was then added and the mixture was 
stirred to effect deprotonation of both the amino acid moiety and the proton at the 1- 
position of the indole ring. The solution was then treated with a slight excess of freshly 
distilled benzyl chloride and the reaction allowed to boil dry overnight. The residue was 
quenched with water, filtered to remove iron residues, and treated with glacial acetic acid to 
induce precipitation of 148.148 was then refluxed overnight in ethanolic hydrogen chloride 
to yield 149-HCI in 58% overall yield (Scheme 5.12).
5 eq. CH3NH2 > \  *
NH2 .hci r%*65h N " 'J NH2
Bn Bn
149-HCI 150
Scheme 5.13
63%
In a modification to the usual route for converting ethyl ester hydrochlorides to 
amino amides, an aqueous freebasing was performed prior to  stirring the material in 
ethanolic methylamine. This eliminated the need to expose the more water-soluble product 
to an aqueous workup. 150 was thus obtained in 63% yield from 149-HCI (Scheme 5.13). 
Racemic 149-HCI was then used to synthesise racemic 150. This material was found to 
separate on the Chiralcel OJ column using a 9:1 hexanes:IPA mobile phase at 1.5 mL min '1 (t =
27.9 min, 39.5 min) and showed that the 150 synthesised from optically pure 149-HCI had an 
ee of >99%.
5.4 Initial Investigations
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Scheme 5.14
In the previous chapter, a synthetic method for production of the acetophenone- 
based imidazolidinones using methanesulfonic acid under microwave irradiation had been 
developed and found to involve very little epimerisation (Scheme 5.14). Unfortunately, the 
requirement for a microwave reactor would place limitations upon the utility of this work 
and reduce the feasibility of scale-up. A logical starting point for development of a suitable 
synthesis therefore seemed to be the use of ytterbium(lll) trifla te  under thermal conditions.
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Scheme 5.15
The use of ytterbium(lll) triflate in refluxing toluene had shown the ability to  facilitate 
imidazolidinone formation (Scheme 5.15). This system appeared to  be a good starting point 
for the synthesis of 7, 2, and 136-140. Having previously observed the thermodynamic 
nature of the reaction under microwave conditions and deduced how removal of water may 
be expected to  boost yields, reactions were performed under nitrogen and over 3A 
molecular sieves.
o o \  7
II M 9 mol%Yb(OTf)3, Y ” N r ~ N
■ W  * V  -= £ 3 r- r W  + r y - f1 reflux, 65 h Ph H \ Ph H \
62 118 2 151
Scheme 5.16
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It was anticipated that the sterically hindered aldehyde 118 could present difficulties. 
118 was refluxed with 62 in the presence of 9 mol% ytterbium (lll) trifla te for 65 hours 
(Scheme 5.16). After an aqueous workup to remove the paramagnetic catalyst, NMR 
showed the reaction to have been a success. 2 and 151 were observed in a 1:1.3 ratio.
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reflux, 17 h
The electron-rich aromatic aldehyde 141 was also found to react readily w ith 62 when 
refluxed together in the presence of 10 mol% ytterbium(lll) trifla te for 17 hours. Column 
chromatography was performed and the desired product 136 (37%) was isolated, along with 
unwanted diastereomer 152 (27%) (Scheme 5.17).
O A \  /
10mol%Yb(OTf)3, V ^ N
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toluene, N2,
NH’  ' i7 h  Hi
62 118 2
26%
Scheme 5.18
Having discovered during the synthesis of acetophenone-based imidazolidinones that 
refluxing in toluene can be expected to  induce significant epimerisation, milder conditions 
were examined. 62 and 118 were stirred at 80 °C in toluene in the presence of 10 mol% 
ytterbium(lll) triflate. After aqueous workup and column chromatography, 2 (26%) and 151 
(47%) were obtained (Scheme 5.18).
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Scheme 5.19
147 was thought to be potentially problematic as it exhibited low solubility in toluene. 
147,118, and 10 mol% ytterbium triflate were stirred in toluene at 80 °C for 16 hours.
Column chromatography yielded 137 (19%) 153 (36%) (Scheme 5.19).
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5.5 Racemate Synthesis
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Having established that 2,136 and 137 may be synthesised under conditions less 
likely to cause racemisation (Scheme 5.20), a protocol for establishing the enantiopurity of 
the target imidazolidinones was desired. Racemic 62 and 118 were stirred at 80 °C in the 
presence of 10 mol% ytterbium(lll) triflate in toluene for 17 hours (Scheme 5.20). Subjecting 
the crude mixture to column chromatography yielded racemic 2 (24%) and 151 (39%). It was 
found that 2 would separate on a Chiralcel OJ column using 19:1 hexanes:IPA at a flow  rate of
1.5 mL min'1 (t = 7.2 min, 10.5 min) and that 151 would separate on the same column using a 
99:1 hexanes:IPA mobile phase at a flow rate of 1.5 mL min 1 (t = 18.2 min, 22.3 min). A 
variable wavelength UV detector was used and set to 220 nm, close to the peak absorption 
of both 2 and 151.
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Scheme 5.21
Stirring racemic 62 with 141 and 12mol% ytterbium (lll) trifla te in toluene at 80 °C for 
16 hours yielded, after chromatography, racemic 136 (21%) and 152 (19%) (Scheme 5.21). It 
was found that 136 would cleanly separate on a Chiralcel OJ column using 9:1 hexanes:IPA at 
a flow rate of 1.5 mL min 1 (t = 10.2 min, 27.3 min) while 152 would partially separate on the 
same column using a 99:1 hexanes:IPA mobile phase at a flow  rate of 1.5 mL min '1 (t = 67.3 
min, 72.8 min).
u I, fi 10 mol% Yb(OTf)3,
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Scheme 5.22
Racemic 147 and 118 were stirred at 80 °C in the presence of 10 mol% ytterbium(lll) 
triflate in toluene for 17 hours (Scheme 5.22). Subjecting the crude mixture to column 
chromatography yielded racemic 137 (20%) and 153 (36%). It was found that 137 would
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separate on a Chiralcel OD column using 37:3 hexanes:IPA at a flow  rate of 1.5 mL min 1 (t =
22.9 min, 29.7 min). Conditions for the separation of 153 were not discovered.
B n v X ^  +  8  B m c M P T j *
^ methanol, / M
2 reflux, 16 h Ph H
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Scheme 5.23
Using the literature preparation of 7, racemic 62 was refluxed in 2:1 
methanohacetone for 16 hours and 7 was obtained after aqueous workup in 70% yield 
(Scheme 5.23). 7 was found to  separate on a Chiralcel OJ column using a 97:3 hexanes:IPA 
mobile phase at a flow rate of 1.5 mL min 1 (t = 16.9 min, 18.5 min).
5.6 Synthesis Refinement
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Scheme 5.24
62 and 141 were stirred in toluene at 80 °C in the presence of 10 mol% ytterbium(lll) 
triflate for 17 hours. After column chromatography, pure 136 (22%, ee not determined) and 
152 (36%, 94% ee) were obtained (Scheme 5.24).
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Scheme 5.25
To investigate whether lowering the catalyst loading could reduce epimerisation, 62, 
141, and 1 mol% ytterbium(lll) triflate were stirred in toluene at 80 °C (Scheme 5.25). Column 
chromatography yielded 136 (19%, ee not determined) and 152 (58%, 97% ee).
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Scheme 5.26
At this stage, the use of a nitrogen atmosphere and molecular sieves were 
discontinued, in order to be able to claim air insensitivity and broaden the appeal of the 
methodology. The effect of lower temperature was also investigated when 62 and 118 were 
stirred together with 5mol% ytterbium(lll) trifla te at 70 °C in toluene (Scheme 5.26). 2 was 
isolated after column chromatography and found to have an ee of 99%.
°v  /ff V n
/  . Ik. ^  5 mol% Yb(OTf)3
NH- H I toluene, r r Y2 60 °C, 16 h Ph
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Scheme 5.27
Lowering the temperature still further, 62 and 118 were stirred together with 5 mol% 
ytterbium(lll) trifla te  at 60 °C in toluene (Scheme 5.27). 2 was isolated after column 
chromatography and again found to have an ee of 99%.
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Scheme 5.28
As the catalyst appeared to be almost insoluble in toluene at 60 °C, 62,118, and 5 
mol% ytterbium (lll) trifla te were stirred together in acetonitrile at 60 °C for 16 hours 
(Scheme 5.28). 1H NMR showed the crude reaction mixture to contain 2,151 and multiple 
side products and this choice of solvent was not investigated further.
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Scheme 5.29
To see whether reduced temperature would still facilitate formation of 62,141 and 5 
mol% ytterbium (lll) trifla te were stirred in toluene with 5 mol% ytterbium(lll) triflate at 70 °C 
for 16 hours (Scheme 5.29). Column chromatography provided 136 (29%) and 152 (37%).
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5 mol% Yb(OTf)3,
62 and 141 were then stirred with 5 mol% ytterbium(lll) trifla te at 60 °C in toluene 
(Scheme 5.30). Column chromatography was not performed as 1H NMR of the reaction 
mixture showed a similar level of conversion to that attained in Scheme 5.29.
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Scheme 5.31
To investigate a lower catalyst loading at the reduced temperature, 62 and 118 were 
stirred with 2 mol% ytterbium(lll) triflate at 60 °C in toluene for 16 hours (Scheme 5.31). 
After column chromatography, 2 (26%, 99% ee) and 151 (54%, 99% ee) were isolated.
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Scheme 5.32
147 and 118 were stirred with 2 mol% ytterbium(lll) trifla te  at 60 °C in toluene for 16 
hours (Scheme 5.32). Isolated yields of 137 and 153 were extremely low (8% and 2%, 
respectively) and the problem was assumed to  be the low solubility of 147 in the reaction 
medium.
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5.7 Solvent Screening
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Scheme 5.33
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Re-attempting the reaction between 147 and 118 at a slightly higher temperature, 
the starting materials were stirred with 2 mol% ytterbium(lll) trifla te  in toluene for 16 hours 
at 66  °C (Scheme 5.33). After aqueous workup, 1H NMR showed the crude to consist largely 
of 154 with smaller amounts of 137 and 153. This indicated that the issue with this reaction 
was not the low solubility of 147 but was in fact the inability of 154 to  cyclise under these 
conditions. As such, it appeared impossible to induce formation of 137 in good yields and 
good enantiopurity by varying only the catalyst loading and temperature of this system.
w jHN NH2
147
2 mol% Yb(OTf)3
acetonitrile,
66 °C, 16 h
118
2 eq.
154
Scheme 5.34
Using the reaction of 147 and 118 as a test case, alternative solvents were 
investigated and the results qualitatively assayed by 1H NMR of the crude reaction mixture. 
147 and 118 were stirred with 2 mol% ytterbium(lll) trifla te at 66  °C in acetonitrile for 16 
hours (Scheme 5.34). The crude was seen to  be similar to that of Scheme 5.33 and to consist 
largely of 154, with some traces of 137 and 153.
V / / jHN NH2
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Scheme 5.35
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147 and 118 were stirred with 2 mol% ytterbium(lll) trifla te  in refluxing THF for 16 
hours (Scheme 5.35). The crude was seen to be a mixture of 137 and 153 in a ratio of 1:1.9.
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Scheme 5.36
147 and 118 were stirred with 2 mol% ytterbium(lll) trifla te in refluxing chloroform 
for 16 hours (Scheme 5.36). The crude was seen to  be a mixture of 137 and 153 in a ratio of 
1:1.3. This result showed chloroform to be the best candidate for synthesis of 137.
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Scheme 5.37
Acetonitrile and toluene appeared unsuitable for synthesis of 137, while THF and 
chloroform appeared to facilitate clean formation. The logical next step was to determine 
whether chloroform or THF would be most suitable for synthesis of the other target 
imidazolidinones. 62 and 118 were stirred with 2 mol% ytterbium (lll) trifla te in refluxing 
chloroform for 16 hours (Scheme 5.37). The crude mixture consisted of 2 and 151 in a 1:1.4 
ratio.
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Scheme 5.38
62 and 118 were stirred with 2 mol% ytterbium (lll) trifla te  in refluxing THF for 16 
hours (Scheme 5.38). The crude mixture consisted of 115, 2 and 151 in a 1:1.0:2.3 ratio. This 
result established chloroform as the solvent of choice for the thermal ytterbium(lll) triflate- 
catalysed synthesis of 137.
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62 and 141 were stirred with 2 mol% ytterbium (lll) trifla te in refluxing chloroform for 
16 hours (Scheme 5.39). The crude mixture consisted of 136 and 152 in a 1:1.0 ratio, 
together w ith traces of the intermediate imine.
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Scheme 5.40
62 and 141 were stirred with 2 mol% ytterbium (lll) trifla te in refluxing chloroform for 
16 hours (Scheme 5.40). The crude mixture consisted of 136 and 152 in a 1:1.3 ratio and 
traces of the intermediate imine. This established chloroform as the preferred media for the 
thermal ytterbium(lll) triflate-catalysed synthesis of 136 and suggested it as the solvent 
around which this synthetic methodology should be standardised.
5.8 Acetone Equivalents
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Scheme 5.41
The literature synthesis of 62 uses a 4:1 methanokacetone mixture as a reaction 
solvent, equivalent to a vast excess of 101. In order to determine whether a vast excess was 
required for the synthetic methodology developed in this chapter, two experiments were 
performed. Additionally, it was thought that lowering the catalyst loading to  1 mol% would 
not significantly hinder target compound formation but would enhance the aesthetic appeal 
of the methodology. 62 and 10 equivalents of 101 were stirred w ith 1 mol% ytterbium(lll) 
triflate in refluxing chloroform for 16 hours (Scheme 5.41). 1H NMR of the crude showed 
clean conversion to 7.
106
V n 7II 1 mol% Yb(OTf)3 J  \ ___
chloroform,
, ||  l ( f)
2 reflux, 16 h H
62 101 7
2 eq.
Scheme 5.42
62 and 2 equivalents of 101 were stirred with 1 mol% ytterbium(lll) triflate in 
refluxing chloroform for 16 hours (Scheme 5.42). 1H NMR of the crude showed clean 
conversion once again, and established that 2 equivalents of 101 was sufficient for synthesis 
of 7.
5.9 Temperature Screening
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Scheme 5.43
Using the new conditions, 62 and 2 equivalents of 118 were stirred with 1 mol% 
ytterbium(lll) triflate in refluxing chloroform for 16 hours (Scheme 5.43). Column 
chromatography provided 2 (28%, 97% ee) and 151 (57%, 99% ee). As the ee of the desired 
product 2 was too low, further optimization of conditions appeared necessary.
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Scheme 5.44
62 and 2  equivalents of 118 were stirred with 1 mol% ytterbium (lll) trifla te in 
chloroform at 40 °C for 16 hours (Scheme 5.44). 1H NMR of the crude showed it to consist 
mainly of 155, showing that the temperature was too low to induce cyclisation.
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62 and 2 equivalents of 118 were stirred with 1 mol% ytterbium (lll) trifla te in 
chloroform at 50 °C for 16 hours (Scheme 5.45). 1H NMR of the crude showed it to consist 
mainly of 155, with traces of 2 and 151. Once again, the temperature appeared to  be too low 
and it was deduced that no significant improvements could be made to product 
enantiopurity by tuning the temperature of the reaction system.
5.10 Reaction Time Optimization
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Figure 5.47
To gauge the effect of lowering the reaction time from 16 hours, the reaction 
between 62 and 141 was performed in deuterated chloroform and aliquots taken periodically 
and analysed by 1H NMR (Scheme 5.46). This reaction proved suitable for monitoring by 1H 
NMR as 141 is non-volatile, so can be used stoichiometrically, and presents clean signals for 
integration. Although the paramagnetic ytterbium(lll) was present, its concentration was 
sufficiently low that the spectra could be interpreted w ithout difficulty. For each spectra, 
signals of the compounds 62,141,136,152,156 were integrated, expressed as a percentage 
of the total, and plotted against the time at which the aliquot was taken (Figure 5.47). The
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results suggested that the reaction was under thermodynamic control and showed that at 
the conclusion of the reaction, small amounts of 141 and 156 were present. Additionally, the 
reaction appeared close to equilibrium after 8 hours, suggesting that reducing reaction time 
may be a fru itfu l way to attain the desired levels of product enantiopurity.
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Scheme 5.48
To see whether reducing reaction times may be fru itfu l w ith a different substrate, 62 
and 2 equivalents of 118 were stirred with 1 mol% ytterbium (lll) trifla te in refluxing 
chloroform for 4 hours (Scheme 5.48). 1H NMR showed the crude to  contain 155, 2 and 151 
in a 1:1.8:6.3 ratio. This equated to an 2:151 ratio of 1:3.4, comparing unfavourably with the 
2:151 isolated yield ratio, which was 1:2.0 in the comparable 16 hour reaction (Scheme 5.43). 
This suggested 151 to be the kinetic product.
5.11 Final Conditions
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Scheme 5.49
As a 16 hour reaction time had induced unacceptable levels of epimerisation and a 4 
hour reaction time had produced the desired product in low yields, an 8 hour reaction time 
appeared suitable. 62,118 and 1 mol% ytterbium (lll) trifla te  were refluxed in chloroform for 
8 hours (Scheme 5.49). Column chromatography provided 2 (22%, >99% ee).
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As expected, the reaction between 62 and 141 in the presence of 1 mol% 
ytterbium(lll) triflate proceeded cleanly when refluxed in chloroform for 8 hours and column 
chromatography was used to provide 136 (32%, >99% ee) (Scheme 5.50).
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Scheme 5.51
147,118 and 1 mol% ytterbium(lll) triflate were refluxed in chloroform for 8 hours 
(Scheme 5.51). Column chromatography provided 137 (26%, >99% ee).
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Scheme 5.52
150,118 and 1 mol% ytterbium(lll) triflate were refluxed in chloroform for 8 hours 
(Scheme 5.52). Column chromatography provided 138 (26%, >99% ee).
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Scheme 5.53
62,101 and 1 mol% ytterbium(lll) trifla te were refluxed in chloroform for 8 hours 
(Scheme 5.53). Column chromatography provided 7 (96%, >99% ee).
8 8 V n/H2N ^ J < n /  +  1 mol%Yb(OTf)3
H CHCI3, \\
reflux, 8 h
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Scheme 5.54
42,118 and 1 mol% ytterbium(lll) trifla te  were refluxed in chloroform for 8 hours 
(Scheme 5.54). Column chromatography provided 140 (55%) as a racemate.
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5.12 UV active derivative synthesis
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Racemic 114 and 2 equivalents of 118 were stirred with 1 mol% ytterbium(lll) trifla te 
in chloroform at 50 °C for 15 hours (Scheme 5.55). After column chromatography, racemic 
139 (23%) was obtained. Lacking the aromatic ring systems of 7, 2,136-138, UV absorbance 
was expected to  be much weaker. UV-visible spectroscopy showed a maxima at 240 nm and 
HPLC separation was attempted with the detector set to this wavelength. Using a 199:1 
hexanesrIPA mobile phase at 1.5 mL min'1 on a Chiralcel OD column, partial separation of 139 
was possible, but the weak signal rendered quantitative analysis impossible.
>1s'1 f  *
139
Scheme 5.56
To circumvent this problem, derivatisation of 139 was investigated. It was found that 
racemic 158, produced from the condensation of racemic 139 and 157 (Scheme 5.56), 
absorbed strongly at 237 nm and would separate on a Chiralcel OD column with a 4:1 
hexanes:IPA mobile phase running at 1.5 mL m in 1 (t = 20.1 min, 27.1 min).
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Scheme 5.57
144-HCI was heated in ethanol with sodium carbonate to  around 60 °C for 1 minute 
and 144 isolated after filtration and evaporation of the solvent. 144,118 and 1 mol% 
ytterbium(lll) trifla te were refluxed in chloroform for 8 hours before the crude was subjected 
to column chromatography to provide 139 in 77% overall yield (Scheme 5.57). HPLC analysis 
of UV-active derivative 158 showed the material to have an ee of >99%.
I l l
158
Figure 5.58
A sample of 158 was crystallised from IPA and submitted for X-ray crystallography. 
The solved structure served to confirm the stereochemistry of 158 and, by implication, 139 
(Figure 5.58).
5.13 Scale-up and Recycling
1 mol% Yb(OTf)3
CHCI3, 
reflux, 8 h
62 118 2 151
2 eq. 22%, >99% ee 46%
Scheme 5.59
To prove that the methodology developed was amenable to scale-up, 5.0 g of 62 was 
refluxed with 2 equivalents of 118 and 1 mol% ytterbium(lll) triflate for 8 hours in chloroform 
(Scheme 5.59). After column chromatography, 2 (22%, >99% ee) and 151 (46%) were 
obtained.
1 mol% Yb(OTf)3
26%, 98%ee
Scheme 5.60
151 obtained in the previous reaction (Scheme 5.59) was refluxed with 1 mol% 
ytterbium(lll) triflate for 8 hours in chloroform (Scheme 5.60). Column chromatography 
provided 2 (26%, 98% ee). This experiment showed the potential for unwanted 
diastereomers to be recycled, albeit with some loss of enantiopurity.
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5.14 Conclusions
O v  + I  K
X H RJ R3 R
1 or 2 eq.
Imidazolidinone R1 R2 R3 yield
7 Bn Me Me 96% >99%
2 Bn fBu H 22% >99%
136 Bn H 32% >99%
\  0
137 3-lndolyl-CH2 fBu H 26% >99%
138 N-Bn-3-lndolyl-CH2 'Bu H 26% >99%
139 CH3 H fBu 77% >99%
140 H 'Bu H 55% 0%
Figure 5.61
Utilising synthetic knowledge and techniques gained in previous chapters, a flexible, 
reliable and air insensitive synthesis has been developed that provides imidazolidinones 2, 7, 
136-140 in good yields and high enantiopurity (Figure 5.61).
As preparations for 137,138 and 140 could not be found in the primary literature, it 
can also be said that this research fills a knowledge gap and allows other researchers easy 
access to these catalysts.
Finally, publicising the utility of ytterbium(lll) triflate in imidazolidinone synthesis may 
allow other researchers to adapt this methodology to attain target compounds of their own 
design.
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Chapter 6: Computer Modelling
6 Computer Modelling
6.1 Introduction
Figure 6.1
The overriding goal of this project was to develop an iminium ion organocatalyst that 
demonstrated both high performance and excellent levels of stereoselectivity. Efforts to 
improve the enantioselectivity of the high performance 110  catalyst had run into a dead end 
and experimental data suggested that its iminium ion geometric selectivity was lacking 
(Figure 6.1). To gain further insight, computer modelling was undertaken. The aim of the 
work documented within this chapter was to gain further understanding into iminium ion 
selectivity and move towards being able to design a catalyst w ith high turnover and good 
enantiocontrol.
Although modern computers have vast amounts of computational power, the 
difficulty involved in chemical modelling rendered the available processing power incapable 
of modelling systems of more than a few dozen atoms to the degree of accuracy deemed 
acceptable for this project. This mandated the design of a system that would at once be 
sufficiently simple as to be modelled on accessible computer hardware and yet sufficiently 
developed as to be able to explain catalyst performance and elucidate general principles for 
catalyst design.
6.2 Model Design
It has long been assumed that the transition state in the benchmark Diels-Alder 
reaction is bimolecular and occurs between an iminium ion and a molecule of 
cyclopentadiene 6 . The transition states are assumed to occur in the absence of the chloride 
counter-ion, which is assumed to be fully solvated in the protic solvent mixture.
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To investigate whether the reaction is bimolecular, the benchmark Diels-Alder 
reaction was performed using 110-HCI and its enantiomer, mixed to attain overall 110-HCI 
ee's of between 40% and 100% (Scheme 6.2). A linear correlation between catalyst ee and 
product ee was noted, indicating that the iminium ions react individually and not as 
aggregates (Figure 6.3).
Another longstanding assumption is that the only active species in iminium ion 
catalysed reactions are the iminium ions. While experiments documented in Chapter 4.3 
showed a small degree of background reaction, this assumption was seen to hold largely true 
for the benchmark Diels-Alder reaction.
Additionally, in the presence of water, the iminium ion catalysed Diels-Alder reaction 
has been shown to be irreversible, meaning only the forward reaction needed to be 
considered.31
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With these assumptions in mind, the stereocontrol exerted by 110 in the benchmark 
reaction may be understood in terms of the relative energies of all possible transition states. 
Assuming the position of the benzyl arm corresponds to its position in the lowest energy 
conformation of the free iminium ions, 8 transition states are possible. These are shown 
without the phenyl ring of the substrate for clarity in Figure 6.4. Reactions proceeding 
through transition states 160 and 163 will generate the major enantiomer of the endo adduct 
8, while reactions proceeding through states 159 and 164 will generate the major 
enantiomer of the exo adduct 9. Transition states 162 and 165 give rise to the minor 
enantiomer of 8, while 161 and 166 give rise to the minor enantiomer of 9.
Taking into account the free rotation of the benzyl arm would increase the number of 
transition states that must be considered. When combined with the computational difficulty 
in determining transition states, this rendered transition state modelling infeasible for use 
within this project.
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A simpler system was therefore devised whereby only the starting material iminium 
ions 18.E and 18.Z were considered. To reduce computational requirements further, 18.E and
18.Z were further simplified to 19.E and 19.Z, formally arising upon condensation of 
benchmark catalyst 7 with 13 (Figure 6.5). 19.E and 19.Z are rigid, planar systems, in which 
the only significant conformational freedom is rotation of the benzyl arm relative to the 
imidazolidinone ring. In the mechanism originally proposed by MacMillan, the position of the 
benzyl arm controls the approach of the diene and determines the likelihood of each 
transition state arising.2 Modelling of the dynamics of the benzyl arm can therefore be used 
to intuit relative favourabilities of all possible transition states.
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A potential energy surface scan was performed whereby the dihedral angles between 
atoms 1-4 of 19.E were varied in units of 10 ° between 0 ° and 350 ° and the spatial 
arrangement of the rest of the iminium ions' atoms optimized at each step. This scan was 
performed using the Hartree-Fock function with the 6-31G* basis set. When the 
conformational energy was plotted against the dihedral angle, 3 local minima were observed 
(Figure 6 .6 ).
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The scan was repeated fo r 19.E using the more accurate and more computationally 
intensive Becke half-and-half function w ith the 6-31+G** basis set.71 This basis set has been 
shown to accurately model n-stacking interactions, believed to  be important to the 
conformational preferences of 19E and 19Z.72 3 local minima were again observed (Figure
6.7). The minima were present at roughly the same dihedral angles, but had different relative 
energies.
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Using the Hartree-Fock function with the 6-31G* basis set, a potential energy surface 
scan was performed whereby the dihedral angles between atoms 1-4 of 19.Z were varied in 
units of 10 ° between 0 ° and 350 ° and the rest of the iminium ions' geometry optimized at 
each step. 3 local minima were observed at similar angles to those observed in Figure 6 .6 , 
but their relative energies were different (Figure 6 .8 ).
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19.Z3 (41.8 kJ mol )
Using these minima as starting points, full geometry optimizations using the Becke 
half-and-half function w ith the 6-31+G** basis set were performed, yielding conformations 
19.E1-E3 and 19.Z1-Z3 (Figure 6.9). As 19.E and 19.Z are geometric isomers, the energies of 
the ir conformations may be compared directly and are given relative to the lowest energy 
conformation, 19.E2.
In MacMillan's seminal paper, 19.E l was stated to be the lowest energy conformation 
and 19.Z1 was stated to be disfavoured due to a steric clash between the proton a- to the 
iminium carbon and the geminal dimethyl groups.2 These results confirm the disfavouring of 
19.Z l, but show that the 19.E2 conformation is substantially lower in energy than the 19.E l 
conformation, a result also found experimentally w ithin the group .28 This appears due to the 
close proxim ity of the benzyl arm to the carbon a- to the iminium ion disfavouring 19.E l and 
also due to the hydrogen bond between the ti system of the benzyl arm and the closest 
proton of the geminal dimethyl groups stabilising 19.E2.
Lacking a computational method for calculating the substrate shielding effect of each 
conformation, 19.E1-E3 and 19.Z1-Z3 were examined visually to ascertain the degree of 
shielding of the a- and II- carbons of the substrate.
1 2 0
19.E1 appeared to  block the top face of the a- and G-positions of the substrate, while 
19.E2 appeared to  block only the a-position. 19.Z2 appeared to shield the a-position, but 
would induce formation of undesired stereoisomers, while 19.E3,19.Z1, and 19.Z3 appeared 
to exert little  shielding influence on either the a- or G-positions of the substrate. It was 
therefore surmised that in the benchmark Diels-Alder reaction, transition states arising from
19.E1 and 19.E2 would yield the desired products, while transition states arising from 19.E3 
or 19.Z1-Z3 may give rise to  either desired or undesired stereoisomers and would represent 
an overall loss of produt ee.
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Nz =  NZ1 +  NZ2 +  Nz 3
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iso m eric  excess  =  — --------------—
Ne +  Nz
Figure 6.10
The concept of isomeric excess developed in Chapter 4.21 appeared to  explain the 
enantioselectivity of the 2-arylimidazolidinones. It was seen that this same metric could also 
be calculated from the relative energies of the conformations of 19.E and 19.Z.
Using the Boltzmann distribution function, a probability measure for each of the 
conformations 19.E1-E3 and 19.Z1-Z3 was calculated (Figure 6.10). Using the same function 
as is used for calculating ee's, these probability measures were used to calculate an isomeric 
excess for benchmark catalyst 7 (95%).
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6.3 Acetophenone Catalysts Evaluated
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R1 R2 calc, ie exp. ie 8  ee 9 ee
7 ch 3 c h 3 95 96 93 93
125 c h 3 p-(NC)C6H4 76 75 83 73
121 c h 3 c6h5 75 72 96 82
110 c h 3 p -n o 2c 6h 4 75 80 97 87
119 c h 3 p-ch 3o c 6h 4 65 67 95 84
123 c h 3 p-c ic6h4 65 67 90 78
126 p-(NC)C6H4 c h 3 23 59 52 42
124 p-c ic6h4 c h 3 23 56 59 50
120 p -ch 3o c 6h 4 c h 3 23 40 68 53
111 p -n o 2c 6h4 c h 3 21 63 94 78
122 c6h 5 c h 3 21 43 65 61
Figure 6.12
100%
80%
60%
Q.
XV 40%
20%
0%
0% 40%20% 60% 80% 100%
calc, ie
Figure 6.13: Experimentally-attained ie vs. calculated ie for each catalyst in Figure 6.12
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Conformations for 110, 111 and 119-126 were optimized and their relative energies 
calculated according to the previously described protocol (Figure 6.12). A strong correlation 
was noted between experimentally determined ie's (Chapter 4.21) and calculated ie's, 
indicating that the computational method for determining a catalyst ie is a good 
approximation of the experimental method (Figure 6.13).
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A correlation between calculated ie and 8 ee's attained in the benchmark Diels-Alder 
reaction for each catalyst in Figure 6.12 was noted (Figure 6.14). A correlation between 
calculated ie and 9 ee's for each catalyst in Figure 6.12 was also noted (Figure 6.15). The 
obvious outlier in both cases was 111 , which exhibited far stronger enantiocontrol than 
calculated ie's would suggest.
As the computational and experimental ie's matched closely, it appeared that the 
unexpectedly good enantiocontrol exhibited by 111  in the benchmark reaction was unlikely 
to be due to 111  possessing superior geometric control and that another mechanism may be 
responsible.
6.4 Conclusions
A computational model was developed for assaying the stereocontrol of iminium ion 
organocatalysts. Using this model, a catalyst may be characterised in terms of the relative 
energies of the six total conformations of the two geometric isomers of the iminium ion 
formed upon its condensation with 13. This represented a substantial saving in 
computational time over the transition state model and rendered it a practical undertaking.
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Previous work in this group had used the Hartree-Fock method exclusively due to the 
more limited computer hardware that was available at the time. This method was deemed 
unsuitable as it does not accurately model n-orbital interactions and could not be relied upon 
to generate the quality of results needed for this project. A more suitable model, the Becke 
half-and-half function was used instead. This algorithm rivals more computationally 
expensive models in terms of accuracy yet allows calculations on these systems to be 
performed in a reasonable time. When the energies of all the conformations of the two 
geometric isomers of an iminium ion were calculated in parallel using the university's Merlin 
cluster, results were returned in around 40 hours.
Calculated ie's were found to be a convenient measure of the iminium ion geometry 
selectivity of a catalyst, and were found to  correlate w ith experimentally observed isomeric 
excesses and experimentally attained product ee's.
Finally, the data provided by this model provided further evidence that the 2- 
arylimidazolidinones attain low ee's in the benchmark Diels-Alder reaction due to poor 
iminium ion geometry control.
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Chapter 7: Computer-Aided Catalyst Design
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7 Computer-Aided Catalyst Design
7.1 Introduction
The success of the theoretical model developed in the previous chapter in explaining 
the shortcomings of the acetophenone series catalysts increased interest in the use of 
computer modelling.
It had been a longstanding goal w ithin the group to  develop a reliable and accurate 
computational model of iminium ion organocatalysis that would allow catalyst structures to 
be evaluated in silico, thus reducing experimental workload and allowing for faster progress 
to be made.
At this stage in the project, there appeared to  be 3 discrete factors influencing 
catalyst performance: EWG strength, iminium ion geometric selectivity, and substrate 
shielding ability o f the dominant iminium ion.
7.2 Proton Affinity Calculation
Ov /  °,\ / _______  ov /  o. /yv  Vyry - 2 yv  VVcF3
"CF3 B n^N  '
H H H H
7 110 90 91
Figure 7.1
Research performed within the group had shown that the RDS in the benchmark 
Diels-Alder reaction catalysed by 7-HCI was iminium ion formation, believed to be a second 
order reaction between the free amine and the aldehyde.31 This suggested that the enhanced 
rate of 110-HCI was attained due to  a decreased proton affin ity and an increased 
concentration of the free amine under reaction conditions. The upper limits for EWG 
strength in a functional catalyst appeared to have been exceeded in the case of 90 and 91, 
which were seen not to catalyse the benchmark reaction.
5 RT
PA =  E(B) -  E (B H +) +  ZPVE +  —
ZPVE =  zero-point vibrational energy
Figure 7.2
To gain understanding into the RDS of the benchmark reaction and generate an extra 
metric by which catalysts may be characterised, proton affinities (PA) were calculated. This
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was performed in accordance w ith the method of Rao and Sastry using the B3LYP/6-31+G* 
level of theory (Figure 7.2).73
R1 R2 PA (kJ mol'1)
33 H p -n o 2c6h4 915
104 p-N02C6H4 H 917
110 CH3 p-N 02C6H4 924
111 p -n o 2c6h 4 ch 3 927
126 p-(NC)C6H4 ch 3 927
125 ch 3 p-(NC)C6H4 928
123 c h 3 p-cic6h4 950
124 p-c ic6h4 ch 3 951
122 c6h 5 ch 3 959
121 ch 3 c 6h 5 960
119 ch 3 p-ch 3o c 6h4 970
120 p -ch 3o c 6h4 ch 3 972
°. /
X  X R1B r X X  -R2
Figure 7.3
Amongst the 2-aryl imidazolidinones, a correlation between experimental catalyst 
performance and calculated proton affin ity was observed within both the (25,55)- series and 
within the (2R,5S)~ series (Figure 7.3). Comparison between these two series was not 
enlightening as proton affin ity varied by no more than 3 kJ mol'1 between diastereomers. 
Experimentally, the (2R,5S)- catalysts had shown substantial rate advantages over the 
(25,55)- catalysts (Chapter 4.14).
R1 R2 PA (kJ m ol'1)
115 (CH2)3 942
7 ch 3 ch 3 945
2 c(ch 3)3 H 948
114 (ch2)4 950
° v  /
Figure 7.4
Very little  spread was observed amongst the 2-alkyl catalysts (Figure 7.4). These 
results failed to  explain why 2, 7 and 115 had very similar experimentally observed turnovers, 
while 114 exhibited much lower performance. Additionally, the proton affinity of benchmark 
catalyst 7 would place it close to  the median proton affin ity of the 2 -aryl catalysts, all of
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which were found to be substantially higher performing in the benchmark Diels-Alder 
reaction (Chapter 4.4, 4.14).
R1 R2 PA (kJ mol'1)
30 c f3 c f 3 855
91 c f3 ch 3 898
90 ch 3 c f 3 899
89 c6h5 c f 3 917
78 c f3 C6H5 917
Figure 7.5
All the trifluoromethyl-containing imidazolidinones evaluated (30, 78, 89, 90, 91) 
were found to have low proton affinities (Figure 7.5). These numbers alone did not explain 
the observed inability of 78 and 89 to form hydrochloride salts as their calculated proton 
affinities were very similar to 90 and 91, which readily formed hydrochloride salts with 
pronounced catalytic activity. When the proton affinities of 7, 91 and 30 were compared, the 
decrease in proton affinity appeared roughly proportional to the number of fluorine atoms in 
the molecule. This showed the potential for the basicity of imidazolidinones to be tuned by 
varying the degree of fluorination of alkyl groups at the 2 -position and suggested that mono- 
or difluorination of 7 could result in a higher performance catalyst.
The calculation of proton affinities was undertaken as it appeared to provide a more 
logical handle on catalyst performance than LUMO energies previously relied upon within the 
group. It had been shown that while proton affinities may go some way to explaining catalyst 
performance, their utility in appraising the catalytic potential of novel structures was limited.
7.3 Substrate Shielding
19.E1 19.E3
Figure 7.6
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A potential energy surface scan was performed whereby the dihedral angles between 
atoms 1-4 of 20.E and 167.E were varied in units of 10 ° between 0 ° and 350 ° and the rest 
of the iminium ions' geometry optimized at each step. Figures 7.8 and 7.9 show 
conformational energy plotted against dihedral angle. These scans were performed using the 
Hartree-Fock function with the 6-31G* basis set.
When compared to Figure 7.7, first generated in Chapter 6.2, Figures 7.8 and 7.9 
indicated that the benzyl arm of 20.E and 167.E would be expected to spend little time in the 
E2 conformation, due to the steric repulsion of the tertiary butyl group and the electronic 
repulsion of the trifluoromethyl group, respectively. The results also indicated that for both
20.E and 167.E, the E3 conformation, in which the benzyl arm sits above the carbonyl of the 
amide, is less disfavoured and that substrate shielding may be compromised as a result.
rel. energy (kJ m o l1) 19 20 167
E l 6.7 0 .0 0.0
E2 0 .0 12.1 12.9
E3 20.7 10.7 14.6
Z-E (kJ m o l1) 10.0 5.6 5.6
Figure 7.10
Using the minima on Figures 7.7, 7.8 and 7.9 as starting points, geometry 
optimizations and energy calculations were performed using the more accurate Becke half- 
and-half function with the 6-31+1G** basis set (Figure 7.10). In all cases, these results 
showed much larger differences between the E3 and E l conformations, indicating good 
benzyl arm control would be expected of these iminium ions. However, both 20.Z and 167.Z 
were found to  have relatively low energies, implying the corresponding catalysts (2 and 91, 
respectively) would have poor iminium ion geometry control.
Experimentally, 7, the parent amine of 19, exhibits good enantiocontrol in the 
benchmark Diels-Alder reaction (93% endo- ee, 93% exo- ee), while 2, the parent amine of 
20, shows very poor enantiocontrol (5% endo- ee, 55% exo- ee). 7 exerts a high degree of 
stereocontrol in other closed transition state reactions such as conjugate addition of pyrrole 
but is not used by MacMillan in open transition state reactions, suggesting a preference for 
the E2 conformation. 2 has been used for conjugate addition, suggesting that E l is its 
preferred conformation, but generally at lower temperatures, suggesting that iminium ion 
geometry control may be an issue. 91, the parent amine of 167, has been reported to be 
catalytically inactive in the benchmark Diels-Alder reaction within this investigation (Chapter
2.8) but 167 was modelled as it manifested a novel method of benzyl arm control.
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Two methods for controlling the rotation of benzyl arms at the 5-position of 
imidazolidinone rings, and hence substrate shielding, have been investigated: the steric 
method, and the electronic method. Both methods have shown good performance, as 
measured computationally. Unfortunately, no experimental methods for measuring 
conformations of imidazolidinone iminium ions have been established at this time.
7.4 E/Z Selectivity
168.E
Parent
amine
R1 R2 Ez2"Ee2 
kJ mol'1
H H 0 .0
H ch 3 5.9
169 H c6h 5 10.0
ch 3 H 1.0
7 ch 3 ch 3 10.0
121 ch 3 c 6h 5 0.9
170 c6h 5 H 2.2
122 c6h 5 ch 3 5.9
c6h5 c6h 5 0.2
Figure 7.11
In an attem pt to  quantify the steric effects of the various possible substituents at the 
2-position o f the imidazolidinone ring, energies for the most favourable conformations of 
168.E and 168.Z were calculated for each substitution pattern in Figure 7.11. In all cases, E2 
was found to  be the lowest energy conformation of 168.E, while Z2 was found to be the 
lowest energy conformation of 168.Z.
The results showed that 169 would be expected to  have iminium ion geometric 
selectivity comparable to  that of benchmark catalyst 7 and potentially high levels of 
enantiocontrol in the benchmark reaction.
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62,171 and 11 mol% PTSA in DMF were irradiated at 120 °C for 120 minutes (Scheme 
7.12). After aqueous workup and column chromatography, 169 (32%) and 170 (14%) were 
isolated and converted to  169-HCI (24% overall) and 170-HCI (9% overall).
o
IPh'/ ♦  O
5 mol% 
catalyst-HCI 
19:1 
CH30H:H20, 
25 °C, 4 h
5 6
2.5 eq.
8 9
Scheme 7.13
In the benchmark Diels-Alder reaction, 169-HCI was seen to  exhibit good turnover but 
attained only 75% 8  ee and 22% 9 ee (Scheme 7.13). 170-HCI also exhibited good turnover 
but attained 21% 8  ee and 44% 9 ee.
When 169-HCI was dissolved in 19:1 deuterated methanokdeuterium oxide with 5 
equivalents 5, a 2 .0 :1134.E:134.Z ratio was observed (Scheme 7.14). The use of 170-HCI 
under the same conditions gave rise to  a 1 .5 :1134.E:134.Z ratio.
Despite the promising computational results, 169 exhibited poor 134.E:134.Z 
formation control and poor enantiocontrol in the benchmark Diels-Alder reaction. It 
appeared that calculated 134.E:134.Z energy differences do not always correlate 
experimentally.
19:1
CD30D:D20
5 eq.
5 169-HCI R1 = H, R2 = C6H5
170-HCI R1 = C6H5, R2 = H
134.E
Scheme 7.14
7.5 The H-bond Effect
172 173.E 173.Z
Figure 7.15
173.E (0 kJ mol'1) 173.Z (10.7 kJ mol"1)
Figure 7.16
While performing a computational screening of potential EWGs, 172 was discovered 
to have an unexpectedly high 173.Z-173.E energy difference of 10.7 kJ m o l1, giving a 
calculated ie of 96%. Upon closer inspection, it was found that 173.E contained a hydrogen 
bond from one of the dihydroamidic oxygen atoms to the iminium proton (2.15 A), whereas 
in the case of 173.Z, the same oxygen atom had a hydrogen bond to the less positive a- 
proton atom (2 .12  A).
Suspecting that controlled formation of hydrogen bonds to the iminium proton may 
be a powerful mechanism for effecting iminium ion geometric selectivity, further in silico 
screening was performed.
66%, substantial for a catalyst with very little steric bulk at the 2-position. 175.E contains a 
hydrogen bond of 1.94 A from the ethereal oxygen to the iminium proton, while 175.Z
175.Z, the 1—2-3 -4  dihedral is 105 ° and 143 °C, respectively. This shows that rotation
174 175.E 175.Z
Figure 7.17
174 was seen to exhibit a Z-E energy difference of 5.6 kJ mol'1 and a calculated ie of
contains a hydrogen bond of 2.09 A from the ethereal oxygen to the a-proton. In 175.E and
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around this dihedral is necessary to allow formation of 175.Z and that hindering this rotation 
may further increase the Z-E  energy difference.
176 177.E 177.Z
Figure 7.18
177.E was seen to be 8.2 kJ mol' 1 lower in energy than 177.Z, while 176 had an overall
iminium proton and a 1 -2 -3 -4  dihedral of 93 °, while 177.Z contained a hydrogen bond of 
2.24 A and a 1 -2 -3 -4  dihedral of 142 °.
176 looked promising but its synthesis was deemed potentially problematic. 179 was 
devised as a similar catalyst tha t may be obtained from commercially available 178. The Z-E 
energy difference was found to be 7.7 kJ mol'1 and overall ie found to be 8 8 %. 180.E 
exhibited a hydrogen bond of 2.18 A from the quinolic nitrogen to  the iminium proton and a 
1 -2 -3 -4  dihedral of 83 while 180.Z exhibited a hydrogen bond of 2.09 A from the quinolic 
nitrogen to  the a-proton and a 1 -2 -3 -4  dihedral of 111 °.
The modelling of the iminium ions of 172,174,176, and 179 explored a theoretical 
mechanism by which imidazolidinones lacking in steric bulk at the 2 -position may attain 
selective iminium ion formation. It was seen that small structural changes may result in 
significant selectivity differences and warranted further investigation of this effect.
It must be appreciated that the benchmark reaction is performed in methanokwater 
mixtures, which could be expected to disrupt any hydrogen bonding network. However, 
imidazolidinone catalysts have been used in aprotic solvents, and the possibility of greatly 
enhanced iminium geometry control made further investigations appear worthwhile .74
ie of 8 6 %. 177.E possessed a hydrogen bond of 2.04 A from the pyridine nitrogen atom to the
c
178 179 180.E
Figure 7.19
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7.6 Fluorine H-bonders
99 181.E 181.Z
Figure 7.20
Since concluding the work within Chapter 2.8, 99 appeared to have potential for high 
catalytic performance and good enantiocontrol (Figure 7.20). To investigate the potential for 
a hydrogen bond between its fluorine atom and the iminium proton to enhance iminium ion 
selectivity, modelling work was undertaken. 181.E was found to have a fluorine to iminium 
proton internuclear distance of 2.22 A and a 1 -2 -3 -4  dihedral of 64 °.
181.Z1 (14.7 kJ mol'1)
Figure 7.21
Interestingly, 181.Z was seen to have two conformational minima with very similar 
energies, 181.Z1 and 181.Z2 (Figure 7.21). 181.Z1 was seen to have a marginally lower 
energy than 181.Z2 and featured a fluorine to benzylic proton distance of 2.33 A, assumed to 
stabilise the conformation. 181.Z1 had a fluorine to a-proton distance of 2.06 A and a 1 -2 -3 -  
4 dihedral of 79 °. This showed the potential for unexpected interactions to stabilise 
otherwise unfavourable conformations. The overall calculated ie of 99 was found to be 99%.
181.Z2 (14.9 kJ mol )
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99 appeared to  be a very strong candidate for synthesis and experimental evaluation. 
Unfortunately, before this work could be carried out, Seebach released a publication 
detailing the mechanisms of iminium organocatalyst stereoselectivity. 99HPF6 was stated to 
have a 182.E:182.Z selectivity of >99:1 in deuterated acetone (Figure 7.22), but no further 
information was given.75 Having lost the ability to claim 99 as a novel catalyst, no 
experimental evaluation was undertaken.
As a derivative of 121,183 appeared a logical candidate for evaluation (Figure 7.23). 
121 had shown good performance in the benchmark Diels-Alder reaction while attaining 
reasonable levels of product ee (96% endo, 82% exo). 121 had shown a calculated ie of 75% 
and an experimental ie o f 72%, indicating that improved iminium ion geometry selectivity 
should result in improved enantiocontrol.
184.E shows a fluorine -  iminium proton distance of 2.32 A, while 184.Z shows a 
fluorine -  a-proton distance of 2.28 A. 183's calculated ie was determined to be 89%, 
suggesting that this catalyst may demonstrate very good levels of experimental 
enantiocontrol.
121 183 184.E
Figure 7.23
KF, Ph3SnF, 
BU4 NHSO4
CH3CN, 
reflux, 69 h
O 0 0
20%
127 185 186
Scheme 7.24
To a solution of 127 and catalytic hydrogen bromide in DCM at 0 °C, bromine was 
added dropwise over the course of 30 minutes, resulting in copious evolution of hydrogen
bromide (Scheme 7.24). After addition was complete, the mixture was stirred at room 
temperature fo r 5 minutes and then evaporated. 185 was obtained as a cream solid after 
multiple recrystallisations from hexanes (38%).
Using a literature procedure, 185 was stirred in refluxing acetonitrile with potassium 
fluoride, tetrabutylamm onium bisulphate, and triphenyltin fluoride for 69 hours.76 The 
mixture was poured into water, extracted twice with diethyl ether, dried, treated with 
pyridine, and refluxed fo r 20 minutes. An aqueous workup was then performed, after which 
distillation yielded 186, a low melting point (23 °C) crystalline solid (52%, 20% overall).
A solution of 62,186, and 30 mol% MsOH in DMF was irradiated at 160 °C for 10 m 
(Scheme 7.25). Analysis of the reaction mixture revealed a number of compounds to be 
present but column chromatography failed to isolate 183. The reaction was repeated at 150 
°C for 30 minutes, at 140 °C for 19 minutes, and at 130 °C for 60 minutes. None of these 
attempts provided 183.
62 and 186 were refluxed in DCM with ytterbium (lll) trifla te  for 24 hours (Scheme 
7.26). Column chromatography provided a compound suspected to be 187. Attempts to 
cyclise this compound using copper(ll) trifla te  under microwave irradiation failed and 183 
could not be obtained.
Further synthetic efforts towards 183 were not undertaken due to time constraints.
7.7 2-(B-Acetamido)-lmidazolidinones
At this stage, the ability for well situated nitrogen, oxygen, and fluorine atoms to 
enhance iminium ion isomeric energy differences by selective hydrogen bond formation had 
been observed. Looking to  enhance this effect, a search o f the literature revealed that 
amides, sulfoxides, sulfones, phosphites and phosphates tended to  be the strongest
MsOH
 K----
MW, DMF
62 186 183
Scheme 7.25
Yb(OTf)3
DCM, 
reflux, 24 h
62 186 187
Scheme 7.26
137
hydrogen bond acceptors.77'78 Of these functional groups, sulfones and amides appeared 
most suitable for incorporation into the imidazolidinone architecture.
Brf
188
Figure 7.27
The im inium ions of 188 were found to have a Z-E energy difference of 23.6 kJ m o l1 
and an overall ie of 100% (Figure 7.27). In the E- iminium ion, a distance of 2.28 A between 
the iminium proton and closest oxygen atom of the sulfone group was noted, while in the Z- 
iminium ion, a distance of 2.27 A between the a-proton and the same oxygen atom was 
noted. 187 was found to  have a calculated PA of 960 kJ m o l1.
Bn’
189
- A
NH,
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Scheme 7.28
188 looked promising, but the stereocenter a- to the sulfone was seen to be a likely 
point for epimerisation and also a source of synthetic difficulty. 189 was devised as a less 
stereocomplex sulfone-containing imidazolidinone (Scheme 7.28). 189 was seen to  have an 
iminium ion Z-E  difference of 17.0 kJ mol'1, an overall ie of 100% and a PA of 920 kJ mol"1. 
While the calculated results looked promising, it was imagined that the extreme acidity of 
the proton a to  both sulfone groups could be problematic, especially in precursor 190.
191 
Figure 7.29
To investigate the positioning of an amidic carbonyl at the 2-position of the 
imidazolidinone ring, 191 was modelled (Figure 7.29). 191 was seen to  have a Z-E difference 
of 12.7 kJ mol'1 and an ie of 99%. The E-iminium ion was seen to  have a distance of 2.32 A 
between the iminium proton and amidic oxygen, while the Z-iminium ion showed a hydrogen 
bond between the a-proton and amidic oxygen of 2.07 A.
138
192 193.E 
Figure 7.30
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Formal insertion of a methylene group between the amidic carbonyl and 
imidazolidinone ring of 191 gave rise to  192 (Figure 7.30). 192 was seen to have a Z-E energy 
difference of 28.9 kJ mol' 1 and an ie of 1 0 0%. 193.E was seen to have a distance of 1.93 A 
between the amidic oxygen and iminium proton and a 1 -2 -3 -4  dihedral of 68  °, while 193.Z 
showed a hydrogen bond between the donor a-proton and acceptor amide of 1.91 A and a 
1 -2 -3 -4  dihedral of 121 °. This showed that 193.Z had to  undergo greater geometric 
distortion in order to  allow an intramolecular hydrogen bond to  form and explained why it 
was found to  be significantly higher in energy than 193.E.
R1 R2 R3 PA (kJ mol'1) Z-E (kJ mol'1)
194 H H ch 3 976 33.4
195 c h 3 c h 3 c h 3 993 32.7
196 -(CF 2 ) 4 - Ph 1010 23.1
197 H H Ph 985 22.3
198 Ph H Ph 991 21.9
199 H H H 969 18.4
R3 O
Figure 7.31
Further exploration of the 2-(8-acetamido) architecture was performed (Figure 7.31). 
All modelled systems had calculated iminium ion energy differences far above that of 
benchmark catalyst 7 (10.0 kJ mol'1). The choice of substituent on the lower face of the 2- 
position (R3) had a pronounced effect, comparable to  those observed in Chapter 7.4. The 
choice of substituent on the amide appeared to  have little effect on the relative iminium ion 
energies, but had a notable effect on proton affinity. This was of particular concern in the 
case of 196, where its proton affin ity was significantly higher than that of benchmark catalyst 
7 (945 kJ m ol'1) and was seen as a forewarning of potentially low performance.
It was fe lt that dihydroamides 194,197 and 199 may have solubility problems and as 
such, alkyl and aryl amides 195,196 and 198 would be better candidates for experimental 
evaluation.
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As the ketone required to  synthesise 195 was not commercially available, 200 was 
purchased instead. 62, 200 and 3 mol% ytterbium(lll) trifla te were refluxed in toluene for 15 
hours (Scheme 7.32). The crude was cooled and filtered to  remove the majority of the 
ytterbium (lll) residues, then treated w ith hydrogen chloride gas and filtered to yield a 
mixture of hydrochloride salts. Repeated recrystallisation yielded 201-HCI (1%).
5 mol% 
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Figure 7.34
201-HCI was used at 5 mol% to  catalyse the benchmark Diels-Alder reaction in 19:1 
methanokwater at 25 °C (Scheme 7.33). As anticipated, its turnover was substantially lower 
than that of benchmark catalyst 7 (Figure 7.34). Product ee's were not measured.
This result demonstrated that the 2-(R-acetamido) moiety can be incorporated into a 
functioning imidazolidinone catalyst, albeit w ith a loss of performance. Although time 
restrictions on the project curtailed further experimental validation of the 2 -(R-acetamido)
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catalysts, the outstanding levels of iminium geometry control theoretically afforded by these 
catalysts warrants further synthetic effort.
7.8 Imidazolidinones w ith  benzyl arm control
An investigation was undertaken to determine if the use of an amide hydrogen bond 
acceptor to  control iminium ion geometry could be combined with a method for controlling 
the benzyl arm conformation, with the eventual aim of finding a catalyst capable of attaining 
good levels o f stereocontrol in open transition state reactions.
Using 2 as a template, 202 was devised (Figure 7.35). 202's Z-E energy difference was
12.2 kJ m o l1 and its preferred conformation was found to be 203.El, 5.7 kJ mol’1 lower in 
energy than 203.E2.
The A/,A/-dimethyl analogue of 202, 204, was found to have a Z-E energy difference of
2 202
203.E1 (0 kJ mor1) 203.E2 (5.7 kJ mol'1)
Figure 7.35
204 205.E3 (62  kJmol'1)
Figure 7.36
18.2 kJ mol'1 but had a low lying E3 conformation at 6.2 kJ mol'1 relative to the preferred El.
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206 
Figure 7.37
206 can be seen as a subtle modification of 204 yet showed very different 
conformation energies. 204 was seen to have a Z-E energy difference of 9.6 kJ m o l1, while its 
iminium ion's preferred conformation was E2.
The modelling of 202, 204, and 206 showed that mimicking the steric bulk of 2 may 
be a viable method of attaining simultaneous iminium ion geometry control and benzyl arm 
control but failed to discover any structures with outstanding calculated selectivity.
91 207
Figure 7.38
208.E1 (0 kJ mol-1) 208.Z1 (1.2 kJ mol1)
Figure 7.39
In Chapter 7.3, the ability of the trifluoromethyl group of 91 to direct the benzyl arm 
was observed. To determine if the same principle could be applied to amide hydrogen- 
bonding catalysts, the iminium ions of 207 were modelled. The E2-E1 energy difference was 
found to be 8.5 kJ m o l1, indicating good benzyl arm control. Unfortunately, 208.Z1 featured 
close proximity between one of the benzylic hydrogens and a fluorine atom (2.33 A), as well 
as between the iminium proton and the other fluorine atom (2.43 A). These interactions 
appeared to stabilise the Z1 conformation as it had an energy of 1.2 kJ m o l1 relative to the 
preferred El. 207's PA was found to be 935 kJ mol'1.
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In an attempt to increase the Z-E energy difference of 207, a methyl group was added 
to the 2-position. 209 was found to have a Z-E energy difference of 16.6 kJ mol'1 and showed 
E l to be its preferred conformation (Figure 7.40). The second most stable conformation, E2, 
was found to have a relative energy of 7.1 kJ mol'1. 209's PA was found to be 942 kJ m o l1, 
showing a slight increase arising from the addition of the 2-methyl group.
210 211
Figure 7 41
During the study of 207, it was seen how the Z1 conformation was stabilised by 
interactions between the difluoromethylene moiety and nearby protons. As it appeared that 
only one fluorine atom would be required to achieve benzyl arm control, the iminium ions of 
diastereomers 210 and 211 were investigated (Figure 7.41).
212.E1 (0 kJ mol'1) 212.E2 (13.0 kJ mol'1)
Figure 7.42
212 was found to  have a Z-E energy difference of 14.4 kJ mol'1 and an E2 
conformation that lay 13.0 kJ mol'1 above the preferred E l conformation (Figure 7.42). 
Preferred conformation 212.El was seen to be stabilised by a hydrogen bond of 2.35 A 
between the fluorine atom and closest benzylic proton as well as a hydrogen bond between 
the iminium proton and amidic oxygen (2.28 A). 212.E2 was seen to be stabilised by a 
hydrogen bond of 2.03 A between the iminium proton and amidic oxygen but was also 
destabilised by close proximity between the fluorine atom and the n-system of the benzyl 
arm, as evidenced by an angle at the benzylic carbon between the imidazolidinone ring and 
phenyl ring of 115 °. 210's PA was found to be 966 kJ mol'1.
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213.E1 (10.6 kJ mol'1) 213.E2 (0 kJ mol'1)
Figure 7.43
213 was found to have a higher Z -E  energy difference of 22.3 kJ mol'1 but showed 
preference for 213.E2, which was seen to be stabilised by an interaction between the benzyl 
arm and proton geminal to the fluorine atom (Figure 7.43). 213.El was seen to have a 
relative energy of 10.6 kJ mol'1, and featured a close proximity of 2.07 A between the proton 
geminal to the fluorine atom and the nearest benzylic proton, an unfavourable interaction. 
211's PA was 971 kJ mol'1.
o
214
Figure 7 44
215.E1 (0 kJ mol'1) 215.E2 (15.0 kJ mol'1) 215.Z1 (13.0 kJ mol'1)
Figure 7.45
Applying the principals examined in the study of 210 and 211, 214 was devised 
(Figure 7.45). 215 was seen to have a Z -E  energy difference of 13.0 kJ mol'1, notable for a 2- 
monosubstituted imidazolidinone. 215.El was found to be the lowest energy conformation, 
stabilised both by a hydrogen bond from a benzylic proton to the fluorine atom (2.26 A) and 
by a hydrogen bond from the iminium proton to the amidic oxygen (1.94 A). 215.E2 showed a 
rotation of the methylpyrrolidinone ring so as to remove the n-fluorine repulsive interaction 
and attain a Ti-hydrogen bond. This rotation meant that the amidic oxygen pointed away 
from the rest of the iminium ion and was not engaged in hydrogen bonding. 215.Z1 showed
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the same rotation of the methylpyrrolidinone ring and consequently was not that much 
lower in energy than the Z2 conformation (18.8 kJ mol'1).
7.9 Conclusions
Three basic principles of iminium ion organocatalyst design were investigated 
independently and the findings combined to  design catalysts theoretically capable of 
unparalleled performance.
Calculated proton affinities were found to  be unsuitable for quantitative comparisons 
amongst structurally diverse catalysts but were found to  serve adequately as a rough 
indicator of catalytic potential.
The substitution pattern at the 2-position of imidazolidinones was varied and the 
effect upon the resultant catalysts' iminium ion geometric selectivity investigated. The 2,2- 
dimethyl substitution pattern was seen to  be optimal, both in theory and in practice. The 
ability to  alter substitution at the 2-position while maintaining good iminium ion geometry 
control was attained when hydrogen-bond acceptor substituents were employed to effect a 
selective hydrogen bond to  the iminium proton. A variety of hydrogen bond acceptors were 
evaluated and amidic oxygen atoms found to  be most suitable.
Two methods for effecting substrate shielding by asserting control over the benzyl 
arm conformational preference were investigated. The use of steric bulk to encourage a 
substrate-facing benzyl arm (E l) was found to  be somewhat effective, but frequently lead to 
a lower energy E3 conformation or a loss of iminium ion geometry control. Careful 
replacement o f hydrogen atoms w ith fluorine atoms was seen to eliminate favourable jt- 
hydrogen bonding and induce the desired conformational preference of the associated 
benzyl arm, while maintaining acceptable levels of iminium ion geometry control.
As evidenced by the catalytic impotence of 91HCI, fluorine atoms have very 
pronounced electron w ithdrawing effects and are best used in moderation (Figure 7.46). 
Accordingly, selective monofluorination of a 2-alkyl group would seem the most promising 
approach towards developing a functional catalyst based on the theoretical principals 
explored w ith in this chapter.
91
Figure 7.46
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7.10 Future Work
Bt
F
183
Figure 7.47
Experimental evaluation of 183 should be at the forefront of any further research into 
imidazolidinone catalyst development (Figure 7.47). 183 holds promise as a high 
performance highly stereoselective iminium organocatalyst.
The synthesis and evaluation of 201-HCI in the benchmark Diels-Alder reaction 
showed that incorporation of the 2 -(G-acetamido) moiety into an imidazolidinone catalyst 
may be expected to  reduce turnover but does not eliminate catalyst activity completely. As 
the incorporation o f a 2 -aryl group has been shown to  give rise to higher performance 
imidazolidinone catalysts, 198 appeared a good target for future experimental work. 198 
may theoretically be obtained from commercially available 216.
•HCI
201HCI 198 216
Figure 7.48
O
210 214
Figure 7.49
Finally, a catalyst w ith a pronounced theoretical preference for the E l conformation, 
such as 210 and 214, should be evaluated in conjugate addition reactions.
Chapter 8: C2-Symmetric Catalysts
8 C2-Symmetric Catalysts
8.1 Introduction
•h c io 4
20 mol% 136-HCIOi
R1 R2 Yield (%) ee (%)
217 c h 3 c h 3 85 61
218 c h 3 Et 89 90
219 c h 3 n-Bu 83 92
22 0 c h 3 /-Am 86 92
221 c h 3 /-Pr 24 0
222 n-Pr Et 84 92
223 /- Pr Et 78 90
Scheme 8.1
Work performed so far in this project had centered around the development of 
catalysts fo r a,B-unsaturated aldehyde substrates. To further leverage the understanding in 
catalyst design developed in this project, the possibility of developing imidazolidinone 
organocatalysts fo r use w ith a,B-unsaturated ketones was investigated. MacMillan describes 
the use of 136 HCI04 in catalysing the Diels-Alder reaction between a range of a,8 - 
unsaturated ketones and 6 (Scheme 8.1).63
116 224
Figure 8.2
As seen in Scheme 8.1, 136 did not achieve good stereocontrol when used with 217 
or 221. Poor enantiocontrol was also observed with 116 (48% ee) and 224 (63% ee) (Figure 
8.2). This showed that 136 had pronounced substrate specificity.
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225.Z 225. E
Figure 8.3
Condensation of 136 and 218 gives rise to 225.E and 225.Z (Figure 8.3). In the 
mechanism postulated by MacMillan, the methyl group a- to the iminium carbon bends out 
of the plane of the n-system.63 In both 225.E and 225.Z, the methyl group shields the Re face, 
while leaving the Si face exposed. Stereocontrol was therefore said to be achieved with 
either 225.E or 225.Z and geometric selectivity in iminium ion formation was not necessary.
The stereocontrol mechanism employed by 136 was seen to limit substrate scope and 
alternatives were sought. One alternative appeared to be catalysts with C2 rotational 
symmetry running through the active nitrogen atom. Such catalysts would not give rise to 
geometric isomers upon condensation with a substrate enone and may demonstrate a more 
general purpose technique for effecting stereocontrol.
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Scheme 8.4
226, described in MacMillan's seminal paper, was shown to  be capable of exerting 
some degree of stereocontrol in the benchmark Diels-Alder reaction, and showed precedent 
for the C2 symmetry approach (Scheme 8.4).2
8.2 Piperazine-2,6 -dione architecture
N ©h2 c r
41-HCI 
20 mol%
CH3OH, 25 °C, 24 h
6
5 eq.
Scheme 8.5
Ph
69%
One of the key catalysts discovered during previous investigations within the group, 
41-HCI, attained 69% conversion after 24 hours in the benchmark Diels-Alder reaction when 
used at 20 mol% in methanol (Scheme 8.5) .30 The piperazine-2,6 -dione architecture had been 
investigated w ith in the group by previous members and was thought to hold promise as the 
foundation around which a C2-symmetric catalyst capable o f catalyzing the reactions of 
ketones as well as aldehydes could be constructed.
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The formal addition o f two benzyl arms to 41 yielded 227, which appeared to be 
obtainable from (/?)-62 and 228 (Scheme 8 .6 ).
A -
6 h
228
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A solution o f 228 and triethylam ine in DCM was treated w ith triflic  anhydride and the 
solution allowed to  react over the course of 2 hours (Scheme 8.7). The DCM was evaporated 
and the residue extracted 6 times petroleum ether, yielding 229. 229, (/?)-62 and 
triethylam ine were stirred in DCM for 19 hours at room temperature. Aqueous workup and 
column chromatography yielded 230 (50%).
CH3ONa
Bn Bn Et2° .
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Scheme 8.8
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230 was stirred w ith sodium methoxide in diethyl ether at room temperature for 4 
hours then subjected to  aqueous workup and column chromatography to provide 227 (76%) 
(Scheme 8 .8 ). 227 HCI was formed by the usual method (53% overall).
6
2.5 eq.
10 mol% 227-HCI
19:1 
CH30H:H20, 
25 °C, 24 h
Scheme 8.9
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227 HCI was found to  be a very low performance catalyst in the benchmark Diels- 
Alder reaction, attaining only 34% conversion when used at 10 mol% in 19:1 methanokwater 
at 25 °C fo r 24 hours (Scheme 8.9). Enantiocontrol was also lacking, w ith ee's of 78% (8 ) and 
37% (9) noted. Experimental evaluation w ith an enone substrate was not performed.
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231.2.2 (9.0 kJ mol'1)231.1.1 (0 kJ mol'1) 231.1.2 (8.6 kJ mol'1)
231.1.1 (0 kJ mol"1) 231.1.2 (8.6 kJ mol'1) 231.2.2 (9.0 kJ mol'1)
Figure 8.10
227 was subjected to the standard computer modelling regime and its iminium ion 
(231) found to exhibit 3 low energy conformations (<19 kJ mol’1) (Figure 8.10). The preferred 
conformation, 231.1.1, could be expected to  effectively shield the top face of the substrate, 
while leaving the bottom face exposed. 231.1.2 may also shield the top face of the substrate 
but may disfavour a bottom-face e/ido-transition state. 231.2.2 appears to not fully shield the 
upper face of the substrate, as the nonplanarity of the piperazine-2,6-dione ring allows the 
substrate to  bend away from the upper shielding arm. Particularly low ee's were noted for 
the endo-product, 8 . This could be explained by the furthest benzyl arm partially blocking the 
bottom face of the substrate of 231.1.2 and 231.2.2 and selectively disfavouring the endo- 
transition state.
Perhaps due to the nonplanarity of its iminium ion, 227 was found to exert poor 
enantiocontrol in the benchmark Diels-Alder reaction. Turnover was also seen to be lacking. 
While synthetically accessible, the piperazine-2,6-dione architecture appeared to hold little  
promise as the scaffold around which a high performance C2-symmetric catalyst could be 
constructed and further investigations were not performed.
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8.3 C2-symmetic imidazolidinone
Y N) , . B n  = 5 .  “ ’y S t  +  J
NH2 Bn
232 62 233
Scheme 8.11
Although not a true C2-symmetric catalyst, 232 appeared a suitable candidate for 
investigation and was thought to  be obtainable from 62 and 233 using synthetic methods 
developed w ith in  this project (Scheme 8.11).
217 234.E 234.Z
Figure 8.12
Modelling work was undertaken to  estimate the stereoselectivity of 232. As the goal 
of the work performed w ith in  this chapter was to  develop a catalyst fo r use w ith enones, 217 
was used as a substrate, giving rise to  234.E and 234.Z (Figure 8.12).
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234.E2.2 (0 kJ mol'1) 234.Z2.2 (0.3 kJ mol'1) 234.E2.1 (6.4 kJ mol'1)
234.E3.2 (9.0 kJ mol'1) 234.Z2.1 (9.1 kJ mol'1) 234.Z3.2 (12.8 kJ mol'1)
Figure 8.13
The pseudo-isosteric pair of iminium ions 234.E2.2 and 234.Z2.2 were found to have 
the lowest energies (Figure 8.13). Unfortunately, in both cases, the benzyl arms appeared to 
block the top and bottom faces of the substrate thus equally disfavouring both desired and 
undesired transition states. The same lack of facial discrimination was apparent in 234.E2.1, 
234.E3.2 and 234.Z2.1. 234.Z3.2 appeared to selectively block the lower face but was 
considered too high in energy relative to  the other conformations to be significant.
Having observed the inability of 232's iminium ions to exhibit effective substrate 
shielding through modelling, it was considered that 232 would most likely show very poor 
enantiocontrol under experimental conditions and that its synthesis was not a worthwhile 
undertaking.
The modelling of 232 showed that a far greater degree of control over benzyl arm 
positioning would be required for any pseudo- or fully- C2-symmetric catalyst to  achieve good 
stereocontrol than for an asymmetric catalyst with good iminium ion geometry selectivity.
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8.4 Isoindolines
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Scheme 8.14
As a true C2-symmetric architecture with near-planarity, 235 appeared to hold 
promise as the basis o f a high performance C2-symmetric catalyst. To test its catalytic 
efficacy, commercially purchased 235-HCl was used at 20 mol% in the benchmark Diels-Alder 
reaction (Scheme 8.14). A fter 1 hour, 16% conversion was observed and after 24 hours, 94% 
conversion was observed. These results indicated that the isoindoline architecture may have 
potential fo r use in im inium ion organocatalysis if augmented w ith EWG's.
Modelling revealed 235 to  have a PA of 946 kJ m o l1, almost identical to that of 
benchmark catalyst 7 (945 kJ m o l1).
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Scheme 8.15
Publications were found in which 239 was obtained by deprotonation of an N- 
protected 235 derivative and quenching of the resultant anion w ith benzyl halides.79,80 In the 
method of Gawley e t  al., 235 was protected w ith a chiral auxiliary, alkylated at the 2- and 7- 
positions, then deprotected to  give 239 in 37% overall yield (Scheme 8.15).
Satisfied tha t the isoindoline architecture was both synthetically accessible and 
catalytically active, theoretical studies were undertaken to assess its potential for effecting 
enantiocontrol.
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»240.2.3 (5.7 kJ mol'1)240.2.2 (0 kJ mol-1) 240.1.2 (4.7 kJ mol"1)
240.3.2 (6.9 kJ mol'1) 240.1.3 (10.5 kJ mol'1) 240.2.1 (11.5 kJ mol'1)
Figure 8.16
The iminium ion arising from condensation of 239 and 217 was seen to have 9 
conformations, corresponding to  the 3 non-eclipsing positions of each benzyl arm, of which 6 
have relative energies of <15 kJ m o l1 (Figure 8.16). The lowest energy conformation 240.2.2 
appeared to block both the top and bottom face of the substrate a- to  the iminium carbon 
atom. This indicated that open transition state reactions would proceed freely but with no 
enantiocontrol, while closed transition state reactions would proceed slowly, if at all. 240.1.2 
and 240.3.2 exhibited uneven facial shielding but would still be expected react very slowly via 
closed transition states. 240.2.3 showed effective shielding of the top face of the substrate 
and allowed free approach towards the lower face of the substrate. This was also seen to be 
the case w ith 240.1.3 and 240.2.1.
As 3 of the 6 lowest energy conformations demonstrated the desired substrate 
shielding pattern, and the other 3 low energy conformations appeared unamenable towards 
closed transition state reactions, it was thought that 239 may have potential for use in the 
Diels-Alder reaction between 217 and 6 .
The proton affin ity of 239 was found to be 1010 kJ m o l1, higher than 235's proton 
affinity of 946 kJ m ol'1, and was seen as a forewarning of performance problems.
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242.2.2 (0 kJ mol'1 242.2.1 (4.6 kJ mol'1)
242.1.2 (4.9 kJ mol'1) 242.1.1 (11.9 kJ mol'1)
Figure 8.17
As 235 had shown a high PA (946 kJ mol'1) and a low turnover in the benchmark Diels- 
Alder reaction, it appeared that the isoindoline architecture may require EWG's to exhibit 
good performance. The formal addition of two trifluoromethyl groups to 239 (PA: 1010 kJ 
m o l1) yielded 241, which was seen to  have a PA of 967 kJ m o l1 (Figure 8.17). This indicated 
that EWG's should be positioned closer to the active nitrogen.
All of 242's 4 lowest energy conformations (<24 Id mol'1) appeared unselective 
towards open transition state reactions and unfavourable for closed transition state 
reactions. 241 therefore did not appear to have potential as an iminium ion organocatalyst.
8.5 Conclusions
v
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rrBn N Bn 
H
227 232
Bn
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Figure 8.18
136, the catalyst used by MacMillan for the Diels-Alder reaction with enones, attains 
good stereocontrol only w ith certain substrates (Figure 8.18). It was imagined that a C2-
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symmetric catalyst could exhibit good enantiocontrol w ith a wider range of substrates and 
work was undertaken to  investigate this idea.
227 was found to  exhibit poor enantiocontrol in the benchmark Diels-Alder reaction 
and computer modelling showed its iminium ions to  be nonplanar, w ith the benzyl arms 
providing poor quality shielding.
232 in itia lly appeared an attractive compromise, utilising the well-tested 
imidazolidinone architecture yet also exhibiting pseudo-C2 symmetry. However, computer 
modelling showed tha t the shielding provided by the benzyl arms failed to  differentiate 
between the tw o  faces of the substrate and did not appear likely to  induce good 
enantiocontrol under experimental conditions.
After verifying tha t it could exhibit catalytic activity in the benchmark Diels-Alder 
reaction, the expected stereocontrol of the isoindoline architecture was investigated. 239 
appeared likely to  attain a moderate level of enantiocontrol in a closed transition state 
reaction and was the most attractive candidate for experimental evaluation.
While the concept of C2-symmetric iminium ion organocatalysts was a novel idea, it 
became apparent tha t the requirement for substrate shielding that clearly differentiates 
between the upper and lower faces of a substrate rendered its implementation a difficult 
undertaking. It is now thought tha t progress may be realised more easily by focussing on the 
design o f structural features able to  induce iminium ion geometry selectivity w ith enone 
substrates and using a single benzyl arm for substrate shielding.
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9 Conclusions and Future Work
9.1 Overview
At the  outset of this project, 3 primary lim itations of iminium organocatalysis were 
identified:
- High catalyst loadings
- Low tem perature requirements fo r conjugate additions
- Specificity fo r aldehyde substrates
Accordingly, this project aimed to  develop catalysts w ith (i) increased efficiency, (ii) 
the ability to  perform conjugate additions at ambient temperature, and (iii) the ability to 
accelerate the  reactions o f enone as well as enal substrates.
110 214 239
Figure 9.1
The firs t goal was realised w ith the synthesis and evaluation of 110 , a catalyst capable 
o f attaining very high performance in the Benchmark reaction, while still exhibiting good 
stereocontrol-
The second goal was not realised experimentally, although modelling work 
investigated the structural features required fo r such a catalyst and arrived at likely 
candidates fo r  experimental evaluation, such as 214.
The th ird goal was also not realised experimentally. However, theoretical 
investigations elucidated structures w ith potential fo r use w ith enones, such as 239.
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9.2 Architectural Comparisons
OTMS
Ar = 3,5-(CF3)2C6H6
7 11
Figure 9.2
Before this work was performed, no direct comparison between imidazolidinone and 
prolinol ether organocatalysts in the Diels-Alder reaction had been performed. The work in 
Chapter 3.5 showed tha t 7 outperformed 11 in the benchmark Diels-Alder reaction, under 
the conditions examined. This result filled a gap in the literature and validated this project's 
focus on the imidazolidinone architecture.
9.3 EWG Investigation
In Chapters 2 and 4, an investigation into the ability o f EWGs to improve the rate of 
reaction catalysed by imidazolidinones was undertaken. 78 and 89 were synthesised, but 
could not be converted to  the ir hydrochloride salts. 78 and 89 both failed to exhibit catalytic 
activity when used in the benchmark reaction w ith  1 equivalent of hydrochloric acid.
90-HCI and 91-HCI were synthesised but found to  be catalytically inactive, presumably 
due to the vastly reduced nucleophilicity of the free amines. Reinforcing this hypothesis was 
the observation tha t both 90-HCI and 91-HCI readily revert to  the corresponding free amines 
when dried in vacuo. Before this project was undertaken, no upper limits to the strength of 
an EWG on an im inium organocatalyst had been envisaged. It has now been shown that 
positioning very strong EWG's close to  the active nitrogen can render an imidazolidinone 
catalytically inactive.
78 89
Figure 9.3
90 91
Figure 9.4
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33 had previously been discovered and evaluated w ith in the group and was found to 
exhibit far higher performance than benchmark catalyst 7, but lower levels of stereocontrol. 
Starting out w ith  the postulate that increasing steric bulk at the 2-position of the 
imidazolidinone ring may improve im inium geometry selectivity and enhance overall 
stereocontrol, ten imidazolidinones were synthesised and the ir hydrochloride salts evaluated 
in the benchmark reaction.
n HCI 
5 mol% 110HCI
19:1 
CH30H:H20. 
25 °C, 2h
2.5 eq. 97% ee 87% ee
97%
Scheme 9.6
5 mol% 110-HCI was seen to  catalyse 97% conversion in the benchmark reaction after 
2 h. When optically pure catalyst was used, product ee's o f 97% (8 ) and 87% (9) were 
observed. When 110-HCI was used at 1 mol%, the benchmark reaction ran to completion 
overnight at room tem perature, attaining 95% (8 ) and 8 8 % (9) ee.
110-HCI was the first imidazolidinone catalyst able to  attain substantially higher 
performance than benchmark catalyst 7 while still maintaining comparable levels of 
stereocontrol. It is possible that fu rther screening of conditions and co-acids (such as TFA, 
found particularly effective in Chapter 3.5) could further boost 110's enantiocontrol.
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9.4 Synthetic Development
Bn
NH2
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79 R = Ph
92 R = CH3
CHCI3
84 R = Ph (63%)
93 R = CH3 (100%)
Cu(OTf)2
MW, dry CH3CN BrfXX
78 R1 = Ph, R2 = CF3 (34%)
89 R1 = CF3, R2 = Ph (29%) 
91 R1 = CH3, R2 = CF3 (13%)
90 R1 = CF3, R2 = CH3 (14%)
Scheme 9.7
A search of the literature revealed only 4 reports o f 2-fluoroakylimidazolidin-4-ones. 
Three of these reports attained the products via inflexible mineral acid-based syntheses; the 
fourth provided no experimental details .81-83,1 The synthetic methodology developed in 
Chapter 2.5 and Chapter 2.7 thus represents the first potentially general purpose synthetic 
route to  this class of compound, using relatively mild conditions and delivering the products 
in reasonable yields (Scheme 9.7).
NH,
Imidazolidinone
O
JJ
R2^ R 3 
1 or 2 eq.
1 mol% Yb(OTf)3
CHCI3, 
reflux, 8h
R2 R3
y/
H 'R3
yield
Bn Me Me 96% >99%
Bn fBu 22% >99%
136 Bn 32% >99%
137 3-lndolyl-CH2 'Bu 26% >99%
138 /V-Bn-3-lndolyl-CH2 fBu 26% >99%
139 CH3 fBu 77% >99%
140 'Bu
Figure 9.8
55% 0%
The use of Lewis acids such as ytterb ium (lll) trifla te  fo r synthesis of imidazolidinones 
was investigated. This research lead to  a general purpose air- and water-insensitive one-step
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reaction, allowing widely used imidazolidinone catalysts to  be obtained in good yields with 
negligible loss of optical purity (Figure 9.8).
o o
Bn
22 mol% MsOH
MW, DMF, 
150 °C, 60 m
Bn'
H
N02
62 112 110
11%, >99% ee
Scheme 9.9
While attem pting to  boost the stereocontrol o f 110, it was found that the use of 
ytterbium (lll) trifla te  induced loss o f enantiopurity both when used under thermal and 
microwave conditions. Alternative methods of synthesis were investigated and a method 
arrived upon tha t allowed 11 0  to  be synthesised in one step under microwave conditions in 
11% yield w ith  99% ee (Scheme 9.9)
While not the primary goal o f this project, development o f synthetic methodology 
was found to  be a necessary prerequisite to  investigation of the catalytic activity of promising 
target structures. The methodology developed has allowed the evaluation of novel catalysts 
and has also opened up synthetic access to the imidazolidinone architecture, removing 
impediments to  future investigations both from w ithin and also from outside the group.
9.5 Improved Stereocontrol
In Chapter 4.21, The development of 1H NMR analysis of a thermodynamic 
distribution o f im inium ions as a tool fo r discerning the geometric selectivity of an iminium 
ion organocatalyst was developed. In Chapter 6.3, a computational method fo r calculating 
the same metric was developed and found to  achieve good agreement w ith the experimental 
method.
These techniques showed that 110 attained far greater geometric selectivity than 33 
yet still fell short of the geometric selectivity attained by benchmark catalyst 7 (Figure 9.10). 
A good agreement between geometric selectivity and stereocontrol in the benchmark Diels- 
Alder reaction was noted, suggesting that fo r an iminium ion organocatalyst to  attain good 
levels o f stereocontrol, it must firs t attain good levels of iminium ion geometry control.
33 110 7
Figure 9.10
164
Br
F H
183 198
Figure 9.11
A thorough computational investigation of the structural motifs that may be used to 
effect im inium ion geometry control was performed. This investigation showed that limited 
control may be achieved by relying upon the use of steric hindrance and that the use of 
tactically positioned hydrogen bond acceptors appears more effective and allows greater 
flexibility in catalyst design. This principle was used in the design of 183 and 198 (Figure 
9.11).
Modelling work was undertaken to  establish the role of the benzyl arm feature of 
imidazolidinone catalysts in effecting stereocontrol. The favoured position of the benzyl arm 
was found to  correlate w ith a catalyst's ability to  attain stereocontrol in open and closed 
transition state reactions. The modelling of 7, 2 and 91 showed the different conformational 
preferences of 7 vs. 2 and 91 and elucidated two mechanism by which benzyl arm position 
may be controlled (Figure 9.12). As the steric method of benzyl arm control, embodied by 2, 
appeared less effective and had detrimental effects on calculated iminium ion geometry 
control, the electronic method embodied in 91 appeared to have the greatest potential for 
incorporation in to a useful catalyst.
The electronic method of benzyl arm control was used in designing 210 and 214, both 
of which are expected to  exhibit good stereocontrol in open transition state reactions, such 
as the conjugate addition of indoles to a,G-unsaturated aldehydes.
7 2 91
Figure 9.12
210 214
Figure 9.13
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9.6 Background Reaction
6
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Scheme 9.14
In Chapter 4.3, 5 mol% 107-HCI was found to  attain 4% conversion after 6 hours in the 
benchmark Diels-Alder reaction at 25 °C (Scheme 9.14). As 107-HCI was incapable of forming 
iminium ions, one or more alternative mechanisms must have been responsible for 
formation of 8  and 9.
6
2.5 eq.
110HCI
19:1 
CH30H:H20, 
rt, 4 h
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Ph
Scheme 9.15
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When the benchmark Diels-Alder reaction was run multiple times w ith 110-HCI of 
differing enantiopurity, a correlation between the ee o f each product and catalyst ee was 
noted (Figure 9.16, 9.17). W ithin the relatively large margins of error in these experiments, 8  
ee roughly matched the ee of 110-HCI, indicating that the reactions giving rise to  8  were 
exclusively bimolecular reactions proceeding through the iminium ion. 9 ee's appeared, 
within error margins, to  be lower than 110 ee's by a consistent amount. This indicated that a 
non-stereoselective side reaction was occurring and was responsible for approximately 9% 
conversion.
As 107-HCI effected only 4% form ation of 8  and 9 in 6 hours, it can be said that the 
side reaction occurring in the presence o f 110-HCI is substantially faster than the dominant 
reaction occurring in the presence of 107-HCI. As 110-HCI is suspected to be more acidic than 
107-HCI, it appeared possible tha t acid catalysis was the mechanism in both cases. This 
suggested tha t careful tuning o f catalyst acidity and counterion basicity may minimise side 
reactions and allow greater stereoselectivity to  be attained in the iminium ion 
organocatalysed Diels-Alder reaction.
9.7 Future w ork
N Ph o N Ph 6
183 198 210 214
Figure 9.18
Having identified structural motifs tha t may be used to  enhance iminium geometry 
control and substrate shielding, multiple target structures incorporating these motifs were 
posited fo r experimental evaluation (Figure 9.18). Unfortunately, due to time constraints, no 
experimental evaluation of these target structures could be performed. Future work should
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therefore focus first on experimental appraisal of the theoretical work performed in Chapter 
7, before additional modelling work is undertaken.
Bn
107-HCI
I -HCI 
243HCI
Figure 9.19
Investigations into background reaction rates in the benchmark Diels-Alder reaction 
showed tha t side reactions appeared to  be occurring and tha t acid catalysis was a likely 
mechanism. To investigate further, 243-HCI could be synthesised and used in the benchmark 
Diels-Alder reaction. 243-HCI is predicted to  induce greater conversion than 107-HCI and 
produce products w ith  extremely low ee's.
Screening of co-acids fo r use w ith 110 would be a quick and easy way to explore the 
potential of this imidazolidinone. As the analysis in Chapter 9.6 makes the case that a loss in 
enantiopurity in the benchmark reaction may be occurring largely through an acid-catalysed 
reaction, there is a good chance that use of an alternative co-acid could boost 110 's 
enantiocontrol beyond the levels demonstrated by benchmark catalyst 7.
Finally, theoretical inroads were made towards targeting enone substrates. The 
isoindoline architecture showed some promise fo r use w ith enones in closed transition state 
reactions, w ith  239 being w orthy of experimental evaluation.
The concept o f C2-symmetric im inium catalysts appeared valid but was shown to 
require very well defined substrate shielding to  be effective. Hence, future work should focus 
on the elucidation of structural motifs able to  control iminium geometry w ith enone 
substrates.
H
110
Figure 9.20
Bn
Bn
239
Figure 9.21
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Chapter 10: Experimental
10 Experimental
10.1 General Procedures
Commercially available solvents and reagents were used w ithout further purification. 
Petroleum ether refers to  the fraction w ith bp 40-60 °C and ether refers to  diethyl ether. 
Flash chromatography was carried out using Merck Kieselgel 60 H silica or Matrex silica 60. 
Analytical th in  layer chromatography was carried out using aluminium-backed plates coated 
with Merck Kieselgel 60 GF254 that were visualized under UV light (at 254 and/or 360 nm). 
Infra-red (IR) spectra were recorded in the range 4000-600 cm-1 using KBr disks for solid 
samples and th in  films between NaCI plates for liquid samples or as a nujol mull and are 
reported in cm-1. Nuclear magnetic resonance (NMR) spectra were recorded in CDCI3 at 21 °C 
and were reported in ppm; J values were recorded in Hz and multiplicities were expressed by 
the usual conventions. Low-resolution mass spectra (MS) were determined using 
electrospray ionization (ES) unless otherwise stated. APCI refers to  atmospheric pressure 
chemical ionization, Cl refers to  chemical ionization (ammonia) and El refers to electron 
ionization. High-resolution mass spectra were obtained courtesy of the EPSRC Mass 
Spectrometry Service at University of Wales, Swansea, U.K. using the ionization methods 
specified. In vacuo refers to  evaporation at reduced pressure using a rotary evaporator and 
diaphragm pump, followed by the removal o f trace volatiles using a vacuum (oil) pump.
10.2 Benchmark Reaction Development
5 mol% CatalystHCI
19:1 
CH3O H : H20,
2.5 eq.
Scheme 10.1
As part o f this project, a catalyst benchmarking reaction was developed, based on the 
Diels-Alder described by MacMillan in his seminal publication. A lower catalyst loading of 5 
mol% was used to  allow more accurate monitoring of high performance catalysts, while a 
slightly lesser excess o f freshly distilled 6 was found necessary to avoid biphase formation 
under certain conditions (Scheme 10.1). The temperature was conveniently fixed at 25 °C, 
and reactions were run fo r 4 hours. To hydrolyse dimethylacetals and ensure that 5, 8  and 9 
were not present in other forms, crude reaction mixtures were stirred vigorously with TFA, 
water, and chloroform  for 2 hours at room temperature. Shorter hydrolysis periods were
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investigated, but were found not to reliably hydrolyse all species. Extended hydrolysis 
periods of up to 6 hours were found not to alter the 8:9 ratio or ee of either product. To 
monitor the relative concentrations of 5, 8 and 9 with respect to time, periodic aliquots were 
removed from the reaction, hydrolysed, and after basic workup, subjected to XH NMR.
L ,___1
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Figure 10.2
As the species of interest were all present as aldehydes, integration of the aldehyde 
region of the 1H NMR spectra was found the most suitable technique for assaying relative 
abundances (Figure 10.2). Using this technique, results could be obtained with an estimated 
error margin of <1%.
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Scheme 10.3
To assay the enantiopurities of 8 and 9, a technique previously developed within the 
group was used (Scheme 10.3). The crude reaction mixture was subjected to column 
chromatography (1:9 ethyl acetate:petroleum ether) to isolate a mixture of 8 and 9. The 
aldehydes were then stirred with an excess of 244 in ethanol for 3 hours at room 
temperature before the ethanol was evaporated and column chromatography (1:3 ethyl 
acetate:petroleum ether) used to provide a mixture of 245 and 246 as an air-stable yellow 
solid.
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Figure 10.4
The mixtures of 245 and 246 were dissolved in their entirety in acetonitrile then 
subjected to HPLC on a Chiralcel OD-R reverse phase column (1:3 water:acetonitrile) and the 
enantiopurities of 245 and 246 determined by integration of UV absorbance at 358 nm 
(Figure 10.4).
Using this protocol, repeated analyses of mixtures of 8 and 9 yielded consistent 
results, with overall variations of <1%.
10.3 Final Benchmark Reaction
The catalyst freebase or hydrochloride salt (1.0 mmol) was dried by heating at 50 °C 
for 60 minutes under high vacuum (1 mbar). The reaction solvent, either toluene (5 ml_), or 
methanol (4.75 mL) and water (0.25 ml_), was then added, followed by TFA (0.148 mL, 0.228 
g, 2.0 mmol) if required. 5 (0.630 mL, 0.661 g, 5.00 mmol) was added and the mixture was 
stirred at 25 °C for 10 minutes. The timer was started as freshly distilled 6 (0.995 mL, 0.826 g,
12.5 mmol) was added. Stirring was continued at 25 °C for 6 hours, during which time
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samples were taken at periodic intervals, before the reaction was terminated by the 
evaporation of 6 and methanol. Chloroform (6  mL), trifluoroacetic acid (3 mL) and water (3 
mL) were added and the biphasic mixture was stirred vigorously for 2 hours, before being 
poured into potassium carbonate (4 M, 30 mL), extracted w ith diethyl ether (30 mL), and 
washed w ith brine (30 mL). The remaining diethyl ether was evaporated and the residue 
separated by column chromatography (1:10  ethyl acetate:petroleum ether) to  yield a 
mixture of 8  and 9 (Rf: 0.36) as a clear oil.
8  and 9 were stirred w ith 244 (1.2 equivalents) in ethanol (10 mL) for 3 hours before 
the ethanol was evaporated and the residue separated by column chromatography (1:3 ethyl 
acetate:petroleum ether) to  yield a mixture of 245 and 256 (Rf: 0.30) as a bright yellow solid.
The mixture o f 245 and 256 dissolved in acetonitrile (5 gL'1) and 2 pL of the solution 
injected onto a Chiralcel OD-R column, eluted w ith 1:3 water:acetonitrile at a flow rate of 
0.85 mL min 1 and the analytes detected by UV absorbance at 358 nm. Retention times for 
the hydrazones were: 20.4 min (major 245), 33.7 min (m inor 245), 38.1 min (major 246), 52.0 
min (minor 246).
At each sampling tim e during the reaction, an aliquot of the reaction mixture (0.15 
mL) was evaporated (40 °C, 20 mbar, 4 minutes) before chloroform (2 mL), water (1 mL), and 
TFA (1 mL) were added and the biphase stirred vigorously fo r 2 hours before being poured 
into potassium carbonate (4 M, 10 mL), extracted w ith diethyl ether (10 mL), washed with 
brine (10 mL) then evaporated (40 °C, 20 mbar, 4 minutes) and the residue taken up in CDCI3 
(0.7 mL) fo r analysis by 1H NMR.
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10.4 Standard Preparation A: 2-Aryl-imidazolidinones
Solvent Rf % Yield Rf % Yield
3:1 ethyl acetate:petrol 33 0.37 41* 104 0.15 35*
ethyl acetate 110 0.47 36 111 0.21 35
3:1 ethyl acetate:petrol 119 0.38 29 120 0 .11 39
ethyl acetate 121 0.46 33 122 0.24 28
ethyl acetate 123 0.53 36 124 0.25 36
ethyl acetate 125 0.43 2 i * * 126 0.19
2:1 ethyl acetate:petrol 169 0.34 32 170 0.15 14
*Prepared under microwave conditions **As the hydrochloride salt
Figure 10.5
2-Aryl imidazolidinones were formed accordingly: A toluene solution of L- 
Phenylalanine /V-methylamide 62 (0.6 M), the appropriate carbonyl compound (0.9 eq.), and 
ytterbium (lll) trifluorom ethanesulfonate (0.05 eq.) were refluxed in toluene for 16-69 h. 
Diethyl ether (2 vol.) was added and the solution washed w ith 4 M potassium carbonate (0.3 
vol.), water (0.3 vol.), and brine (0.3 vol.), then evaporated and the desired products 
obtained by column chromatography (Figure 10.5).
10.5 Standard Preparation B: MacMillan imidazolidinones
Solvent Rf % Yield Rf % Yield
ethyl acetate 7 0.32 96 - - -
3:1 ethyl acetate:petrol 2 0 .22 22 151 0.36 46
ethyl acetate 136 0 .22 32 152 0.46 58*
ethyl acetate 137 0.15 26 153 0.35 36*
ethyl acetate 138 0.14 26 247 0.46 -
ethyl acetate 139 0.16 77 n.d - -
4:1 ethyl acetate:methanol 140 0.3 55 - - -
*N ot using final reaction conditions
Figure 10.6
MacMillan imidazolidinones were formed accordingly: A chloroform solution of the 
amino amide (0.6 M), the appropriate aldehyde or acetone (2 eq.), and ytterbium(lll) 
trifluoromethanesulfonate (0 .0 1  eq.) was refluxed fo r 16 hours, after which the solvent was 
evaporated and the products isolated via column chromatography (Figure 10.6).
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10.6 Standard Preparation C: hydrochloride salts
Hydrochloride salts were formed as follows: a solution of the amine in diethyl ether 
was treated w ith hydrogen chloride gas fo r 10  minutes before the precipitate was filtered, 
washed w ith diethyl ether and petroleum ether, then dried in vacuo.
10.7 Compounds
(25,55)-5-Benzyl-2-tert-butyl-3-methylimidazolidin-4-one 2
Prepared according to  Standard Preparation B. vmax (NaCI disk)/cm_1 3354, 2975, 1676, 1392, 
1340, 1106; XH NMR (500 MHz, CDCI3) 6 H 7.24-7.14 (5H, m, ArH), 3.99 (1H, s, CH3NCH), 3.64 
(1H, dd, J = 7.3 Hz, 3.9 Hz, COCH), 3.08 (1H, dd, J = 13.7 Hz, 3.9 Hz, CH2), 2.87 (1H, dd, J = 13.7 
Hz, 7.3 Hz, CHz), 2.85 (3H, s, NChb), 0.76 (9H, s, CCH3); 13C NMR (125 MHz, CDCI3) 6 C 175.3 (C),
137.9 (C), 129.6 (CH), 128.6 (CH), 126.6 (CH), 82.5 (CH), 59.4 (CH), 38.3 (CH2), 35.0 (C), 30.7 
(CH3), 25.3 (CH3); LRMS m/z  (ES+) [M+H]+ = 247.2; HRMS m/z  (ES+) [M+H]+ = 247.1803; HRMS 
m/z calc. [M+H]+ = 247.1810; Mpt. 78-80 °C; [a ]D30 -48.6 (c 0.1, CH3OH).13
(2S,5S)-5-Benzyl-2-terf-butyl-3-methylimidazolidin-4-one hydrochloride 2-HCI
•HCI
Prepared according to  Standard Preparation C. vmax (NaCI disk)/cm 1 3423, 1723, 1478, 1412, 
1261, 1083; LRMS m/z (AP+) [M —Cl]+ = 247.2; HRMS m/z  (ES+) [M -CI]+ = 247.1801; HRMS m/z 
calc. [M -C I]+ = 247.1810; Mpt. 124-126 °C; [a ]D34-23.0 (c 0.1, CH3OH).
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(5)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one 7
L-Phenylalanine /V-methylamide 62 (0.467 g, 2.62 mmol), acetone (1.92 mL, 1.52 g, 26.1 
mmol) and ytterb ium (lll) trifluoromethanesulfonate (0.016 g, 0.026 mmol) were refluxed in 
chloroform (26 mL) fo r 16 hours, poured into diethyl ether (50 mL), washed with potassium 
carbonate (4 M, 25 mL), water (25 mL), and brine (25 mL), then evaporated to  yield the 
desired product, a clear oil (0.503 g, 2.31 mmol, 8 8 %). vmax (NaCI disk)/cm_1 3318, 2975, 
1682, 1428, 1400, 1148, 1090, 748, 702; *H NMR (500 MHz, CDCI3) 6 H 7.29 (2H, t, J = 7.2 Hz, 
ArH), 7.23-7.20 (3H, m, ArH), 3.79 (1H, dd, J = 6 .8  Hz, 4.5 Hz, COCH), 3.14 (1H, dd, J = 14.2 Hz,
4.5 Hz, CH2), 3.00 (1H, dd, J = 14.2 Hz, 6 .8  Hz, CH2), 2.74 (1H, s, NCH3), 1.25 (3H, s, CCH3), 1.15 
(3H, s, CCH3); 13C NMR (125 MHz, CDCI3) 6 C 173.4 (C), 137.2 (C), 129.5 (CH), 128.6 (CH), 126.8 
(CH), 75.6 (C), 59.3 (CH), 37.2 (CH2), 27.2 (CH3), 25.3 (CH3), 25.2 (CH3); LRMS m/z  (ES+) [M+H]+ 
= 219.1; HRMS m/z  (ES+) [M+H]+ = 219.1492; HRMS m/z calc. [M+H]+ = 219.1497; [a ]D30 -57.8 
(c 0.1, CH3OH).2
(5)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one hydrochloride 7-HCI
Bn
•HCI
Prepared according to  Standard Preparation C. vmax (NaCI disk)/cm_1 3403,1711, 1455,1428, 
1396, 1273, 1159, 1061; *H NMR (500 MHz, CD3OD) 6 H 7.34 (2H, d, J = 7.2 Hz, o-ArH), 7.30 
(2H, t, J = 7.8 Hz, m-ArH), 7.22 (1H, t, J = 7.3 Hz, p-ArH), 4.57 (1H, dd, J = 10.7 Hz, 3.5 Hz, 
COCH), 3.43 (1H, dd, J = 15.2 Hz, 3.5 Hz, CPU), 2.99 (1H, dd, J = 15.2 Hz, 10.7 Hz, Chh), 2.82 
(3H, s, NCJi), 1.65 (3H, s, CCH3), 1.50 (3H, s, CCH3); 13C NMR (125 MHz, CD3OD) 6 C 167.7 (C),
136.6 (C), 130.3 (CH), 130.2 (CH), 128.8 (CH), 79.1 (C), 59.8 (CH), 35.0 (CH2), 25.7 (CH3), 24.3 
(CH3), 22.2 (CH3); LRMS m/z  (ES+) [M+H]+ = 219.1; Mpt. 133-134 °C; [a ] D30 -60.6 (c 0.1, 
CH3OH).2
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(2/?,55)-5-Benzyl-3-methyl-2-(4-nitrophenyl)imidazolidin-4-one 33
Prepared according to  Standard Preparation A. vmax (NaCI disk)/cm_1 1699, 1522, 1349; 1H 
NMR (500 MHz, CDCI3) 6 H 8.15 (2H, td, J = 6.9 Hz, 1.8 Hz, ArH), 7.26-7.17 (7H, m, ArH), 4.88 
(1H, s, NCH3CH), 4.98-5.00 (1H, m, COCH), 3.06 (1H, dd, J = 13.8 Hz, 4.2 Hz, CH2), 2.94 (1H, 
dd, J = 13.8 Hz, 6.9 Hz, CH2), 2.52 (3H, s, NCH3); 13C NMR (125 MHz, CDCI3) 6 C 174.0 (C), 148.5 
(C), 146.5 (C), 137.0 (C), 129.6 (CH), 128.6 (CH), 127.8 (CH), 127.0 (CH), 124.3 (CH), 76.6 (CH),
59.7 (CH), 38.6 (CH2), 28.3 (CH3); LRMS m/z  (El+) [M ]+ = 311.0; HRMS m/z (El+) [M ]+ = 
311.1260; HRMS m/z calc. [M ]+ = 311.1270; [a ] D32 21.8 (c 0.1, CH2CI2).30
(25,55)-5-Benzyl-3-methyl-2-(4-nitrophenyl)imidazolidin-4-one hydrochloride 33-HCI
BnXN> CXNo*
Bn H
•HCI
Prepared according to  Standard Preparation C (85%). vmax (NaCI disk)/cm-1 1739, 1555, 1514, 
1349; *H NMR (500 MHz, CD3OD) 6 H 8.40 (2H, dt, J = 8 .8  Hz, 2.5 Hz, o-N02ArH), 7.79 (2H, dt, J 
= 8 .8  Hz, 2.5 Hz, /T7-N0 2ArH), 7.45 (2H, d, J = 7.2 Hz, o-CH2ArH), 7.40 (2H, t, J = 7.8 Hz, m- 
CH2ArH), 7.33 (1H, tt, J = 7.3 Hz, 2.13 Hz, p-CH2ArH), 6.10 (1H, s, ArCH), 4.72 (1H, dd, J = 10.3 
Hz, 3.6 Hz, COCH), 3.59 (1H, dd, J = 15.1 Hz, 3.6 Hz, CH2), 3.21 (1H, dd, J = 15.1 Hz, 10.3 Hz, 
CH2), 2.88 (3H, s, CH3); 13C NMR (125 MHz, CD3OD) 6 C 170.0 (C), 149.2 (C), 137.0 (C), 131.1 
(CH), 129.6 (CH), 128.9 (CH), 127.2 (CH), 124.2 (CH), 73.3 (CH), 59.2 (CH), 35.0 (CH2), 28.3 
(CH3); LRMS m/z  (ES+) [M -C I]+ = 312.1; HRMS m/z (ES+) [M -C I]+ = 312.1345; HRMS m/z calc. 
[M -CI]+ = 312.1348; decomp. 132-135 °C; [a ] D34 2.2 (c 0.1, CH3OH).30
Glycine /V-methylamide 42
o
H
Glycine ethyl ester hydrochloride (5.23 g, 37.5 mmol) was stirred in a 33% w /w  ethanolic 
solution of methylamine (25 mL, 6.24 g, 201 mmol) at 50 °C for 30 minutes before sodium 
hydroxide (1.61 g, 40.4 mmol) was added and stirring continued for 3 minutes. The mixture 
was evaporated to  give a slurry then extracted w ith ethyl acetate (2 x 50 mL), which was 
filtered and removed in vacuo to  yield the desired product, a clear oil (2.56 g, 29.1 mmol,
177
77%). vmax (NaCI disk)/cm -1 3353, 3101, 2947, 1659, 1564, 1414, 1312, 1161; XH NMR (500 
MHz, DMSO-d6) 6 h 7.79 (1H, bs, CONH), 3.06 (2H, s, CH2), 2.61 (3H, d, J = 4.7 Hz, CH3), 1.89 
(2H, s, NH2); 13C NMR (125 MHz, DMSO-d6) 6 C 173.6 (C), 45.3 (CH2), 25.7 (CH3); LRMS m/z  (El+) 
[M ]+ = 88.1; HRMS m/z  (El+) [M ]+ = 88.0634; HRMS m/z calc. [M ]+ = 88.0637.69
Piperazine-2,6-dione 46
H
Glycine methyl ester hydrochloride (10.0 g, 79.1 mmol), 2-bromoacetamide (11.0 g, 79.7 
mmol) and potassium bicarbonate (20.0 g, 200 mmol) were refluxed in acetonitrile (600 mL) 
for 23 hours then stirred at room temperature fo r 42 hours. The solution was evaporated 
and the residue dissolved in methanol (100 mL). Diethyl ether (100 mL) was then added and 
the precipitate filtered and washed w ith diethyl ether (100 mL) then dried to yield the 
desired product, a white solid (2.0 g, 18 mmol, 23%). vmax (NaCI disk)/cm-1 3434, 1644; *H 
NMR (400 MHz, DMSO-d6) 6 H 10.85 (1H, bs, CONH), 3.37 (4H, d, J = 7.0 Hz, CH2), 3.08 (1H, t, J 
= 8.4 Hz, CH2NH); 13C NMR (62.5 MHz, DMSO-d6) 6 C 173.3 (C), 48.4 (CH2); LRMS m/z (El+) [M ]+ 
= 114.0; HRMS m/z  (El+) [M ]+ = 114.0424; HRMS m/z  calc. [M ]+ = 114.0429; decomp. 158 °C.
tert-Butyl 3,5-dioxopiperazine-l-carboxylate 50
N |
0X 0J <
Piperazine-2,6 -dione 46 (1.04 g, 9.11 mmol) and di-tert-butyl dicarbonate (1.97 g, 9.02 mmol) 
were stirred fo r 17 hours in DMF (15 mL). Water (25 mL) was then added and the mixture 
extracted w ith diethyl ether (2 x 50 mL). The combined diethyl ether was then washed with 
water (4 x 50 mL) and brine (50 mL) then evaporated to  yield the desired product, a white 
solid (1.05 g, 4.90 mmol, 54%). vmax (NaCI diskJ/cnrT1 3429, 2981, 1736, 1700; *H NMR (500 
MHz, CDCI3) 6 h 9.05 (1H, bs, NH), 4.24 (4H, s, CH2), 1.41 (9H, s, CH3); 13C NMR (125 MHz, 
CDCI3) 6 c 168.7 (C), 153.1 (C), 82.4 (C), 46.5 (CH2), 28.2 (CH3); LRMS m/z (El+) [M ]+ = 214.1; 
HRMS m/z  (El+) [M ]+ = 214.0950; HRMS m/z  calc. [M ]+ = 214.0954; Mpt. 124-126 °C.
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Diethyl 2,2'-(te/t-butoxycarbonylazanediyl)diacetate 56
o o
Diethyliminodiacetate (3.0 g, 16 mmol) and di-tert-butyl dicarbonate (3.2 g, 15 mmol) were 
stirred in THF (10 mL) for 26 hours then evaporated to give a residue, which was dissolved in 
ethyl acetate (40 mL) and washed with citric acid (1 M, 2 x 30 mL) and brine (30 mL) then 
evaporated to yield the desired product, a clear oil (4.4 g, 15 mmol, 100%). vmax (NaCI 
diskj/crrf1 3433, 2980, 1750, 1706, 1646, 1191; XH NMR (500 MHz, CDCI3) 6 H 4.12 (4H, m, 
CH3 CH2 ), 4.04 (2H, s, NCH2 ), 3.93 (2H, s, NCH2 ), 1.37 (9H, s, CCH3), 1.21 (6 H, q, J = 7.3 Hz, 
CH2 CH3 ); 13C NMR (125 MHz, CDCI3) 6 C 169.7 (C), 169.6 (C), 155.0 (C), 80.8 (C), 61.0 (CH2),
60.9 (CH2), 49.6 (CH2), 49.0 (CH2), 28.0 (CH3), 14.1 (CH3), 14.0 (CH3); LRMS m /z  (ES+) [M+Hf = 
290.2; HRMS m /z  (ES+) [M+NH4]+ = 307.1860; HRMS m /z  calc. [M+NH4]+ = 307.1869.
L-Phenylalanine /V-methylamide 62
o
L-Phenylalanine ethyl ester hydrochloride (100.80 g, 439 mmol) was stirred in a 33% w/w 
ethanolic solution of methylamine (300 mL, 74.8 g, 2.41 mol) for 95h. The solution was 
evaporated and the residue dissolved in sodium hydrogen carbonate solution (saturated, 2 0 0  
mL) then extracted with chloroform (4 x 100 mL). The combined extracts were dried over 
sodium carbonate and evaporated to give the crude product, a white solid (52.41 g, 294 
mmol, 67%). This was recrystallised from ethyl acetate:hexanes (1:2, 600 mL) and dried in 
vacuo to give the pure product as white crystals (42.67 g, 240 mmol, 55%). vmax (NaCI 
diskJ/cnrT1 3358, 1651, 1573, 1496, 1454, 1412; JH NMR (500 MHz, CDCI3) 6 H 7.34-7.22 (5H, 
m, ArH), 3.61 (1H, dd, J = 9.5 Hz, 4.0 Hz, COCH), 3.29 (1H, dd, J = 13.7 Hz, 4.0 Hz, CH2), 2.82 
(3H, d, J = 5.0 Hz, NCH3), 2.68 (1H, dd, J = 13.7 Hz, 9.5 Hz, CH2), 1.44 (2H, s, NH2); 13C NMR 
(125 MHz, CDCI3) 6 c 174.8 (C), 138.0 (C), 129.3 (CH), 128.7 (CH), 126.8 (CH), 56.5 (CH), 41.1 
(CH2), 25.8 (CH3); LRMS m /z  (ES+) [M +Hf = 179.1; HRMS m /z  (ES+) [M+H]+ = 179.1181; HRMS 
m /z  calc. [M+Hf = 179.1184; Mpt. 58-60 °C; [a] D 3 4  72.6 (c 0.1, CH2 CI2).
179
D-Phenylalanine /V-methylamide (/?)-62
o
r H
n h 2
Prepared as 62, from  D-phenylalanine ethyl ester hydrochloride. [a ]D32 82.8 (c 0.1, CH2CI2).
(S)-2-(l,l,l,3,3,3-Hexafluoro-2-hydroxypropan-2-ylamino)-A/-methyl-3-phenylpropanamide
64
"x Hv V
F3C CF3 Bn
Anhydrous hexafluroacetone (ca. 57 mmol) was bubbled through a solution of phenylalanine 
/V-methylamide 62 (3.0 g, 17 mmol) in DCM (25 mL) held at -78  °C for 90 minutes. The 
solution was allowed to  warm to  room temperature and was evaporated to yield the desired 
product, a white solid (5.4 g, 16 mmol, 93 %). vmax (NaCI disk)/cm_1 3412, 1651, 1551, 1308, 
1220, 957; *H NMR (500 MHz, CDCI3) 6 H 7.38-7.28 (4H, m, ArH, CF3CNH), 7.20 (2H, d, J = 6.9 
Hz, ArH), 6.83 (1H, d, J = 4.8 Hz, CH3NH), 6.32 (1H, s, OH), 4.04 (1H, dd, J = 11.7 Hz, 5.5 Hz, 
COCH), 3.14 (1H, dd, J = 13.8 Hz, 5.5 Hz, CH2), 3.04 (1H, dd, J = 13.8 Hz, 7.03 Hz, Chh), 2.79 
(3H, d, J = 4.8 Hz, CHa); 13C NMR (125 MHz, CDCI3) 6 C 175.2 (C), 135.7 (C), 129.3 (CH), 129.0 
(CH), 127.6 (CH), 122.1 (CF3, J = 289 Hz), 121.9 (CF3, J = 286 Hz), 83.4 (C, J = 30 Hz), 55.6 (CH),
39.3 (CH2), 26.2 (CH3); LRMS m/z  (El+) [M -H 20 ]+ = 326.1; Mpt. 71-74 °C; [a ]D30 -28.8 (c 0.1, 
CH2CI2).
(5)-/V-Methyl-3-phenyl-2-(2,2,2-trifluoroacetamido)propanamide 65
fV yV
O Bn
L-Phenylalanine /V-methylamide 62 (0.51 g, 2.9 mmol), TFAA (0.55 mL, 0.83 g, 4.0 mmol) and 
potassium bicarbonate (0.65 g, 6.5 mmol) were stirred in acetonitrile (8 mL) for 32 hours and 
then evaporated to  give a sludge, which was taken up in aqueous potassium carbonate 
(saturated) and extracted w ith ethyl acetate (15 mL). The ethyl acetate was washed with 
hydrochloric acid (2 M, 15 mL) and brine (15 mL) then evaporated to give a yellow solid 
which was washed w ith  1:1 diethyl ether:petroleum ether (3 x 10 mL) and 3:1 diethyl 
ether:petroleum ether (3 x 10 mL) to  yield the desired product, a white solid (0.34 g, 1.2 
mmol, 46%). vmax (NaCI disk)/cm_1 3312, 2358, 1701, 1655, 1554, 1182; *H NMR (500 MHz,
180
DMSO-d6) 6 h 9.69 (1H, d, J = 8.5 Hz, CF3CONH), 8.20 (1H, d, J = 4.4 Hz, CH3NH), 7.29-7.24 (4H, 
m, ArH), 7.18-7.22 (1H, m, ArH), 4.47-5.53 (1H, m, COCH), 3.08 (1H, dd, J = 13.6 Hz, 4.25 Hz, 
CH2), 2.91 (1H, dd, J = 13.6 Hz, 10.9 Hz, CH2), 2.62 (3H, d, J = 4.4 Hz, NCJ^); 13C NMR (125 
MHz, DMSO-de) 6 C 170.3 (C), 156.6 (C, J = 38 Hz), 138.0 (C), 129.5 (CH), 128.6 (CH), 126.9 
(CH), 116.2 (CF3, J = 286 Hz), 55.3 (CH), 37.3 (CH2), 26.1 (CH3); LRMS m/z  (AP+) [M+H]+ = 
275.1; HRMS m/z  (ES+) [M+NH4]+ = 292.1270; HRMS m/z  calc. [M+NH4]+ = 292.1273; Mpt. 
158-160 °C; [a ]D34 24.6 (c 0.1, CH3OH).
(S)-tert-Butyl l-(methylamino)-l-oxo-3-phenylpropan-2-ylcarbamate 75
•»JsN 
H 
Bn
L-Phenylalanine /V-methylamide 62 (1.34g, 17.5 mmol) and di-tert-butyl dicarbonate (1.54g,
7.05 mmol) were stirred in DCM (15 mL) fo r 24 hours then poured into ethyl acetate (30 mL) 
and washed w ith hydrochloric acid (3 x 40 mL) and brine (40 mL) then evaporated to yield 
the desired product, a pure white solid (1.70 g, 6.12 mmol, 81%). vmax (NaCI disk)/cm -1 3340, 
1686, 1657, 1523, 1169; *H NMR (500 MHz, CDCI3) 6 H 7.24-7.12 (5H, m, ArH), 5.77 (1H, bs, 
CH3NH), 5.02 (1H, bs, OCONH), 4.20-4.26 (1H, m, COCH), 2.98 (2H, m, ChU), 2.65 (3H, d, J =
6.4 Hz, CHs), 1.33 (9H, s, CCH3); 13C NMR (125 MHz, CDCI3) 6C 136.9 (C), 129.3 (CH), 128.6 
(CH), 126.9 (CH), 56.1 (CH), 38.8 (CH2), 28.3 (CH3), 26.1 (CH3); LRMS m/z (El+) [M ]+ = 270.0; 
HRMS m/z (ES+) [M+H]+ = 279.1706; HRMS m/z calc. [M+H]+ = 279.1709; Mpt. 122-125 °C; 
[a ]D3211.2 (c 0.1, CH2CI2).
(2S,5S)-5-Benzyl-3-methyl-2-phenyl-2-(trifluoromethyl)imidazolidin-4-one and (2R,5S)-5- 
benzyl-3-methyl-2-phenyl-2-(trifluoromethyl)imidazolidin-4-one 78 and 89
/
,c f 3
78 89
Pre-dried (5)-A/-methyl-3-phenyl-2-(2,2,2-trifluoro-l-phenylethylideneamino)propanamide 84 
(0.95 g, 2.85 mmol) and copper(ll) trifluoromethanesulfonate (0.52 g, 1.43 mmol) were 
dissolved in 15 mL dry acetonitrile and subjected to  microwave irradiation at 125 °C for 90 
minutes (200 W initial power). The acetonitrile was evaporated and the resultant residue 
taken up in diethyl ether (60 mL) and washed w ith water (3 x 30 mL) and brine then 
evaporated. The resultant oil was subjected to  column chromatography (3:1 petroleum 
ether:ethyl acetate) to  give 78 (Rf-. 0.45), a yellow solid (0.33 g, 0.98 mmol, 34%), and 89 (Rf:
181
0.27), an orange solid (0.28 g, 0.83 mmol, 29%). 78 vmax (NaCI disk)/cm_1 3346, 1717, 1388, 
1161, 699; *H NMR (500 MHz, CDCI3) 6 H 7.29-7.19 (4H, m, ArH), 7.13-7.10 (4H, m, ArH), 6.67 
(2H, d, 7 = 7.9 Hz, ArH), 3.97 (1H, t, 7 = 4.6 Hz, COCH), 3.30 (1H, dd, 7 = 14.2, 4.6 Hz, CH2), 2.97 
(1H, dd, 7 = 14.2, 5.1 Hz, CH2), 2.53 (3H, s, NCH3), 2.12 (1H, bs, NH); 13C NMR (125 MHz, CDCI3) 
6C 174.5 (C), 135.8 (C), 134.3 (C), 130.1 (CH), 129.6 (CH), 129.2 (CH), 129.0 (CH), 127.3 (CH),
126.6 (CH), 81.7 (q, 7 = 29 Hz, CCF3), 59.5 (CH), 36.4 (CH2), 27.4 (CH3); 19F NMR (282 MHz, 
CDCI3) 6 f 73.3(C); LRMS m/z  (El) [M+H]+ = 335.1; HRMS m/z (ES+) [M + H f = 335.1360; HRMS 
m/z calc. [M + H f = 335.1371; Mpt. 85-87 °C; [a ]D30 -72.4 (c 0.1, CH2CI2). 89 vmax (NaCI 
d isk j/c rrf1 3393, 1712, 1389, 1163, 698; *H NMR (500 MHz, CDCI3) 6 H 7.33-7.28 (5H, m, ArH), 
7.19-7.10 (5H, m, ArH), 3.92 (1H, dd, 7 = 10.7, 2.6 Hz, COCH), 3.16 (1H, dd, 7 = 13.4, 2.6 Hz, 
Chh), 2.75 (3H, s, NCH3), 2.69 (1H, dd, 7 = 13.4, 5.7 Hz, CH2), 2.19 (d, 7 = 8.3 Hz, NH); 13C NMR 
(125 MHz, CDCI3) 6 c 173.9 (C), 138.5 (C), 135.8 (C), 129.8 (CH), 129.5 (CH), 129.4 (CH), 128.4 
(CH), 126.5 (CH), 125.9 (CH), 125.4 (CH), 81.7 (q, 7 = 30 Hz, CCF3), 59.5 (CH), 39.9 (CH2), 27.4 
(CH3); 19F NMR (282 MHz, CDCI3) 6 F 73.9(C); LRMS m/z  (El) [M + H f = 335.2; HRMS m/z (ES+) 
[M + H f = 335.1367; HRMS m/z calc. [M + H f = 335.1371; Mpt. 80-83 °C; [a ]D30 -32.6 (c 0.1, 
CH2CI2).
(S)-(l-(Methylamino)-l-oxo-3-phenylpropan-2-ylamino)triphenylphosphonium bromide 82
/  BrPh3P N Br
;  h
Bn
To a solution o f triphenylphosphine (5.04 g, 19.2 mmol) in dry DCM (100 mL) stirred over 
potassium carbonate (7.86 g, 56.8 mmol) at 0 °C was added bromine (0.950 mL, 2.96 g, 18.5 
mmol) in dry DCM (20 mL). The mixture was allowed to warm to  room temperature over the 
course of an hour before L-phenylalanine /V-methylamide 62 (3.65 g, 20.5 mmol) in dry DCM 
(30 mL) was added, dropwise, and the mixture refluxed for 19 hours then filtered and 
evaporated. The residue was purified via column chromatography (9:1 DCM:methanol) and 
recrystallised from DCM/THF to  yield the desired product, a cream solid (4.28 g, 8.24 mmol, 
45%). vmax (NaCI d isk j/c rrf1 3426, 1657, 1439, 1116, 727, 691; *H NMR (500 MHz, CDCI3) 6 H 
8.85-8.89 (1H, m, PNH), 7.82 (1H, t, 7 = 10.7 Hz, p-CArH), 7.72 (3H, td, 7 = 7.4 Hz, 1.6 Hz, p- 
PArH), 7.55-7.51 (6 H, m, PArH), 7.48-7.44 (6 H, m, PArH), 7.33-7.31 (2H, m, CArH), 7.26-7.24 
(3H, m, CArH, CH3NH), 3.72-3.80 (1H, m, COCH), 3.60 (1H, t, 7 = 11.9 Hz, CH2), 3.16 (1H, dt, 7 =
14.0 Hz, 3.8 Hz, CH2), 2.65 (3H, d, J = 4.7 Hz, CH3); 13C NMR (125 MHz, CDCI3) 6 C 172.6 (C),
137.6 (C), 134.8 (CH, 7 = 3 Hz), 133.7 (CH, 7 = 11 Hz), 130.2 (CH), 129.8 (CH, 7 = 13 Hz), 128.5 
(CH), 126.8 (CH), 120.4 (C, 7 = 103 Hz) 61.1 (CH), 39.7 (CH2), 25.8 (CH3); LRMS m/z  (ES+) [M - 
B r f  = 439.2; HRMS m/z  (ES+) [M -B r f  = 439.1929; HRMS m/z calc. [M -B r f  = 439.1939; Mpt. 
200-201 °C; [a ]D30-47 .6  (cO .l, CH2CI2).
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(5)-/V-Methyl-3-phenyl-2-(2,2,2-trifluoro-l-phenylethylideneamino)propanamide 84
L-Phenylalanine A/-methylamide 62 (1.12 g, 6.29 mmol), 2,2,2-trifluoroacetophenone (0.85 
mL, 1.05 g, 6.05 mmol), and ytterbium (lll) trifluoromethanesulfonate (0.17 g, 0.28 mmol) 
were refluxed in chloroform (20 mL) over 3A molecular sieves for 16 h. The mixture was 
filtered and column chromatography (1:1 petroleum ethenethyl acetate) was used to provide 
the desired product (Rf: 0.47), a pale yellow solid (1.27 g, 3.81 mmol, 63%). 0 max (NaCI 
disk)/cm -1 3362, 1667, 1538, 1199, 1134; *H NMR (500 MHz, CDCI3) 6 H 7.36 (1H, t, J = 1.4 Hz, 
ArH), 7.29-7.19 (5H, m, ArH), 6.99 (2H, dd, J = 7.3, 1.4 Hz, ArH), 6.65 (1H, bs, NH), 6.40 (2H, d, 
J = 7.3 Hz, ArH), 4.18 (1H, dd, J = 10.1, 2.9 Hz, COCH), 3.25 (1H, dd, J = 13.3, 2.9 Hz, CH2), 2.95 
(1H, dd, J = 13.3, 10.1 Hz, CH2), 2.91 (3H, d, J = 4.9 Hz, NCH3); 13C NMR (125 MHz, CDCI3) 6C
171.2 (C), 160.2 (q, J = 34 Hz, CCF3), 136.5 (C), 130.0 (CH), 128.9 (CH), 128.5 (CH), 128.4 (CH),
127.2 (CH), 126.9 (CH), 119.3 (q, J = 228 Hz, CF3), 67.4 (CH), 41.0 (CH2), 26.1 (CH3); 19F NMR 
(282 MHz, CDCI3) 6 f 71.1 (C); LRMS m/z (El) [M+H]+ = 335.1; HRMS m/z (ES+) [M+H]+ = 
335.1630; HRMS m/z  calc. [M + H f = 335.1371; Mpt. 95-97 °C; [a ]D30 24.6 (c 0.1, CH2CI2).
Gallium(lll) trifluoromethanesulfonate 86
Gallium (3.2 g, 45 mmol) and trifluoromethanesulfonic acid (30 mL, 50.9 g, 339 mmol) 
were heated together at 160 °C fo r 96 hours then cooled to  room temperature and poured 
into water (150 mL), filtered, and the filtra te  evaporated and dried in vacuo at 180 °C to yield 
the desired product, a light grey powder (15.6g, 30 mmol, 6 6%).
(2/?,55)-5-Benzyl-3-methyl-2-phenyl-2-(trifluoromethyl)imidazolidin-4-one 89: See 78.
CF3 Bn
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(2R,5S)-5-Benzyl-2,3-dimethyl-2-(trifluoromethyl)imidazolidin-4-one and (2S,5S)-5-benzyl- 
2,3-dimethyl-2-(trifluoromethyl)imidazolidin-4-one 90 and 91
90 91
Pre-dried (5)-N-methyl-3-phenyl-2-(l; l,l-trifluoropropan-2-ylideneamino)propanamide 93 
(8.1 g, 29.8 mmol) and copper(ll) trifluoromethanesulfonate (2.59 g, 7.16 mmol) were 
dissolved in dry acetonitrile (40 mL) and subjected to  microwave irradiation at 140 °C for 60 
minutes (200 W initial power). The acetonitrile was evaporated and the resultant residue 
taken up in diethyl ether (60 mL) and washed w ith water (3 x 30 mL) and brine then 
evaporated. The resultant oil was subjected to  column chromatography (3:1 petroleum 
ethenethyl acetate) to  give 90 (Rf: 0.46), a yellow solid (1.13 g, 4.16 mmol, 14%), and 91 (Rf: 
0.29), an orange solid (0.88 g, 3.23 mmol, 13%). 90 vmax (NaCI disk)/cm -1 3323, 2926, 1708, 
1429, 1396, 1308, 1278, 1152, 1098; *H NMR (500 MHz, CDCI3) 6 H 7.24 (2H, tt, J = 7.5 Hz, 1.4 
Hz, m-ArH), 7.18 (1H, tt, J = 7.50 Hz, 2.6 Hz, p-ArH), 7.10 (2H, d, J = 6.9 Hz, o-ArH), 3.84 (1H, 
at, J = 5.3 Hz, COCH), 3.06 (1H, dd, J = 14.2 Hz, 5.3 Hz, CH2), 2.98 (1H, dd, J = 14.2 Hz, 5.0 Hz, 
CHz), 2.76 (3H, s, NCH3), 1.77 (1H, bs, NH), 1.08 (3H, s, CCH3); 13C NMR (125 MHz, CDCI3) 6 C
174.1 (C), 136.0 (C), 129.6 (CH), 128.8 (CH), 127.2 (CH), 125.2 (q, J = 289 Hz, CF3), 77.2 (q, J = 
30 Hz, CCF3), 58.8 (CH), 37.2 (CH2), 26.3 (CH3), 19.0 (CH3); LRMS m/z (ES+) [M+H]+ = 273.1; 
HRMS m/z (ES+) [M+H]+ = 273.1212; HRMS m/z  calc. [M+H]+ = 273.1215; [a jD20 -22.6 (c 0.1, 
CHCI3). 91 vmax (NaCI disk)/cm_1 3344, 2930, 1701, 1428, 1397, 1154, 1097; *H NMR (500 
MHz, CDCI3) 6 h 7.23 (2H, t, J = 7.31 Hz, m-ArH), 7.19-7.14 (3H, m, ArH), 3.77 (1H, d, J = 10.59 
Hz, COCH), 3.09 (1H, dd, J = 13.48 Hz, 2.91 Hz, CH2), 2.85 (3H, s, NCH3), 2.59 (1H, dd, J = 13.38 
Hz, 11.15 Hz, CH2), 1.95 (1H, bs, NH), 1.46 (3H, s, CCH3); 13C NMR (125 MHz, CDCI3) 6 C 173.4 
(C), 138.6 (C), 129.5 (CH), 128.5 (CH), 126.5 (CH), 124.3 (q, J = 287 Hz, CF3), 77.1 (q, J = 31 Hz, 
CCF3), 59.6 (CH), 39.6 (CH2), 26.5 (q, J = 1 Hz, H3CCCF3), 19.7 (CH3); LRMS m/z  (El+) [M ]+ = 
272.1; HRMS m/z  (ES+) [M+H]+ = 273.1210; HRMS m/z  calc. [M+H]+ = 273.1215; Mpt. 99-102 
°C; [a ]D20-116.4 (cO .l, CHCI3).
(ZRjSSj-S-Benzyl-Z^-dimethyl-Z-ftrifluoromethylJimidazolidin^-one hydrochloride 90 HCI
Prepared according to  Standard Preparation C. vmax (NaCI disk)/cm 1 3318, 2927, 1706, 1397, 
1152, 1098; XH NMR (500 MHz, CDCI3) SH 7.33-7.23 (5H, m, ArH), 3.94-3.98 (1H, m, COCH), 
3.14 (1H, dd, J = 14.50 Hz, 4.34 Hz, CH2), 3.01 (1H, dd, J = 14.50 Hz, 6.93 Hz, CH2), 2.86 (3H, s,
NCH3), 1.39 (3H, s, CCHs); 13C NMR (125 MHz, CDCI3) 5C 176.6 (C), 138.7 (C), 131.6 (CH), 139.6 
(CH), 129.1 (CH), 127.5 (q, J = 289 Hz, CF3), 80.1 (q, J = 30 Hz, CCF3), 61.7 (CH), 39.0 (CH2), 27.8 
(q, J = 2 Hz, H3CCCF3), 19.6 (CH3); LRMS m/z (AP+) [M -C lf  = 273.1; HRMS m/z (ES+) [M-CI]+ = 
273.1207; HRMS m/z calc. [M -C I]+ = 273.1215; decomp. 55 °C; [a ] D22 58.6 (c 0.1, CH3OH).
(2S,5S)-5-Benzyl-2,3-dimethyl-2-(trifluoromethyl)imidazolidin-4-one 91: See 90.
(2S,5S)-5-Benzyl-2,3-dimethyl-2-(trifluoromethyl)im idazolidin-4-one hydrochloride 91HCI
/
N
X
N
H *HCI
Prepared according to  Standard Preparation C. vmax (NaCI diskj/cnrf1 3328, 2926, 1700, 1398, 
1154, 1136; *H NMR (500 MHz, CDCI3) 6 H 7.21-7.06 (5H, m, ArH), 3.80 (1H, dd, J = 10.4 Hz,
2.2 Hz, COCH), 2.95 (1H, dd, J = 13.4 Hz, 10.7 Hz, CH2), 2.80 (3H, s, NCHs), 2.51 (1H, dd, J =
13.2 Hz, 10.7 Hz, CH2), 1.44 (3H, s, CCH3 ); 13C NMR (125 MHz, CDCI3) 6 C 175.0 (C), 138.7 (C),
129.1 (CH), 127.8 (CH), 125.9 (CH), 125.4 (q, J = 286 Hz, CF3), 78.1 (q, J = 30 Hz, CCF3), 59.6 
(CH), 39.4 (CH2), 25.3 (CH3), 17.4 (CH3); LRMS m/z (AP+) [M -CI]+ = 273.1; HRMS m/z (ES+) [M - 
Cl]+ = 273.1208; HRMS m/z  calc. [M -C I]+ = 273.1215; decomp. 80 °C; [a ]D22 83.2 (c 0.025, 
CH3OH).
(5)-N -M ethyl-3-phenyl-2-(l,l,l-trifluoropropan-2-ylideneam ino)propanam ide 93
L-Phenylalanine A/-methylamide 62 (5.28 g, 29.6 mmol), 1,1,1-trifluoroacetone (7.26 g, 64.8 
mmol) and TFA (1 drop) were stirred in chloroform (25 mL) at room temperature fo r 17 
hours. The reaction m ixture was evaporated to  yield the desired product, a cream solid (8.1 
g, 100%). vmax (NaCI disk)/cm -1 3415, 3031, 2931, 1676, 1533, 1339,1200,1120; aH NMR (500 
MHz, CDCI3) 6 h 7.29-7.22 (3H, m, ArH), 7.11 (2H, d, J = 6 .6  Hz, o-ArH), 6.87 (1H, bs, NH), 4.20 
(1H, dd, J = 10.6 Hz, 2.7 Hz, COCH), 3.46 (1H, dd, J = 13.2 Hz, 2.7 Hz, CH^, 2.88 (3H, d, J = 5.0 
Hz, NCH3), 2.80 (1H, dd, J = 13.2 Hz, 10.6 Hz, CHz), 1.19 (3H, s, CChb); 13C NMR (100 MHz, 
CDCI3) 6 c 171.4 (C), 157.9 (q, J = 33 Hz, CCF3), 136.7 (C), 129.9 (CH), 128.6 (CH), 127.0 (CH),
119.3 (q, J = 279 Hz, CF3), 66.2 (CH), 40.4 (CH2), 26.0 (CH3), 12.4 (CH3); LRMS m/z  (AP+) [M+H]+
XBn
185
= 273.2; HRMS m/z (ES+) [M+H]+ = 273.1210; HRMS m/z  calc. [M+H]+ = 273.1215; Mpt. 93-95 
°C; [a ]D20 42.0 (c 0.1, CHCI3).
(5,£)-/V-Methyl-3-phenyl-2-(2,2,2-trichloroethylideneamino)propanamide 98
o
£ H
Bn
L-Phenylalanine A/-methylamide 62 (1.15 g, 6.47 mmol), anhydrous chloral (0.720 mL, 1.09 g, 
7.42 mmol) and p-toluenesulfonic acid monohydrate (0.12 g, 0.61 mmol) were stirred in DCM 
(10 mL) fo r 66  hours then poured into diethyl ether (20 mL) and washed with potassium 
carbonate (2 M, 40 mL) and brine (40 mL) then evaporated to give an oil, which was purified 
via column chromatography (diethyl ether) to  yield the desired product (Rf: 0.44), an orange 
oil (0.71 g, 2.31 mmol, 36%). vmax (NaCI diskj/cm "1 3408, 1668, 1538, 809, 739, 701; *H NMR 
(500 MHz, CDCIs) 6 h 7.26 (2H, t, J = 7.4 Hz, m-ArH), 7.19 (1H, t, J = 7.4 Hz, p-ArH), 7.08 (2H, d, 
J = 7.0 Hz, o-ArH), 6.99 (1H, s, CI3CCH), 6.80 (1H, d, J = 4.5 Hz, NH), 4.01 (1H, dd, J = 10.5 Hz, 
3.1 Hz, COCH), 3.45 (1H, dd, J = 13.6 Hz, 3.1 Hz, CH2), 2.86 (3H, d, J = 4.5 Hz, CH3), 2.84 (1H, 
dd, J = 13.6 Hz, 4.3 Hz, ChU); 13C NMR (125 MHz, CDCI3) 6 C 171.1 (C), 157.7 (C), 136.1 (C),
130.0 (CH), 128.7 (CH), 127.0 (CH), 93.0 (C), 71.7 (CH), 40.5 (CH2), 26.1 (CH3); LRMS m/z (El+) 
[M ]+ = 306.0; HRMS m/z  (El+) [M ]+ = 306.0088; HRMS m/z calc. [M ]+ = 306.0093; [a ]D34 -1 .6  (c 
0.1, CH2CI2).
(25,5S)-5-Benzyl-3-methyl-2-(4-nitrophenyl)imidazolidin-4-one 104
n o 2
Prepared according to  Standard Preparation A. vmax (NaCI disk)/cm -1 1698, 1523, 1349; 1H 
NMR (500 MHz, CDCl3) 6 H 8.02 (2H, td, J = 6.83 Hz, 1.92 Hz, ArH), 7.26-7.23 (3H, m, ArH), 7.15 
(2H, m, ArH), 6.90 (2H, td, J = 6 .8  Hz, 1.9 Hz, ArH), 5.19 (1H, d, J = 1.4 Hz, NCH3CH), 3.86-3.89 
(1H, m, COCH), 3.19 (1H, dd, J = 14.0 Hz, 5.5 Hz, CH2), 3.03 (1H, dd, J = 14.0 Hz, 4.6 Hz, CH2), 
2.48 (3H, s, NCH3); 13C NMR (125 MHz, CDCI3) 6 C 173.9 (C), 148.6 (C), 145.9 (C), 136.7 (C),
130.0 (CH), 128.9 (CH), 128.3 (CH), 127.1 (CH), 124.2 (CH), 76.4 (CH), 60.1 (CH), 37.2 (CH2),
27.4 (CH3); LRMS m/z  (El+) [M ]+ = 311.0; HRMS m/z  (El+) [M ]+ = 311.1262; HRMS m/z calc. 
[M ]+ = 311.1270; [a ]D32 -78.2  (c 0.1, CH2CI2).
186
(2/?,5S)-5-Benzyl-3-methyl-2-(4-nitrophenyl)imidazolidin-4-one hydrochloride 104-HCI
•HCI
Prepared according to  Standard Preparation C (85%). vmax (NaCI disk)/cm_1 2590,1729, 1524, 
1351; *H NMR (500 MHz, CD3OD) 6 H 8.40 (2H, d, J = 8 .8  Hz, o-N02ArH), 7.79 (2H, d, J = 8.8  Hz, 
m-N02ArH), 7.45 (2H, d, J = 7.4 Hz, o-ArH), 7.40 (2H, t, J = 7.4 Hz, m-ArH), 7.32 (1H, tt, J = 7.4 
Hz, 1.2 Hz, p-ArH), 6.10 (1H, s, CONCH), 4.72 (1H, dd, J = 10.3 Hz, 3.6 Hz, COCH), 3.21 (1H, dd, 
J = 15.1 Hz, 10.3 Hz, C ji) ,  2.88 (3H, s, NCH3), 3.59 (1H, dd, J = 15.1 Hz, 3.6 Hz, CH^); 13C NMR 
(125 MHz, CD3OD) 6 C LRMS m/z  (ES+) [M -C I]+ = 312.1; HRMS m/z (ES+) [M -CI]+ = 312.1342; 
HRMS m/z calc. [M -C I]+ = 312.1348; decomp. 130-132 °C; [ct]D32 -12.0 (c 0.1, CH3OH).
(5,£)-/V-Methyl-2-(4-nitrobenzylideneamino)-3-phenylpropanamide 106
L-Phenylalanine /V-methylamide 62 (5.07 g, 28.5 mmol) and 4-nitrobenzaldehyde (4.29g, 28.4 
mmol) were stirred over 3 A molecular sieves under nitrogen in DCM (50 mL) for 68  hours to 
give the desired product in quantitative yield. vmax (NaCI disk)/cm-1 1676, 1526, 1348, 1265; 
XH NMR (500 MHz, CDCI3) 6 H 8.18 (2H, d, J = 8.4 Hz, N 02CCH), 7.69 (2H, d, J = 8.4 Hz, 
N02CCCH), 7.51 (1H, s, ArCH), 7.16-7.10 (3H, m, ArH), 6.99 (2H, d, J = 6.9 Hz, ArH), 6.77 (1H, 
s, NH), 3.96 (1H, dd, J = 10.1 Hz, 3.0 Hz, COCH), 3.40 (1H, dd, J = 13.5 Hz, 3.0 Hz, CH2), 2.85 
(1H, dd, J = 13.5 Hz, 10.1 Hz, CH2), 2.84 (3H, d, J = 4.9 Hz, CHa); 13C NMR (100 MHz, CDCI3) 6C
172.2 (C), 160.4 (C), 149.3 (C), 140.6 (C), 137.1 (C), 130.0 (CH), 128.9 (CH), 128.3 (CH), 126.8 
(CH), 124.0 (CH), 75.4 (CH), 41.1 (CH2), 26.1 (CH3); LRMS m/z (ES+) [M+H]+ = 312.1; HRMS m/z 
(ES+) [M+H]+ = 312.1343; HRMS m/z  calc. [M+H]+ = 312.1348; [a ] D34 -152.4 (cO .l, CH2CI2).
187
(5)-5-Benzyl-l,2,2,3-tetramethylimidazolidin-4-one hydrochloride 107-HCI
(S)-5-benzyl-2,2,3-trimethylimidazolidin-4-one hydrochloride 7-HCI (0.549 g, 2.16 mmol) and 
sodium cyanoborohydride (0.490 g, 7.81 mmol) were stirred in aqueous formaldehyde (37%, 
6 mL, 37 mmol) fo r 67 hours then poured into diethyl ether (30 mL) and washed with 
potassium carbonate (4 M, 30 mL), water (30 mL), and brine (30 mL) then evaporated. The 
residual oil was taken up in diethyl ether (30 mL), treated with anhydrous hydrogen chloride 
then filte red and the residue washed w ith diethyl ether (10 mL) and dried to yield the desired 
product, a white powder (0.470 g, 1.75 mmol, 81%). vmax (NaCI disk)/cm-1 3422, 1715, 1396, 
1288, 1157, 751, 706; *H NMR (500 MHz, CD3OD) 6 H 7.37 (2H, d, J = 7.5 Hz, o-ArH), 7.29 (2H, 
t, J = 7.5 Hz, m-ArH), 7.22 (1H, t, J = 7.5 Hz, p-ArH), 4.44 (1H, dd, J = 9.0 Hz, 4.3 Hz, CH), 3.48 
(1H, dd, J = 15.4 Hz, 4.3 Hz, CH2), 3.12 (1H, dd, J = 15.4 Hz, 9.0 Hz, CH2), 2.86 (3H, s, CHNCH3), 
2.59 (3H, s, CONCH3), 1.71 (3H, s, CCH3), 1.46 (3H, s, CCH3); 13C NMR (125 MHz, CD3OD) 6 C
165.7 (C), 135.7 (C), 128.9 (CH), 128.7 (CH), 127.3 (CH), 83.2 (C), 67.5 (CH2), 65.3 (CH), 33.8 
(CH3), 25.0 (CH3), 20.5 (CH3), 17.2 (CH3); LRMS m/z  (AP+) [M -CI]+ = 233.2; HRMS m/z (ES+) [M - 
Cl]+ = 233.1643; HRMS m/z calc. [M -C I]+ = 233.1654; decomp. 167 °C; [a] D34 -48.0 (c 0.1, 
CH3OH).
(2/?,5S)-5-Benzyl-2,3-dimethyl-2-(4-nitrophenyl)imidazolidin-4-one 110
/
Bn H
N02
Prepared according to  Standard Preparation A. vmax (NaCI disk)/cm_1 3306, 2922, 1694,1519, 
1396, 1350, 857, 734, 701; *H NMR (500 MHz, CDCI3) 6 H 8.19 (2H, d, J = 8.8  Hz, ArH), 7.46 (2H, 
d, J = 8 .8  Hz, ArH), 7.33-7.29 (2H, m, ArH), 7.26-7.23 (3H, m, ArH), 3.82 (1H, dd, J = 6.3 Hz,
4.6 Hz, COCH), 3.16 (1H, dd, J = 14.1 Hz, 4.6 Hz, CH2), 3.09 (1H, dd, J = 14.1 Hz, 6.3 Hz, CH2), 
2.79 (3H, s, NCH3), 1.56 (3H, s, CCH3); 13C NMR (125 MHz, CDCI3) 6 C 173!6 (C), 149.9 (C), 147.6 
(C), 136.8 (C), 129.6 (CH), 128.7 (CH), 127.0 (CH), 126.4 (CH), 124.0 (CH), 78.1 (C), 59.0 (CH),
37.6 (CH2), 26.3 (CH3), 26.0 (CH3); LRMS m/z (ES+) [M+H]+ = 326.2; HRMS m/z  (ES+) [M+H]+ = 
326.1503; HRMS m/z calc. [M+H]+ = 326.1505; [a ]D34 31.0 (c 0.1, CH2CI2).
188
(2fl,55)-5-Benzyl-2,3-dimethyl-2-(4-nitrophenyl)imidazolidin-4-one hydrochloride 110HCI
n o 2
T V
•HCI
Prepared according to  Standard Preparation C. vmax (NaCI disk)/cm_1 2462, 1721,1523,1352, 
857, 698; *H NMR (500 MHz, CD3OD) 6 H 8.26 (2H, dt, J = 9.0 Hz, 2.0 Hz, o-N02ArH), 7.61 (2H, 
dt, J = 9.0 Hz, 2.0 Hz, m -N 02ArH), 7.27-7.18 (5H, m, CH2ArH), 4.32 (1H, dd, J = 9.6 Hz, 3.9 Hz,
CH), 3.44 (1H, dd, J = 15.2 Hz, 3.9 Hz, CEU), 3.02 (1H, dd, J = 15.2 Hz, 9.6 Hz, CHz), 2.83 (3H, s, 
NCH3), 2.06 (3H, s, CCH3); 13C NMR (125 MHz, CD3OD) 6 C 174.5 (C), 149.2 (C), 141.3 (C), 135.1 
(C), 128.9 (CH), 128.6 (CH), 128.0 (CH), 127.3 (CH), 124.2 (CH), 79.2 (C), 58.3 (CH), 34.7 (CH2),
25.5 (CH3), 22.5 (CH3); LRMS m/z  (AP+) [M -C I]+ = 326.2; HRMS m/z  (ES+) [M -CI]+ = 326.1497; 
HRMS m/z  calc. [M -C I]+ = 326.1505; Mpt. 108 °C; [a ]D34 48.4 (c 0.1, CH3OH). See Appendix A 
for X-ray crystallography data.
(2S,5S)-5-Benzyl-2,3-dimethyl-2-(4-nitrophenyl)imidazolidin-4-one 111
Prepared according to  Standard Preparation A. vmax (NaCI disk)/cm 1 3327, 2921,1694, 1519, 
1396, 1350, 856, 750, 701; *H NMR (500 MHz, CDCI3) 6 H 7.97 (2H, d, J = 8.9 Hz, ArH), 7.25- 
7.22 (3H, m, ArH), 7.13-7.11 (2H, m, ArH), 6.96 (2H, d, J = 8.9 Hz, ArH), 3.90 (1H, t, J = 5.0 Hz, 
COCH), 3.19 (1H, dd, J = 14.0 Hz, 5.0 Hz, CH2), 2.98 (1H, dd, J = 14.0 Hz, 5.0 Hz, CHj), 2.47 (3H, 
s, NChb), 1.69 (3H, s, CCH3); 13C NMR (125 MHz, CDCI3) 6 C 173.3 (C), 149.2 (C), 147.8 (C),
136.7 (C), 130.0 (CH), 128.9 (CH), 127.3 (CH), 127.1 (CH), 123.8 (CH), 78.2 (C), 59.3 (CH), 36.7 
(CH2), 26.1 (CH3), 23.2 (CH3); LRMS m/z  (AP+) [M+H]+ = 326.2; HRMS m/z (ES+) [M+H]+ = 
326.1496; HRMS m/z  calc. [M+H]+ = 326.1505; [a ]D34 -138.0 (c 0.1, CH2CI2).
189
(25,55)-5-Benzyl-2,3-dimethyl-2-(4-nitrophenyl)imidazolidin-4-one hydrochloride 111HCI
•HCI
Prepared according to  Standard Preparation C. vmax (NaCI diskj/cnrf1 2354, 1718, 1524, 1393, 
1352, 699; *H NMR (500 MHz, CD3OD) 6 H 8.25 (2H, dt, J = 9.0 Hz, 2.0 Hz, o-N02ArH), 7.60 (2H,
26.0 (CH3), 19.8 (CH3); LRMS m/z (ES+) [M -C I]+ = 326.2; HRMS m/z (ES+) [M-CI]+ = 326.1501; 
HRMS m/z  calc. [M -C I]+ = 326.1505; Mpt. 106 °C; [a ]D34 -106.6 (c 0.1, CH30H).
(5)-3-Benzyl-l-m ethyl-l,4-diazaspiro[4.4]nonan-2-one hydrochloride 114 HCI
L-Phenylalanine A/-methylamide 62 (1.12 g, 6.28 mmol), cyclopentanone (0.510 mL, 0.485 g,
5.77 mmol) and p-toluenesulfonic acid monohydrate (0.065 g, 0.34 mmol) were refluxed in 
isopropanol (16 mL) fo r 18 hours. The solvent was evaporated and the residue taken up in 
diethyl ether (45 mL) then washed w ith potassium carbonate (4 M, 20 mL) and brine (20 mL), 
dried over sodium carbonate, and evaporated to  give an oil which was separated by column 
chromatography (1:1 petroleum ether:ethyl acetate) to yield the free amine (Rf: 0.14), a 
brown oil (0.679 g, 2.78 mmol, 48%). The amine was dissolved in diethyl ether (75 mL), 
treated w ith  anhydrous hydrogen chloride, filtered, and the residue washed with diethyl 
ether (20 mL) and dried to  yield the desired product, a cream solid (0.534 g, 2.19 mmol, 
38%). vmax (NaCI disk)/cm -1 3414, 1716, 1455, 1425, 1402, 1341, 1259; *H NMR (500 MHz, 
CD3OD) 6 h 7.33 (2H, d, J = 7.4 Hz, o-ArH), 7.29 (2H, t, J = 7.4 Hz, m-ArH), 7.22 (1H, t, J = 7.4 Hz, 
p-ArH), 4.49 (1H, dd, J = 10.3 Hz, 3.8 Hz, COCH), 3.41 (1H, dd, J = 15.1 Hz, 3.8 Hz, ArCH2), 2.99 
(1H, dd, J = 15.1 Hz, 10.3 Hz, ArCH2), 2.83 (3H, s, CH3), 2.23-2.29 (1H, m, CHzChU), 2.06-1.96 
(2H, m, CH2CH2), 1.87-1.94 (1H, m, CH2CH2), 1.82-1.65 (4H, m, CH2CH2); 13C NMR (125 MHz, 
CD3OD) 6 c 165.1 (C), 133.6 (C), 127.5 (CH), 127.3 (CH), 125.9 (CH), 85.6 (C), 57.1 (CH), 32.3 
(CH2), 32.2 (CH2), 30.6 (CH2), 23.1 (CH3), 22.3 (CH2), 22.0 (CH2); LRMS m/z (ES+) [M-CI]+ = 
245.2; HRMS m/z  (ES+) [M -C I]+ = 245.1650; HRMS m/z  calc. [M -CI]+ = 245.1654; Mpt. 133- 
135 °C; [a ]D30 -104.0 (c 0.1, CH3OH).
dt, J = 9.0 Hz, 2.0 Hz, m -N 0 2ArH), 7.29-7.16 (5H, m, CH2ArH), 4.62 (1H, dd, J = 9.2 Hz, 3.8 Hz,
CH), 3.39 (1H, dd, J = 15.2 Hz, 3.8 Hz, CH^, 2.99 (1H, dd, J = 15.2 Hz, 9.2 Hz, CH2), 2.71 (3H, s, 
NCHa), 2.02 (3H, s, CCH3); 13C NMR (125 MHz, CD3OD) 6 C 179.0 (C), 149.1 (C), 135.2 (C), 129.0 
(CH), 128.7 (CH), 128.5 (CH), 127.3 (CH), 124.0 (CH), 122.9 (C), 79.6 (C), 58.8 (CH), 34.6 (CH2),
190
(5)-7-Benzyl-5-methyl-5,8-diazaspiro[3.4]octan-6-one hydrochloride 115-HCI
V n
Bn N
•HCI
L-Phenylalanine A/-methylamide 62 (0.940 g, 5.28 mmol), cyclobutanone (0.360 mL, 0.338 g, 
4.82 mmol) and p-toluenesulfonic acid monohydrate (0.218 g, 1.15 mmol) in DMF (7 mL) 
were subjected to  microwave irradiation at 140 °C for 50 minutes with an initial power of 100 
W. The reaction m ixture was then poured into diethyl ether (70 mL), shaken with potassium 
carbonate (4 M, 20 mL) and the top layer washed with water (2 x 20 mL) and brine (20 mL) 
then evaporated and the resultant oil separated by column chromatography (ethyl acetate) 
to yield the free amine (Rfi 0.22), a yellow oil (0.441 g, 1.92 mmol, 40%). The free amine was 
taken up in diethyl ether (60 mL), treated with anhydrous hydrogen chloride, filtered, and 
the residue washed w ith  diethyl ether (20 mL) and dried to yield the desired product, a pink 
solid (0.387 g, 1.45 mmol, 30%). vmax (NaCI diskj/cm"1 3415, 1715, 1400, 1327, 1292, 1257, 
1119, 1034; *H NMR (500 MHz, CD3OD) 6 H 7.32-7.28 (4H, m, ArH), 7.21-7.24 (1H, m, p-ArH),
4.41 (1H, dd, J = 9.8 Hz, 3.9 Hz, CH), 3.36 (1H, dd, J = 15.1 Hz, 3.9 Hz, ArCH2), 3.00 (1H, dd, J =
15.1 Hz, 9.8 Hz, ArCH2), 2.95 (3H, s, CH3), 2.65-2.72 (1H, m, CH2CH2), 2.54-2.61 (1H, m, 
CHzCHz), 2.47-2.36 (2H, m, CHzCHz), 1.91-1.78 (2H, m, CHzChh); 13C NMR (125 MHz, CD3OD) 
6 C 166.6 (C), 134.8 (C), 129.0 (CH), 128.8 (CH), 127.5 (CH), 79.6 (C), 58.4 (CH), 33.7 (CH2), 29.6 
(CH2), 29.4 (CH2), 24.7 (CH2), 11.6 (CH3); LRMS m/z  (ES+) [M -CI]+ = 231.2; HRMS m/z (ES+) [M -
Cl]+ = 231.1489; HRMS m/z  calc. [M -C I]+ = 231.1497; Mpt. 135-137 °C; [a ]D30 -57.8 (c 0.1, 
CH3OH).
(2R,55)-5-Benzyl-2-(4-methoxyphenyl)-2,3-dimethylimidazolidin-4-one 119
/
a x
Prepared according to  Standard Preparation A. vmax (NaCI disk)/cm 1 3360, 2933,1690, 1608, 
1510, 1397, 1252, 1181, 1031, 833, 701; *H NMR (500 MHz, CDCI3) 6 H 7.23-7.08 (7H, m, ArH),
6.78 (2H, d, J = 8.9 Hz, ArH), 3.81 (1H, dd, J = 7.2 Hz, 4.2 Hz, COCH), 3.71 (3H, s, OCH3), 3.08 
(1H, dd, J = 13. 9 Hz, 4.2 Hz, CHz), 2.93 (1H, dd, J = 13.9 Hz, 7.2 Hz, CH2), 2.64 (3H, s, NCH3), 
1.46 (3H, s, CCHa); 13C NMR (125 MHz, CDCI3) 6 C 173.6 (C), 159.4 (C), 137.7 (C), 134.9 (C),
129.7 (CH), 128.5 (CH), 126.7 (CH), 126.5 (CH), 114.1 (CH), 78.4 (C), 59.4 (CH), 55.3 (CH3), 38.4
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(CH2), 26.4 (CH3), 26.1 (CH3); LRMS m/z (ES+) [M+H]+ = 311.2; HRMS m/z (ES+) [M+H]+ = 
311.1753; HRMS m /z calc. [M+H]+ = 311.1760; [a ]D30 (c 0.1, CH2CI2).
(2/?,5S)-5-Benzyl-2-(4-methoxyphenyl)-2,3-dimethylimidazolidin-4-one hydrochloride
119-HCI
°tv
B n 'S  f
•HCI
Prepared according to  Standard Preparation C (6 6 %). vmax (NaCI disk)/cm-1 3418, 1715, 1608, 
1515, 1393, 1258, 1183, 1025; 13C NMR (125 MHz, CD30D) 6C 165.8 (C), 160.1 (C), 133.4 (C),
127.3 (CH), 127.1 (CH), 126.3 (CH), 125.8 (CH), 123.6 (C), 113.1 (CH), 78.5 (C), 55.4 (CH), 53.1 
(CH3), 32.4 (CH2), 23.9 (CH3), 20.1 (CH3); LRMS m/z (ES+) [M -C l]+ = 311.2; HRMS m/z (ES+) [M -
Cl]+ = 311.1753; HRMS m /z calc. [M -C I]+ = 311.1760; Mpt. 117-119 °C; [ct]D30 36.0 (c 0.1, 
CH3OH). See Appendix A fo r X-ray crystallography data.
(25,55)-5-Benzyl-2-(4-methoxyphenyl)-2,3-dimethylimidazolidin-4-one 120
Prepared according to  Standard Preparation A. vmax (NaCI disk)/cm -1 3323, 2933,1694, 1610, 
1513, 1395, 1254; *H NMR (500 MHz, CDCI3) 6 H 7.24-7.20 (3H, m, ArH), 7.15-7.14 (2H, m, 
ArH), 6.67-6.61 (4H, m, ArH), 3.84 (1H, t, J = 4.9 Hz, COCH), 3.70 (3H, s, OCHa), 3.23 (1H, dd, J 
= 14.0 Hz, 5.2 Hz, CH2), 2.99 (1H, dd, J = 14.0 Hz, 4.9 Hz, Chh), 2.42 (3H, s, NCH3), 1.59 (3H, s, 
CCH3); 13C NMR (125 MHz, CDCI3) 6 C 173.6 (C), 159.6 (C), 136.7 (C), 133.8 (C), 130.0 (CH),
128.9 (CH), 127.4 (CH), 126.9 (CH), 113.9 (CH), 78.7 (C), 59.4 (CH), 55.3 (CH3), 36.3 (CH2), 26.1 
(CH3), 22.8 (CH3); LRMS m /z (ES+) [M+H]+ = 311.2; HRMS m/z (ES+) [M+H]+ = 311.1755; HRMS 
m/z calc. [M+H]+ = 311.1760; [a ]D30 -121.0 (c 0.1, CH2CI2).
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(2S,5S)-5-Benzyl-2-(4-methoxyphenyl)-2,3-dimethylimidazolidin-4-one hydrochloride
120-HCI
•HCI
Prepared according to  Standard Preparation C (80%). vmax (NaCI diskj/cm"1 3420,1710, 1515, 
1391, 1257, 1184; 13C NMR (125 MHz, CD3OD) 6C 167.5 (C), 161.8 (C), 134.9 (C), 129.1 (CH),
128.9 (CH), 128.8 (CH), 128.6 (CH), 125.8 (C), 114.6 (CH), 80.5 (C), 58.4 (CH), 54.7 (CH3), 37.4 
(CH2), 26.0 (CH3), 19.3 (CH3); LRMS m/z  (ES+) [M -CI]+ = 311.2; HRMS m/z  (ES+) [M-CI]+ = 
311.1756; HRMS m/z  calc. [M -C I]+ = 311.1760; Mpt. 115-117 °C; [a ]D30 -117.6 (c 0.1, CH3OH).
(2/?,5S)-5-Benzyl-2,3-dimethyl-2-phenylimidazolidin-4-one 121
Bn
Prepared according to  Standard Preparation A. vmax (NaCI disk)/cm 1 1693, 1454,1396, 1080, 
745, 699; *H NMR (500 MHz, CDCI3) 6 H 7.23 (2H, t, J = 6.2 Hz, ArH), 7.20-7.09 (8 H, m, ArH), 
3.76 (1H, dd, J = 7.1 Hz, 4.2 Hz, COCH), 3.05 (1H, dd, J = 13.9 Hz, 4.2 Hz, CH2), 2.91 (1H, dd, J =
13.9 Hz, 7.1 Hz, CH2), 2.63 (3H, s, NCJ^), 1.45 (3H, s, CCH3); 13C NMR (125 MHz, CDCI3) 6C
173.7 (C), 142.8 (C), 137.6 (C), 129.7 (CH), 128.9 (CH), 128.5 (CH), 128.1 (CH), 126.7 (CH),
125.1 (CH), 78.6 (C), 59.3 (CH), 38.3 (CH), 26.3 (CH3), 26.2 (CH3); LRMS m/z (ES+) [M+H]+ = 
281.2; HRMS m/z  (ES+) [M+H]+ = 281.1646; HRMS m/z calc. [M+H]+ = 281.1654; [a ]D30 3.0 (c 
0.1, CH2CI2).
Y k
(2/?,55)-5-Benzyl-2,3-dimethyl-2-phenylimidazolidin-4-one hydrochloride 121-HCI
/r
•HCI
Prepared according to  Standard Preparation C (89%). vmax (NaCI disk)/cm-1 3412, 2096, 1644, 
1393, 1220; *H NMR (500 MHz, CD3OD) 6 H 7.60-7.55 (3H, m, CArH), 7.50-7.46 (2H, m, CArH),
7.41 (2H, d, J = 7.6 Hz, o-CH2ArH), 7.36 (2H, t, J = 7.6 Hz, m-CH2ArH), 7.30 (1H, tt, J = 7.60 Hz,
2.4 Hz, p-CH2ArH), 4.44 (1H, dd, J = 9.7 Hz, 4.0 Hz, CH), 3.57 (1H, dd, J = 15.2 Hz, 4.0 Hz, CH*),
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3.24 (1H, dd, J = 15.2 Hz, 9.7 Hz, CH2), 2.94 (3H, s, NCH3), 2.21 (3H, s, CCH3); 13C NMR (125 
MHz, CD3OD) 6 C 167.6 (C), 134.9 (C), 134.3 (C), 130.8 (CH), 129.5 (CH), 129.0 (CH), 128.8 (CH),
127.4 (CH), 126.9 (CH), 80.5 (C), 58.6 (CH), 34.0 (CH2), 26.2 (CH3), 19.4 (CH3); LRMS m/z (ES+) 
[M —Cl]+ = 281.2; HRMS m/z  (ES+) [M -C I]+ = 281.1646; HRMS m/z calc. [M -CI]+ = 281.1654; 
Mpt. 139-141 °C; [a ] D34 7.6 (c 0.1, CH2CI2). See Appendix A for X-ray crystallography data.
(25,55)-5-Benzyl-2,3-dimethyl-2-phenylim idazolidin-4-one 122
Prepared according to  Standard Preparation A. vmax (NaCI disk)/cm 1 3319, 2928, 1690, 1427, 
1396, 764, 700; *H NMR (500 MHz, CDCI3) 6 H 7.21-7.10 (8 H, m, ArH), 6.77 (2H, d, J = 7. 6 Hz, 
ArH), 3.83 (1H, t, J = 5.0 Hz, COCH), 3.19 (1H, dd, J = 14.0 Hz, 5.0 Hz, Chh), 2.99 (1H, dd, J =
14.2 Hz, 5.0 Hz, CH2), 2.43 (3H, s, NCHU), 1.61 (3H, s, NCHs); 13C NMR (125 MHz, CDCI3) 6C
173.7 (C), 141.9 (C), 136.7 (C), 129.9 (CH), 128.9 (CH), 128.7 (CH), 128.5 (CH), 126.9 (CH),
126.0 (CH), 79.0 (C), 59.5 (CH), 36.4 (CH), 26.2 (CH3), 22.8 (CH3); LRMS m/z (ES+) [M+H]+ = 
281.2; HRMS m/z  (ES+) [M+H]+ = 281.1644; HRMS m/z  calc. [M+H]+ = 281.1654; [a ]D30 -114.4 
(c 0.1, CH3OH).
(25,55)-5-Benzyl-2,3-dimethyl-2-phenylim idazolidin-4-one hydrochloride 122-HCI
•HCI
Prepared according to  Standard Preparation C (82%). vmax (NaCI disk)/cm_1 3882, 2434, 1716, 
1393, 700; *H NMR (500 MHz, CD3OD) 6 H 7.61-7.59 (3H, m, ArH), 7.54-7.51 (2H, m, ArH), 
7.41-7.33 (5H, m, ArH), 3.55 (1H, dd, J = 15.3 Hz, 3.9 Hz, CH), 3.55 (1H, dd, J = 15.3 Hz, 3.9 Hz, 
CH2), 3.12 (1H, dd, J = 15.3 Hz, 9.5 Hz, CH2), 2.83 (3H, s, N O ^), 2.15 (3H, s, CCH3); 13C NMR 
(125 MHz, CD3OD) 6 c  167.6 (C), 134.9 (C), 134.3 (C), 130.8 (CH), 129.5 (CH), 128.9 (CH), 128.8 
(CH), 127.4 (CH), 126.9 (CH), 80.5 (C), 58.6 (CH), 34.0 (CH2), 26.1 (CH3), 19.3 (CH3); LRMS m/z 
(ES+) [M —Cl]+ = 281.2; HRMS m/z (ES+) [M -C I]+ = 281.1648; HRMS m/z calc. [M-CI]+ = 
281.1654; M pt. 132-134 °C; [a ]D34-95.6 (cO .l, CH3OH).
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(2/?,55)-5-Benzyl-2-(4-chlorophenyl)-2,3-dimethylimidazolidin-4-one 123
Bn
Cl
Prepared according to  Standard Preparation A. vmax (NaCI disk)/cm_1 3316, 2720,1704,1493, 
1398, 1096; *H NMR (500 MHz, CDCI3) 6 H 7.23-7.19 (4H, m, ArH), 7.16-7.14 (3H, m, ArH), 
7.13-7.09 (2H, m, ArH), 3.76 (1H, dd, J = 6.9 Hz, 4.3 Hz, COCH), 3.06 (1H, dd, J = 14.0 Hz, 4.3 
Hz, CH2), 2.95 (1H, dd, J = 14.0 Hz, 6.9 Hz, Chh), 2.64 (3H, s, NCH3), 1.44 (3H, s, CCHa); 13C NMR 
(125 MHz, CDCI3) 6 c 173.5 (C), 141.4 (C), 137.3 (C), 134.1 (C), 129.7 (CH), 129.0 (CH), 128.6 
(CH), 126.8 (CH), 126.7 (CH), 78.2 (C), 59.2 (CH), 38.0 (CH2), 26.2 (CH3), 21.0 (CH3); LRMS m/z 
(ES+) [M+H]+ = 315.1; HRMS m/z (ES+) [M+H]+ = 315.1253; HRMS m/z calc. [M+H]+ = 
315.1264; [a ] D30 5.2 (cO .l, CH3OH).
(2/?,55)-5-Benzyl-2-(4-chlorophenyl)-2,3-dimethylimidazolidin-4-one hydrochloride 123 HCI
& / ~ H  I
•HCI
Cl
Prepared according to  Standard Preparation C. vmax (NaCI disk)/cm 1 3414,1720,1495, 1398, 
1099, 1011, 830; *H NMR (500 MHz, CD3OD) 6 H 7.58 (2H, dt, J = 8.8  Hz, 1.9 Hz, o-CIArH), 7.47 
(2H, dt, J = 8 .8  Hz, 1.9 Hz, m-CIArH), 7.42 (2H, d, J = 7.4 Hz, o-CH2ArH), 7.36 (2H, t, J = 7.4 Hz, 
m-CH2ArH), 7.30 (1H, t, J = 7.4 Hz, p-CH2ArH), 4.46 (1H, dd, J = 9.7 Hz, 4.0 Hz, COCH), 3.57 
(1H, dd, J = 15.2 Hz, 4.0 Hz, CH2), 3.25 (1H, dd, J = 15.24 Hz, 9.7 Hz, CH2), 2.93 (3H, s, NCH3),
2.20 (3H, s, CCH3); 13C NMR (125 MHz, CD3OD) 6 C 167.3 (C), 136.8 (C), 134.9 (C), 132.4 (C),
129.6 (CH), 129.0 (CH), 128.7 (CH), 128.2 (CH), 127.3 (CH), 79.6 (C), 58.0 (CH), 33.8 (CH2), 25.5 
(CH3), 22.2 (CH3); LRMS m/z  (AP+) [M -C I]+ = 315.1; HRMS m/z  (ES+) [M-CI]+ = 315.1257; HRMS 
m/z  calc. [M -C I]+ = 315.1264; Mpt. 133-135 °C; [ct]D30 38.0 (c 0.1, CH3OH).
(2S,5S)-5-Benzyl-2-(4-chlorophenyl)-2,3-dimethylimidazolidin-4-one 124
Prepared according to  Standard Preparation A. vmax (NaCI disk)/cm -1 3328, 2929, 1694, 1396, 
1097, 1012, 702; *H NMR (500 MHz, CDCI3) 6 H 7.24-7.22 (3H, m, CH2ArH), 7.14-7.12 (2H, m,
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CH2ArH), 7.09 (2H, dt, J = 8.7 Hz, 2.0 Hz, o-CIArH), 6 .68  (2H, dt, J = 8.7 Hz, 2.0 Hz, m-CIArH), 
3.85 (1H, t, J = 4.8 Hz, COCH), 3.22 (1H, dd, J = 14.0 Hz, 5.2 Hz, CH2), 2.98 (1H, dd, J = 14.0 Hz,
4.8 Hz, ChU), 2.43 (3H, s, NCH3), 1.61 (3H, s, CChU); 13C NMR (125 MHz, CDCI3) 6 C 173.4 (C),
140.5 (C), 136.6 (C), 134.6 (C), 129.7 (CH), 128.9 (CH), 128.9 (CH), 127.6 (CH), 127.0 (CH), 78.4 
(C), 59.4 (CH), 36.4 (CH2), 26.1 (CH3), 22.9 (CH3); LRMS m/z (ES+) [M+H]+ = 315.1; HRMS m/z 
(ES+) [M+H]+ = 315.1256; HRMS m/z  calc. [M+H]+ = 315.1264; [a ]D30 -82.0 (c 0.1, CH3OH).
(25,5S)-5-Benzyl-2-(4-chlorophenyl)-2,3-dimethylimidazolidin-4-one hydrochloride 124HCI
•HCI
Prepared according to  Standard Preparation C. vmax (NaCI disk)/cm_1 3414, 1720, 1494, 1392, 
1097, 1011, 827; *H NMR (500 MHz, CD3OD) 6 H 7.34 (2H, dt, J = 8.8  Hz, 2.0 Hz, o-CIArH), 7.34 
(2H, dt, J = 8 .8  Hz, 2.0 Hz, m-CIArH), 7.29 (2H, d, J = 7.5 Hz, o-CH2ArH), 7.23 (2H, t, J = 7.5 Hz, 
m-CH2ArH), 7.17 (1H, t, J = 7.5 Hz, p-CH2ArH), 4.33 (1H, dd, J = 9.7 Hz, 4.0 Hz, COCH), 3.44 
(1H, dd, J = 15.2 Hz, 4.0 Hz, CH^, 3.12 (1H, dd, J = 15.2 Hz, 9.7 Hz, CHj), 2.80 (3H, s, NCH3),
2.07 (3H, s, CCH3); 13C NMR (125 MHz, CD3OD) 6 C 167.3 (C), 136.8 (C), 134.9 (C), 132.4 (C),
129.6 (CH), 129.0 (CH), 128.7 (CH), 128.2 (CH), 127.3 (CH), 79.6 (C), 58.0 (CH), 33.8 (CH2), 25.5 
(CH3), 22.2 (CH3); LRMS m/z  (ES+) [M -C lf  = 315.1; HRMS m/z (ES+) [M-CI]+ = 315.1254; HRMS 
m/z  calc. [M —Cl]+ = 315.1264; Mpt. 118-120 °C; [a ]D30 -102.6 (c 0.1, CH3OH).
(2/?,5S)-5-Benzyl-2,3-dimethyl-2-(4-cyanophenyl)imidazolidin-4-one 125
/
CN
Prepared according to  Standard Preparation A. vmax (NaCI disk)/cm 1 2228, 1695, 1424, 1396, 
1077; XH NMR (500 MHz, CDCI3) 6 H 7.57 (2H, dt, J = 10.4 Hz, 1.7 Hz, ArH), 7.31 (2H, dt, J = 10.4 
Hz, 1.7 Hz, ArH), 7.24 (2H, t, J = 7. 5 Hz, ArH), 7.20-7.15 (3H, m, ArH), 3.72 (1H, dd, J = 6.3 Hz,
4.7 Hz, COCH), 3.07 (1H, dd, J = 14.1 Hz, 4.7 Hz, CH2), 3.00 (1H, dd, J = 14.1 Hz, 6.3 Hz, CH2), 
2.99 (3H, s, NCH3), 1.94 (1H, s, NH), 1.45 (3H, s, CCH3); 13C NMR (125 MHz, CDCI3) 6 C 173.6 (C),
147.9 (C), 136.8 (C), 132.7 (CH), 129.6 (CH), 128.7 (CH), 127.0 (CH), 126.1 (CH), 118.3 (C),
112.1 (C), 78.2 (C), 59.0 (CH), 37.6 (CH2), 26.3 (CH3), 25.8 (CH3); LRMS m/z  (AP+) [M+H]+ = 
306.2; HRMS m/z  (ES+) [M+H]+ = 306.1600; HRMS m/z calc. [M+H]+ = 306.1606; [a ]D22 41.8 (c 
0.1, CH3OH).
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(2/?,5S)-5-Benzyl-2,3-dimethyl-2-(4-cyanophenyl)imidazolidin-4-one hydrochloride 125 HCI
•HCI CN
Prepared according to  Standard Preparation C. vmax (NaCI disk)/cm_1 3415, 2534, 2231,1722, 
1395, 1259, 1016; *H NMR (500 MHz, CD3OD) 6 H 7.91 (2H, d, J = 8.6  Hz, ArH), 7.65 (2H, d, J =
8 .6  Hz, ArH), 7.40 (2H, d, J = 7.5 Hz, ArH), 7.34 (2H, t, J = 7.5 Hz, ArH), 7.28 (1H, t, J = 7.5 Hz, 
ArH), 4.44 (1H, dd, J = 9.6 Hz, 3.9 Hz, COCH), 3.55 (1H, dd, J = 15.2 Hz, 3.9 Hz, CH2), 3.23 (1H, 
dd, J = 15.2 Hz, 9.6 Hz, CH2), 2.93 (3H, s, NCH3), 2.21 (3H, s, CCH3); 13C NMR (125 MHz, 
CD3OD) 6 C 167.4 (C), 138.7 (C), 134.9 (C), 133.2 (CH), 129.0 (CH), 128.7 (CH), 127.7 (CH),
127.3 (CH), 117.3 (C), 114.5 (C), 79.3 (C), 58.1 (CH), 33.8 (CH2), 25.6 (CH3), 22.1 (CH3); LRMS 
m/z  (AP+) [M —Cl]+ = 306.1; HRMS m/z  (ES+) [M+H]+ = 306.1597; HRMS m/z  calc. [M-CI]+ = 
306.1606; Mpt. 109-111 °C; [a ]D22 +43.6 (cO .l, CH3OH).
(2S,55)-5-Benzyl-2,3-dimethyl-2-(4-cyanophenyl)imidazolidin-4-one 126
Prepared according to  Standard Preparation A. vm3X (NaCI disk)/cm 1 3328, 2228, 1696,1496, 
1395, 1232, 1101; XH NMR (500 MHz, CDCI3) 6 H 7.42 (2H, d, J = 8.3 Hz, ArH), 7.23-7.21 (3H, 
m, ArH), 7.12-7.10 (2H, m, ArH), 6.90 (2H, d, J = 8.3 Hz, ArH), 3.86-3.90 (1H, m, COCH), 3.17 
(1H, dd, J = 14.0 Hz, 5.4 Hz, CHz), 2.97 (1H, dd, J = 14.0 Hz, 4.7 Hz, CH2), 2.45 (3H, s, NCH3), 
1.90 (1H, s, NH), 1.65 (3H, s, CCH3); 13C NMR (125 MHz, CDCI3) 6 C 173.3 (C), 147.4 (C), 136.7 
(C), 132.5 (CH), 130.0 (CH), 128.9 (CH), 127.0 (CH), 118.2 (C), 112.4 (C), 78.2 (C), 59.3 (CH),
36.7 (CH2), 26.1 (CH3), 23.0 (CH3); LRMS m/z  (AP+) [M+H]+ = 306.1; HRMS m/z  (ES+) [M+H]+ = 
306.1600; HRMS m/z  calc. [M+H]+ = 306.1606; [ct]D22 -104.6 (c 0.1, CH3OH).
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(2S,55)-5-Benzyl-2,3-dimethyl-2-(4-cyanophenyl)imidazolidin-4-one hydrochloride 126 HCI
Prepared according to  Standard Preparation C. vmax (NaCI disk)/cm_1 2601, 2230, 1722, 1559, 
1394, 1269; *H NMR (500 MHz, CD3OD) 6 H 7.81 (2H, d, J = 8.5 Hz, ArH), 7.52 (2H, d, J = 8.5 Hz, 
ArH), 7.35-7.28 (5H, m, ArH), 4.56 (1H, dd, J = 8.3 Hz, 4.0 Hz, COCH), 3.36 (1H, dd, J = 14.9 Hz,
4.0 Hz, CH2), 3.09 (1H, dd, J = 14.9 Hz, 8.3 Hz, CH2), 2.73 (3H, s, NCH3), 2.02 (3H, s, CCHa); 13C 
NMR (125 MHz, CD3OD) 6 C 168.2 (C), 140.0 (C), 135.0 (C), 133.1 (CH), 129.1 (CH), 128.7 (CH),
128.1 (CH), 127.3 (CH), 117.4 (C), 114.3 (C), 79.9 (C), 58.9 (CH), 34.3 (CH2), 26.1 (CH3), 19.7 
(CH3); LRMS m/z  (AP+) [M -C I]+ = 306.1; HRMS m/z  (ES+) [M -C I]+ = 306.1597; HRMS m/z calc. 
[M -C I]+ = 306.1606; Mpt. 84-86 °C; [a ]D22-124.0 (cO .l, CH3OH).
(2S,5S)-5-Benzyl-3-methyl-2-(5-methylfuran-2-yl)imidazolidin-4-one 136
/
N
Prepared according to  Standard Preparation B. vmax (NaCI disk)/cm 1 3331, 2920, 1694, 1454, 
791, 702; XH NMR (500 MHz, CDCI3) 6 H 7.20 (2H, t, J = 7.3 Hz, PhH), 7.16-7.11 (3H, m, PhH),
6.02 (1H, d, J = 3.1 Hz, OCCH), 5.80 (1H, dd, J = 3.1 Hz, 0.9 Hz, OCCH), 5.09 (1H, s, ArCH), 3.68 
(1H, dd, J = 7.6 Hz, 4.2 Hz, COCH), 3.15 (1H, dd, J = 14.2 Hz, 4.2 Hz, CH2), 2.99 (1H, dd, J = 14.2 
Hz, 7.6 Hz, CPU), 2.54 (3H, s, NCh^), 2.11 (1H, s, NH), 2.11 (3H, s, ArCHa); 13C NMR (125 MHz, 
CDCI3) 6 c 173.7 (C), 153.3 (C), 148.7 (C), 137.2 (C), 129.4 (CH), 128.6 (CH), 126.7 (CH), 110.8 
(CH), 106.4 (CH), 70.9 (CH), 60.1 (CH), 37.6 (CH2), 26.9 (CH3), 13.5 (CH3); LRMS m/z (ES+) 
[M+H]+ = 271.2; HRMS m/z  (ES+) [M+H]+ = 271.1444; HRMS m/z  calc. [M+H]+ = 271.1447; 
[a ]D30 -151.0 (c 0.1, CH3OH).63
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(25,55)-5-((lH-lndol-3-yl)methyl)-2-tert-butyl-3-methylimidazolidin-4-one 137
Prepared according to  Standard Preparation B. vmax (NaCI disk)/cm -1 3299, 2960, 1682,1481, 
1432, 1400, 1103; *H NMR (500 MHz, CDCI3) 6 H 8.38 (1H, s, ArH), 7.62 (1H, d, J = 7.8 Hz, ArH),
7.27 (1H, d, J = 7.8 Hz, ArH), 7.11 (1H, td, J = 7.8 Hz, 0.8 Hz, ArH), 7.05 (1H, td, J = 7.8 Hz, 0.8 
Hz, ArH), 7.01 (1H, d, J = 2.2 Hz, ArH), 3.93 (1H, s, CH3CCH), 3.64-3.67 (1H, m, COCH), 3.27 
(1H, dd, J = 14.7 Hz, 4.2 Hz, CH2), 3.08 (1H, dd, J = 14.7 Hz, 6.4 Hz, Chh), 2.81 (3H, s, NCH3), 
1.74 (1H, bs, NH), 0.63 (9H, s, CCH3); 13C NMR (125 MHz, CDCI3) 6 C 176.2 (C), 136.3 (C), 128.1 
(C), 123.2 (CH), 122.1 (CH), 119.6 (CH), 118.9 (CH), 111.2 (C), 111.2 (CH), 82.6 (CH), 59.5 (CH),
34.7 (C), 30.7 (CH3), 27.0 (CH2), 25.3 (CH3); LRMS m/z  (ES+) [M+H]+ = 286.2; HRMS m/z (ES+) 
[M+H]+ = 286.1925; HRMS m/z  calc. [M+H]+ = 268.1919; Mpt. 178-181 °C; [a ]D30 -85.8 (c 0.1, 
CH3OH).
(2/?,5S)-5-((l-Benzyl-lH-indol-3-yl)methyl)-2-te/t-butyl-3-methylimidazolidin-4-one 138
Prepared according to  Standard Preparation B. vmax (NaCI disk)/cm 1 2962, 1720,1468, 1397, 
1262, 740; *H NMR (500 MHz, CDCI3) 6 H 7.63 (1H, d, J = 7.7 Hz, ArH), 7.21-7.14 (4H, m, ArH),
7.09 (1H, td, J = 8.2 Hz, 1.03 Hz, ArH), 7.05-7.02 (3H, m, ArH), 6.97 (1H, s, ArH), 5.17 (2H, s, 
PhCH2), 3.91 (1H, s, CH3CCH), 3.63 (1H, t, J = 5.0 Hz, COCH), 3.25 (1H, dd, J = 14.7 Hz, 5.0 Hz, 
CPU), 3.09 (1H, dd, J = 14.7 Hz, 5.0 Hz, CH2), 2.79 (3H, s, NCH3), 0.60 (9H, s, CCH3); 13C NMR 
(125 MHz, CDCI3) 6 c 176.2 (C), 137.6 (C), 136.6 (C), 128.8 (CH), 128.7 (C), 127.6 (CH), 127.3 
(CH), 126.9 (CH), 121.9 (CH), 119.4 (CH), 119.2 (CH), 110.4 (C), 109.7 (CH), 82.6 (CH), 59.4 
(CH), 50.0 (CH2), 34.6 (C), 30.6 (CH3), 26.9 (CH2), 25.3 (CH3); LRMS m/z  (ES+) [M+H]+ = 376.2; 
HRMS m/z  (ES+) [M+H]+ = 376.2380; HRMS m/z calc. [M+H]+ = 376.2389; [a ]D30 -11.4 (c 0.1, 
CH3OH).
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(2/?,5S)-5-Methyl-2-tert-butyl-3-methylimidazolidin-4-one 139
Prepared according to Standard Preparation B. vmax (NaCI disk)/cm_1 3419, 2981, 1664, 1479, 
1404; *H NMR (500 MHz, CD3OD) 6 H 4.92 (1H, s, CH3CCH), 4.29 (1H, d, J = 7.1 Hz, COCH), 3.08 
(3H, s, NCHa), 1.58 (1H, d, J = 7.1 Hz, CHCH3), 1.18 (9H, s, CHCCHs); 13C NMR (125 MHz, 
CD3OD) 6c 174.7 (C), 84.5 (CH), 49.2 (CH2), 37.8 (C), 31.1 (CH3), 25.9 (CH3); LRMS m/z (AP+) 
[M+H]+ = 171.2; HRMS m/z  (ES+) [M+H]+ = 171.1492; HRMS m/z  calc. [M+H]+ = 171.1497; 
[cx]d25-1 .8  ( c  0.1, CH3OH).
2-tert-Butyl-3-methylimidazolidin-4-one 140
/
Y >
Prepared according to Standard Preparation B. vmax (NaCI disk)/cm 1 3339, 2957, 1694, 1483, 
1432, 1400, 1322, 1260; *H NMR (500 MHz, DMSO-d6) 6 H 4.05 (1H, s, CH), 3.21 (2H, s, CH2),
2.82 (3H, s, NCH3), 0.89 (9H, s, CCH3); 13C NMR (125 MHz, DMSO-d6) 6C 174.6 (C), 84.5 (CH),
49.2 (CH2), 37.8 (CH3), 25.8 (CH3); LRMS m/z (ES+) [M+H]+ = 157.1; HRMS m/z (ES+) [M+H]+ = 
157.1334; HRMS m/z  calc. [M+H]+ = 157.1341.
L-Alanine /V-methylamide 144
L-Alanine ethyl ester hydrochloride (8.05 g, 52.4 mmol) was stirred in an ethanolic 
methylamine solution (36 mL, 289 mmol) for 97 hours then evaporated. The residue was 
taken up in potassium carbonate (4 M, 30 mL) and sodium bicarbonate (saturated, 20 mL) 
then extracted w ith  chloroform (5 x 25 mL) which was dried over sodium carbonate and 
evaporated to  yield the desired product, a red oil (3.62 g, 35.5 mmol, 6 8%). vmax (NaCI 
disk)/cm_1 3364, 1646, 1575, 1456, 1413, 1375, 1318, 1272, 1160; *H NMR (500 MHz, CDCI3) 
6 h 7.37 (1H, bs, NH), 3.34 (1H, q, J = 7.0 Hz, CH), 2.66 (3H, d, J = 5.0 Hz, NCH3), 1.39 (2H, bs, 
NH2), 1.17 (3H, d, J = 7.0 Hz, CHCH3); 13C NMR (125 MHz, CDCI3) 6 C 176.5 (C), 50.6 (CH), 25.7 
(CH2), 21.6 (CH3); LRMS m/z  (El+) [M ]+ = 102.1; HRMS m/z (El+) [M ]+ = 102.0788; HRMS m/z 
calc. [M ]+ = 102.0793; [a ]D34 2.0 (c 0.1, CH2CI2).
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L-Alanine A/-methylamide hydrochloride 144 HCI
o
Hydrogen chloride gas was bubbled through a solution of L-Alanine /V-methylamide 144 (1.90 
g, 18.5 mmol) in diethyl ether (200 mL) fo r 10 minutes before the product was removed by 
filtra tion, and washed w ith  diethyl ether to  yield the desired product, a clear crystalline solid 
(2.21 g, 16.0 mmol, 8 6 %). The product was further purified by recrystallisation from ethanol 
and hexane. vmax (NaCI d is k j/c ir f1 3408, 1674, 1514, 1417, 1275, 1169; *H NMR (400 MHz, 
D20) 6 h 3.85 (1H, q, J = 7.1 Hz, CH), 2.60 (3H, s, NCH3), 1.32 (3H, d, J = 7.1 Hz, CCH3); 13C NMR 
(100 MHz, D20) 6 c 174.1 (C), 51.2 (CH), 28.5 (CH3), 19.2 (CH3); LRMS m/z  (ES+) [M-CI]+ = 
103.1; HRMS m/z  (ES+) [M -C I]+ = 103.0867; HRMS m/z calc. [M -CI]+ = 103.0871; Mpt. 213- 
215 °C; [a ] D25 19.6 (c 0.1, CH3OH).
L-Tryptophan A/-methylamide 147
o
Thionyl chloride (10.0 mL, 16.3 g, 134 mmol) was added dropwise to ethanol (130 mL). The 
solution was cooled to  room temperature before L-tryptophan (9.73 g, 47.6 mmol) was 
added and the m ixture stirred for 24 hours then evaporated. The residue was washed with 
ethyl acetate (1 x 300 mL, 1 x 100 mL) and petroleum ether (ca. 100 mL) then dried to yield a 
cream solid. The solid was stirred in an ethanolic solution of methylamine (70 mL, 560 mmol) 
for 120 hours then evaporated, taken up in sodium bicarbonate (saturated, 100 mL) and 
extracted w ith  chloroform  (4 x 40 mL). The combined chloroform was dried over sodium 
carbonate and evaporated to  yield the desired product, a yellow solid (6.1 g, 28 mmol, 59%). 
vmax (NaCI disk)/cm_1 3282, 1650, 1537, 1457, 1411, 1342, 1232, 1101; *H NMR (500 MHz, 
DMSO-de) 6 h 10.85 (1H, bs, ArH), 7.79-7.82 (1H, m, ArH), 7.34 (1H, d, J = 8.1 Hz, ArH), 7.15 
(1H, d, J = 2.2 Hz, ArH), 7.06 (1H, td, J = 7.0 Hz, 0.9 Hz, ArH), 6.97 (1H, td, J = 7.0 Hz, 0.9 Hz, 
ArH), 3.41 (1H, dd, J = 8.0 Hz, 4.8 Hz, COCH), 3.06 (1H, dd, J = 14.2 Hz, 4.8 Hz, CH2), 2.75 (1H, 
dd, J = 14.2 Hz, 8.0 Hz, CH2), 2.58 (3H, d, J = 4.7 Hz, CH3), 1.62 (1H, bs, Nh^); 13C NMR (125 
MHz, DMSO-de) 6 c 175.7 (C), 136.7 (C), 128.0 (C), 124.2 (CH), 121.3 (CH), 119.0 (CH), 118.7 
(CH), 111.8 (CH), 111.3 (C), 56.0 (CH), 31.7 (CH2), 26.0 (CH3); LRMS m/z  (ES+) [M+H]+ = 218.1;
201
HRMS m/z (ES+) [M+H]+ = 218.1285; HRMS m/z calc. [M+H]+ = 218.1293; Mpt. 123-125 °C; 
[a]D34 32.0 (c 0.1, CH3OH).
1-Benzyl-L-tryptophan ethyl ester hydrochloride 149 HCI
n h 2
•HCI
Iron(lll) n itrate nonahydrate (0.31 g, 0.78 mmol) was dissolved in liquid ammonia (500 mL). 
Sodium (3.95 g, 172 mmol) was dissolved and the ammonia was kept at reflux for 1 hour 
before L-tryptophan (15.4 g, 75.4 mmol) was added, along with anhydrous diethyl ether (10 
mL). The reaction was refluxed fo r 60 minutes and benzyl chloride was added dropwise (12.0 
mL, 13.2 g, 104 mmol). The reaction mixture was then allowed to evaporate slowly overnight 
and quenched by the addition of water (600 mL) then heated to  precipitate a solid, which 
was removed by filtra tion . The filtra te  was treated with glacial acetic acid (65 mL), cooled to 
around 10 °C and the resultant white precipitate filtered, washed with water (500 mL), 
ethanol (200 mL), and 40-60 °C petroleum ether (200 mL) then dried in vacuo. It was then 
refluxed fo r 23 hours in an ethanolic solution of hydrogen chloride formed by the cautious 
addition of thionyl chloride (30 mL) to  ethanol (1.1 L). The solution was then evaporated and 
the residue washed w ith  1:1 ethyl acetate:diethyl ether (300 mL) and copious diethyl ether 
then dried to  give the desired product, a flu ffy white solid (17.7 g, 43.4 mmol, 58%). vmax 
(NaCI disk)/cm_1 1736, 1507, 1238, 734, 699; *H NMR (500 MHz, DMSO-d6) 6 H 8.81 (3H, s, 
NH3+), 7.62 (1H, d, J = 7.5 Hz, ArH), 7.42 (1H, d, J = 7.5 Hz, ArH), 7.39 (1H, s, ArH), 7.31 (2H, t, J 
= 7.5 Hz, ArH), 7.25 (1H, t, J = 7.1 Hz, ArH), 7.21 (2H, d, J = 7.1 Hz, ArH), 7.12 (1H, t, J = 7.1 Hz, 
ArH), 7.05 (1H, t, J = 7.1 Hz, ArH), 5.39 (2H, t, J = 16.5 Hz, PhCH2), 4.15 (1H, dd, J = 7.9 Hz, 5.3 
Hz, COCH), 4.08 -  3.95 (2H, m, CH3CH2), 3.41 (1H, dd, J = 14.6 Hz, 5.3 Hz, CHCH2), 3.27 (1H, 
dd, J = 14.6 Hz, 7.9 Hz, CHCH2), 1.00 (3H, t, J = 7.1 Hz, CH2CH3); 13C NMR (125 MHz, DMSO-d6) 
6 C 169.8 (C), 138.6 (C), 136.5 (C), 128.9 (CH), 128.1 (C), 127.8 (CH), 127.5 (CH), 122.0 (CH),
119.4 (CH), 119.0 (CH), 110.7 (CH), 107.3 (C), 62.0 (CH2), 53.3 (CH), 49.5 (CH2), 26.7 (CH2),
14.1 (CH3); LRMS m/z  (El) [M -C I]+ = 323.2; HRMS m/z  (ES+) [M -CI]+ = 323.1758; HRMS m/z  
calc. [M —Cl]+ = 323.1760; Mpt. 192-195 °C; [a ]D25 4.6 (c 0.1, CH2CI2).
202
1-Benzyl-L-tryptophan A/-methylamide 150
NH
NH;
1-Benzyltryptophan ethyl ester hydrochloride 149-HCI (5.34 g, 14.9 mmol) was taken up in 
potassium carbonate (4 M, 100 mL) and extracted w ith chloroform (3 x 50 mL). The 
chloroform  was evaporated and the residue was stirred in an ethanolic methylamine solution 
(25 mL, 201 mmol) fo r 62 hours then evaporated and dried to  yield the desired product, a 
cream solid (3.71 g, 12.1 mmol, 86%). vmax (NaCI disk)/cm_1 3362, 3059, 2935, 1655, 1537, 
1467, 1333, 1178; *H NMR (500 MHz, CDCI3) 6H 7.61 (1H, d, J = 7.9 Hz, ArH), 7.23-7.16 (5H, 
m, ArH, NH), 7.11 (1H, td, J = 8.2 Hz, 1.0 Hz, ArH), 7.06-7.02 (3H, m, ArH), 6.91 (1H, s, ArH), 
5.19 (2H, s, PhChb), 3.62 (1H, dd, J = 8.8 Hz, 3.9 Hz, COCH), 3.30 (1H, dd, J = 14.5 Hz, 3.9 Hz, 
CHCH2), 2.84 (1H, dd, J = 14.5 Hz, 8.8 Hz, CHCH2), 2.70 (3H, d, J = 5.0 Hz, CH3), 140 (2H, bs, 
NH2); 13C NMR (125 MHz, CDCI3) 6C 175.5 (C), 137.6 (C), 136.9 (C), 128.8 (CH), 128.4 (C), 127.7 
(CH), 127.2 (CH), 126.9 (CH), 122.1 (CH), 119.4 (CH), 119.3 (CH), 111.1 (C), 109.9 (CH), 55.8 
(CH), 49.9 (CH2), 30.9 (CH2), 25.8 (CH3); LRMS m/z (ES+) [M+H]+ = 308.2; HRMS m/z (ES+) 
[M+H]+ = 308.1756; HRMS m/z  calc. [M+H]+ = 308.1763; Mpt. 80-82 °C; [cx]D34 -51.8 (c 0.1, 
CH2CI2).
(2/?,55)-5-Benzyl-2-tert-butyl-3-methylimidazolidin-4-one 151
/
N /
Prepared according to  Standard Preparation B. vmax (NaCI disk)/cm 1 2956, 1691, 1454, 1397, 
1104, 702; *H NMR (500 MHz, CDCI3) 6H 7.30 (2H, t, J = 7.1 Hz, ArH), 7.25-7.22 (3H, m, ArH), 
3.84-3.87 (1H, m, COCH), 3.81 (1H, d, J = 1.8 Hz, CH3CCH), 3.11 (1H, dd, J = 14.0 Hz, 4.2 Hz, 
CHj), 2.90 (1H, dd, J = 14.0 Hz, 7.1 Hz, CH;), 2.89 (3H, s, NCH3), 0.90 (9H, s, CCH3); 13C NMR 
(125 MHz, CDCI3) 5C 175.3 (C), 137.5 (C), 129.5 (CH), 128.5 (CH), 126.7 (CH), 83.4 (CH), 59.5 
(CH), 38.6 (CH2), 37.7 (C), 41.3 (CH3), 25.6 (CH3); LRMS m/z (ES+) [M+H]* = 247.2; HRMS m/z 
(ES+) [M+H]+ = 247.1802; HRMS m/z calc. [M+H]*' = 247.1810; Mpt. 8 6 -8 8  X ; [a ]030 -51.2 (c 
0.1, CH3OH).
J
Bn
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(2/?,55)-5-Benzyl-2-tert-butyl-3-methylimidazolidin-4-one hydrochloride 151HCI
° J N>'
Bn H
•HCI
Prepared according to  Standard Preparation C. vmax (NaCI disk)/cm_1 1704, 1458,1398,1338, 
1064; *H NMR (500 MHz, CD3OD) 6H 7.34 (2H, t, J = 7.5 Hz, ArH), 7.28 (2H, t, J = 7.5 Hz, ArH), 
7.22 (1H, t, J = 7.5 Hz, p-ArH), 4.59 (1H, s, CH3CCH), 4.37 (1H, dd, J = 8.6 Hz, 4.6 Hz, COCH), 
3.34 (1H, dd, J = 15.0 Hz, 4.6 Hz, CH2), 3.05 (1H, dd, J = 15.0 Hz, 8.6 Hz, CH2), 2.96 (3H, s, 
NCH3), 1.01 (9H, s, CCH3); 13C NMR (125 MHz, CD3OD) 6C 168.4 (C), 134.7 (C), 129.3 (CH),
128.7 (CH), 127.4 (CH), 81.2 (CH), 58.9 (CH), 36.2 (C), 35.2 (CH3), 31.1 (C), 23.9 (CH3); LRMS 
m/z  (ES+) [M —Cl]+ = 247.2; HRMS m/z (ES+) [M-CI]+ = 247.1801; HRMS m/z calc. [M-CI]+ = 
247.1810; decomp. 145 °C; [a ]D34-72.2 (cO .l, CH3OH).
(2/?,55)-5-Benzyl-3-methyl-2-(5-methylfuran-2-yl)imidazolidin-4-one 152
/N
Prepared according to  Standard Preparation B. vmax (NaCI disk)/cm 1 3354,1697, 1454, 1400, 
1334, 1262, 1217, 1094, 1021; *H NMR (500 MHz, CDCI3) 6H 7.20-7.18 (4H, m, PhH), 7.12- 
7.16 (1H, m, PhH), 6.09 (1H, d, J = 3.1 Hz, OCCH), 5.80 (1H, d, J = 2.4 Hz, OCCH), 4.85 (1H, s, 
ArCH), 3.94 (1H, dd, J = 7.3 Hz, 4.0 Hz, COCH), 3.05 (1H, dd, J = 13.8 Hz, 4.0 Hz, CH2), 2.85 (1H, 
dd, J = 13.8 Hz, 7.3 Hz, CH2), 2.55 (3H, s, NCH3), 2.14 (3H, s, ArChb), 2.26 (1H, bs, NH); 13C 
NMR (125 MHz, CDCI3) 6C 173.7 (C), 153.3 (C), 149.2 (C), 137.7 (C), 129.6 (CH), 128.4 (CH),
126.6 (CH), 110.2 (CH), 106.3 (CH), 70.9 (CH), 59.7 (CH), 38.3 (CH2), 27.0 (CH3), 13.6 (CH3); 
LRMS m/z  (AP+) [M+H]+ = 271.1; HRMS m/z (ES+) [M+H]+ = 271.1443; HRMS m/z calc. [M+H]+ 
= 271.1447; [a ]D30 29.2 (c 0.1, CH3OH).
X
Bn
(25,55)-5-((lH-lndol-3-yl)methyl)-2-fert-butyl-3-methylimidazolidin-4-one 153
f
Prepared according to  Standard Preparation B. vmax (NaCI d isk j/c rrf1 3298, 2957,1678,1457, 
1400, 1258, 1100; NMR (500 MHz, CDCI3) 6H 8.32 (1H, s, ArH), 7.58 (1H, d, J -  8.0 Hz, ArH),
204
7.28 (ArH, d, J = 8.0 Hz, ArH), 7.12 (1H, td, J = 7.6 Hz, 0.96 Hz, ArH), 7.04 (1H, td, J = 7.6 Hz, 0.7 
Hz, ArH), 7.01 (1H, d, J = 2.3 Hz, ArH), 3.82 (1H, t, J = 5.2 Hz, COCH), 3.69 (1H, d, J = 1.57 Hz, 
CH3CCH), 3.21 (1H, dd, J = 15.0 Hz, 5.2 Hz, CH2), 3.03 (1H, dd, J = 15.0 Hz, 5.2 Hz, CH2), 2.80 
(3H, s, NCH3), 0.81 (3H, s, CCH3); 13C NMR (125 MHz, CDCI3) 6 C 176.1 (C), 136.3 (C), 128.0 (C), 
123.3 (CH), 122.1 (CH), 119.6 (CH), 119.0 (CH), 111.2 (CH), 110.9 (C), 83.4 (CH), 59.2 (CH),
37.9 (C), 31.4 (CH3), 27.7 (CH2), 25.7 (CH3); LRMS m/z (AP+) [M+H]+ = 286.2; HRMS m/z (ES+) 
[M+H]+ = 286.1911; HRMS m/z calc. [M+H]+ = 286.1919; [a ]D30 -64.4 (c 0.1, CH3OH).
(2R,5S)-2-fert-Butyl-l-(3,5-dinitrobenzoyl)-3,5-dimethylimidazolidin-4-one 158
o 2n
n o 2
(2/?,5S)-5-Methyl-2-te/t-butyl-3-methylimidazolidin-4-one 139 (0.028 g, 0.16 mmol), 3,5- 
dinitrobenzoyl chloride (0.060 g, 0.26 mmol) and triethylamine (0.040 mL, 0.030 g, 0.30 
mmol) were stirred in DCM (2 mL) for 1 hour, before sodium hydroxide (4 M, 2 mL) was 
added and stirring was continued for 10 minutes. The mixture was poured into sodium 
bicarbonate (saturated, 20 mL), extracted w ith chloroform (20 mL), dried over sodium 
carbonate, and column chromatography (1:1 petroleum ether:ethyl acetate) used to obtain 
the desired product (Rf: 0.38), a cream solid. vmax (NaCI disk)/cm_1 3403, 1695, 1651, 1537, 
1345; *H NMR (500 MHz, CDCI3) 6 H 9.20 (1H, t, J = 2.0 Hz, p-ArH), 8.75 (2H, s, o-ArH), 5.69 
(1H, s, (CH3)3CCH), 4.36 (1H, q, J = 6.5 Hz, COCH), 4.35 (3H, s, NCH3), 4.34 (9H, s, (CHahC), 1.09 
(3H, s, COCCH3); 13C NMR (125 MHz, CDCI3) 6 C 170.8 (C), 166.2 (C), 148.9 (C), 140.3 (C), 127.5 
(CH), 121.1 (CH), 80.3 (CH), 56.8 (CH), 40.8 (C), 32.3 (CH3), 26.4 (CH3), 20.3 (CH3); LRMS m/z 
(AP+) [M+H]+ = 365.2; HRMS m/z  (AP+) [M+H]+ = 365.1445; HRMS m/z calc. [M+H]+ = 
365.1461; M pt. 209-210 °C; [a ] D25 140 (cO.Ol, CH3CN).
(2/?,55)-5-Benzyl-3-methyl-2-phenylimidazolidin-4-one 169
Prepared according to  Standard Preparation A. vmax (NaCI disk)/cm 1 3326, 2920, 1694, 1455, 
1400, 754, 700; XH NMR (500 MHz, CDCI3) 6 H 7.28-7.24 (3H, m, ArH), 7.21-7.18 (4H, m, ArH), 
7.15-7.11 (3H, m, ArH), 4.77 (1H, d, J = 1.5 Hz, NCH3CH), 3.94-3.97 (1H, m, COCH), 3.03 (1H,
XBn
205
dd, J = 13.7 Hz, 4.0 Hz, CH2), 2.86 (1H, dd, J = 13.7 Hz, 7.4 Hz, CH2), 2.48 (3H, s, NCH3); 13C 
NMR (125 MHz, CDCI3) 6C 174.2 (C), 139.4 (C), 137.8 (C), 129.7 (CH), 129.3 (CH), 129.1 (CH),
128.6 (CH), 128.4 (CH), 126.7 (CH), 77.8 (CH), 60.1 (CH), 38.8 (CH2), 27.2 (CH3); LRMS m/z  (El+) 
[M ]+ = 266.1; HRMS m/z  (El+) [M ]+ = 266.1412; HRMS m/z  calc. [M ]+ = 266.1419; [a ]D34 31.0 (c 
0.1, CH2CI2).
(2/?,5S)-5-Benzyl-3-methyl-2-phenylimidazolidin-4-one hydrochloride 169 HCI
M  o
Bn H
•HCI
Prepared according to  Standard Preparation C (64%). vmax (NaCI disk)/cm-1 2478, 1716, 1457, 
1402, 699; *H NMR (500 MHz, CD3OD) 6H 7.60-7.57 (3H, m, ArH), 7.52-7.50 (2H, m, ArH), 
7.46 (2H, d, J = 7.3 Hz, ArH), 7.39 (2H, t, J = 7.3 Hz, ArH), 7.33 (1H, t, J = 7.3 Hz, ArH), 5.93 (1H, 
s, ArCH), 4.70 (1H, dd, J = 10.0 Hz, 3.8 Hz, COCH), 3.57 (1H, dd, J = 15.1 Hz, 3.8 Hz, CH2), 3.24 
(1H, dd, J = 15.1 Hz, 10.0 Hz, CH2), 2.84 (3H, s, CH3); 13C NMR (125 MHz, CD3OD) 6C 167.4 (C),
134.7 (C), 131.4 (CH), 130.5 (C), 129.6 (CH), 128.9 (CH), 128.8 (CH), 127.7 (CH), 127.5 (CH),
74.0 (CH), 58.0 (CH), 34.3 (CH2), 26.7 (CH3); LRMS m/z (AP+) [M-CI]+ = 267.2; HRMS m/z (ES+) 
[M -C I]+ = 267.1490; HRMS m/z calc. [M -C I]+ = 267.1497; Mpt. 130-132 °C; [a ]D34 11.8 (c 0.1, 
CH3OH).
(2S,55)-5-Benzyl-3-methyl-2-phenylimidazolidin-4-one 170
5^-0Bn
Prepared according to  Standard Preparation A. vmax (NaCI disk)/cm-1 3328, 3030,1690, 1458, 
1401, 1097; *H NMR (500 MHz, CDCI3) 6H 7.34-7.24 (8H, m, ArH), 6.85 (2H, d, J = 7.3 Hz, ArH),
5.14 (1H, s, NCH3CH), 3.88 (1H, t, J = 5.1 Hz, COCH), 3.25 (1H, dd, J = 14.1 Hz, 5.1 Hz, CH2),
3.15 (1H, dd, J = 14.1 Hz, 4.1 Hz, CH2), 2.56 (3H, s, NCH3); 13C NMR (125 MHz, CDCI3) 6C 174.4 
(C), 138.5 (C), 136.8 (C), 129.8 (CH), 129.5 (CH), 129.0 (CH), 128.8 (CH), 127.1 (CH), 126.9 
(CH), 77.6 (CH), 60.5 (CH), 37.0 (CH2), 27.3 (CH3); LRMS m/z  (El+) [M ]+ = 266.1; HRMS m/z (El+) 
[M ]+ = 266.1414; HRMS m/z  calc. [M ]+ = 266.1419; [a ]D34 -138.0 (c 0.1, CH2CI2).
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(2S,5S)-5-Benzyl-3-methyl-2-phenylimidazolidin-4-one hydrochloride 170 HCI
•HCI
Prepared according to  Standard Preparation C (75%). vmax (NaCI diskj/cm"1 3381, 2517,1719, 
1462, 1419, 699; *H NMR (500 MHz, CD3OD) 6 H 7.64-7.57 (3H, m, ArH), 7.50-7.48 (2H, m, 
ArH), 7.43-7.38 (4H, m, ArH), 7.36-7.34 (1H, m, ArH), 5.90 (1H, s, ArCH), 4.63 (1H, dd, V = 9.9 
Hz, 3.7 Hz, COCH), 3.57 (1H, dd, J = 15.4 Hz, 3.7 Hz, Q k), 3.18 (1H, dd, J = 15.4 Hz, 9.9 Hz, 
CH2), 2.82 (3H, s, CH3); 13C NMR (125 MHz, CD3OD) 6 C 168.4 (C), 135.0 (C), 131.5 (CH), 129.9 
(C), 129.5 (CH), 128.8 (CH), 128.4 (CH), 127.4 (CH), 74.2 (CH), 59.9 (CH), 33.8 (CH2), 27.3 
(CH3); LRMS m/z  (AP+) [M -C I]+ = 267.2; HRMS m/z (ES+) [M -CI]+ = 267.1493; HRMS m/z calc. 
[M—Cl]+ = 267.1497; [a ] D34 -54 .0  (c 0.1, CH3OH).
2-Fluoroacetophenone 186
o
F
To a solution of acetophenone (130.9 g, 1089 mmol) and 45% hydrogen bromide in acetic 
acid (1.2 mL) in DCM (370 mL) at - 8  °C was added bromine (56 mL, 174 g, 1.09 mol) dropwise 
over the course o f 30 minutes. The mixture was allowed to  warm to room temperature and 
was stirred fo r 5 minutes, before being evaporated and the residue recrystallised from 
hexanes to  yield 2-bromoacetophenone as a cream solid (81.8 g, 410 mmol, 38%). 2- 
bromoacetophenone (31.8 g, 160 mmol), potassium fluoride (44.6, 768 mmol), 
tetrabutylam m onium  bisulfate (7.47, 22.0 mmol) and triphenyltin fluoride (6.61 g, 17.9 
mmol) in acetonitrile (120 mL) were refluxed for 69 hours before being cooled, filtered and 
evaporated. The residue was taken up in water (400 mL), extracted with diethyl ether (1 x 
200 mL, 2 x 100 mL), dried over magnesium sulfate, treated with pyridine (10 mL) and 
refluxed fo r 20 minutes. The reaction mixture was washed w ith hydrochloric acid (4 M, 2 x 
100 mL), dried over magnesium sulfate and evaporated and the desired product isolated by 
distillation (105 °C, 1 mbar) as a clear crystalline solid (11.53 g, 83.5 mmol, 52%). vmax (NaCI 
disk)/cm -1 1707, 1598, 1451, 1233, 1089, 968, 757; *H NMR (400 MHz, CDCI3) 6 H 7.89 (2H, d,J 
= 7.6 Hz, o-ArH), 7.63 (1H, t, J = 7.6 Hz, p-ArH), 7.50 (2H, t, J = 7.6 Hz, m-ArH), 5.55 (2H, d, J =
46.8 Hz, CH^F); 13C NMR (100 MHz, CDCI3) 6 C 193.4 (C, d, J = 15 Hz), 134.2 (CH), 133.6 (C), 
129.0 (CH), 127.8 (CH, d, J = 22 Hz), 83.5 (CH2, d, J = 182 Hz); LRMS m/z (El+) [M ]+ = 138.0; 
HRMS m/z  (El+) [M ]+ = 138.0476; HRMS m/z calc. [M ]+ = 138.0481; Mpt. 25-27 °C.76
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2-((2R,4S)-4-Benzyl-l,2-dimethyl-5-oxoimidazolidin-2-yl)-N,N-diethylacetamide
hydrochloride 201HCI
o r
Brf
•HCI
L-Phenylalanine A/-methylamide 62 (7.94 g, 44.6 mmol), A/,A/-diethylacetoacetamide (7.69 g,
48.9 mmol) and y tterb ium (lll) trifluoromethanesulfonate (0.85 g, 1.4 mmol) were refluxed in 
toluene (300 mL) fo r 15 hours, cooled to room temperature, filtered, and the clear solution 
treated w ith  hydrogen chloride gas for 30 minutes. The mixed hydrochloride salts were 
isolated by filtra tion , washed w ith diethyl ether and recrystallised repeatedly from 
acetonitrile:chloroform :diethyl ether:ethyl acetate and DCM:hexanes to provide the desired 
product as as clear crystals (0.12 g, 0.34 mmol, 1%). vmax (NaCI disk)/cm_1 2909, 2380, 1717, 
1616, 1456, 1394, 1354, 1265; *H NMR (500 MHz, CH3OD) 6 H 7.41-7.37 (4H, m, ArH), 7.32 
(1H, t, J = 6.4 Hz, ArH), 4.73 (1H, dd, J = 8.7 Hz, 4.8 Hz, COCH), 3.49-3.37 (5H, m, PhCH2, 
NCH2), 3.26-3.19 (2H, m, PhCHh, COCH2), 3.09 (1H, d, J = 17.1 Hz, COCH2), 2.91 (3H, s, NCH3), 
1.67 (3H, s, CCH3 ), 1.21 (3H, t, J = 7.1 Hz, CH2CH3), 1.10 (3H, t, J = 7.1 Hz, CH2CH3); 13C NMR 
(125 MHz, CDCI3) 6 c 166.6 (C), 165.8 (C), 133.4 (C), 127.2 (CH), 127.1 (CH), 125.8 (CH), 76.9 
(C), 56.7 (CH), 40.6 (CH2), 38.9 (CH2), 33.6 (CH2), 32.5 (CH2), 23.2 (CH3), 20.7 (CH3), 11.5 (CH3),
10.1 (CH3); HRMS m/z  (ES+) [M -C lj+ = 318.2178; HRMS m/z calc. [M-CI]+ = 318.2182; decomp. 
158 °C; [a ]D22 21.2 (c 0.1, CH3OH).
(3/?,5/?)-3,5-Dibenzyl-l-methylpiperazine-2,6-dione 227
(/?)-Methyl-2-((/?)-l-(methylamino)-l-oxo-3-phenylpropan-2-ylamino)-3- 
phenylpropanoate 230 (0.480 g, 1.41 mmol) was dissolved in diethyl ether (25 mL) and 
sodium methoxide (0.062 g, 1.15 mmol) was added. The suspension was stirred for four 
hours at room tem perature then washed w ith brine (2 x 30 mL) and evaporated to yield an 
off-white solid tha t was purified via column chromatography (1:1 petroleum ether:diethyl 
ether) to  give the desired product 16 (Rfi 0.38) as a white solid (0.33 g, 1.07 mmol, 76%). vmax 
(NaCI disk)/cm_13401, 3321, 1728, 1675, 1296, 1118; *H NMR (500 MHz, CDCI3) 6H 7.24 -7 .19  
(6 H, m, Ar-H), 7.00 (4H, dd, J = 7.1 Hz, J = 1.1 Hz, Ar-H), 3.89 (2H, dd, J = 10.6 Hz, J = 3.3 Hz, 
COCH), 3.29 (2H, dd, J = 13.7 Hz, J = 3.3 Hz, CH2), 3.23 (3H, s, NCHa), 2.87 (2H, dd, J = 13.7 Hz, 
J = 10.7 Hz, CH2); 13C NMR (125 MHz, CDCI3) 6 C 172.4 (C), 136.7 (C), 129.1 (CH), 128.9 (CH),
126.8 (CH), 57.1 (CH), 36.2 (CH2), 26.4 (CH3); LRMS m/z  (ES+) [M+H]+ = 309.2; HRMS m/z (ES+)
H
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[M + H f = 309.1601; HRMS m/z  calc. [M+H]+ = 309.1603; Mpt. 70-72 °C; [a ]D32 54.6 (c 0.1, 
CH2CI2).
(3R,5/?)-3,5-Dibenzyl-l-methylpiperazine-2,6-dione hydrochloride 227 HCI
•HCI
Prepared according to  Standard Preparation C (70%). vmax (NaCI disk)/cnrf1 2354, 1692, 1427,
(CH), 55.9 (CH), 34.1 (CH2), 26.0 (CH3); LRMS m/z  (AP+) [M -CI]+ = 309.2; HRMS m/z (ES+) [M - 
Cl]+ = 309.1600; HRMS m/z  calc. [M -C I]+ = 309.1603; Mpt. 87-89 °C; [a ]D34 31.2 (c 0.1, 
CH2CI2).
(A?)-Methyl 2-((/?)-l-(methylamino)-l-oxo-3-phenylpropan-2-ylamino)-3-phenylpropanoate
To a solution of trifluoromethanesulfonic anhydride (1.0 mL, 1.68 g, 5.96 mmol) in 
dichloromethane (6 mL) at -42  °C was added a solution of methyl L-3-phenyllactate (1.09 g,
6.07 mm ol) and trie thylam ine (1.0 mL, 0.72 g, 7.11 mmol) in dichloromethane (6 mL) 
dropwise. The combined solution was allowed to  warm slowly to  room temperature and 
stirred fo r 2 hours, before it was evaporated and the residual oil extracted with petroleum 
ether (6 x 10 mL). The combined extracts were evaporated and a solution of D-Phenylalanine 
A/-methylamide (1.14 g, 6.38 mmol) and triethylam ine (1.0 mL, 0.72g, 7.11 mmol) in 
dichloromethane (15 mL) was added and the mixture stirred for 19 hours at room 
tem perature. The m ixture was then evaporated and the residue taken up in ethyl acetate (30 
mL), washed w ith  4M potassium carbonate (20 mL) and brine (20 mL), and then evaporated. 
The resultant oil was taken up in diethyl ether (70 mL), washed with 4M potassium carbonate 
(40 mL), water (2 x 40 mL) and brine (20 mL) then evaporated to yield an oil which was 
subjected to  column chromatography (diethyl ether) to yield the desired product (Rf: 0.27) as 
a pale green oil (1.01 g, 2.97 mmol, 50%). vmax (NaCI disk)/cm-1 3371, 2949,1737,1667,1530; 
*H NMR (500 MHz, CDCI3) 6H 7.28-7.19 (6H, m, Ar-H), 7.12 (4H, d, J = 7.0 Hz, Ar-H), 6.00 (1H,
1300, 1137, 749, 700; *H NMR (500 MHz, CD3OD) 6H 7.39-7.28 (10H, m, ArH), 4.62 (2H, t, J =
6.8 Hz, CH), 3.53 (2H, dd, J = 14.6 Hz, 6.8 Hz, CH2), 3.29 (2H, dd, J = 14.6 Hz, 7.8 Hz, CH2), 3.24 
(3H, s, CH3); 13C NMR (125 MHz, CD3OD) 6C 166.4 (C), 134.0 (C), 129.2 (CH), 128.9 (CH), 127.7
230
o o
Bn Bn
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s, CONH), 3.43 (3H, s, OCH3), 3.18-3.04 (1H, m, COCH), 2.06-2.40 (2H, m, CH/CHz); 13C NMR 
(125 MHz, CDCI3) 6C 137.0 (C), 129.6 (CH), 129.3 (CH), 128.6 (CH), 128.5 (CH), 126.9 (CH),
126.9 (CH), 62.6 (CH), 62.4 (CH), 52.0 (CH3), 39.8 (CH2), 39.7 (CH2), 25.6 (CH3); LRMS m/z (El) 
[M +] = 340; HRMS m/z  (ES+) [M+H]+ = 341.1863; HRMS m/z calc. [M+H]+ = 341.1865; [a ]D32
83.4 (c 0.1, CH2CI2).
(2S,5S)-5-((l-Benzyl-lH-indol-3-yl)methyl)-2-tert-butyl-3-methylimidazolidin-4-one 247
Prepared according to  Standard Preparation B. vmax (NaCI disk)/cm_1 3474, 3356, 2956,1694, 
1454, 1396, 740; *H NMR (500 MHz, CDCI3) 6H 7.59 (1H, d, J = 7.9 Hz, ArH), 7.21-7.14 (4H, m, 
ArH), 7.10 (1H, td, J = 7.9 Hz, 1.1 Hz, ArH), 7.04 (1H, td, J = 7.9 Hz, 1.1 Hz, ArH), 7.00 (2H, d, J =
7.9 Hz, ArH), 6.94 (1H, s, ArH), 5.18 (2H, dd, J = 24.2 Hz, 16.0 Hz, PhCH2), 3.79 (1H, t, J = 5.0 
Hz, COCH), 3.61 (1H, s, CH3CCH), 3.18 (1H, dd, J = 14.9 Hz, 5.0 Hz, CHChb), 3.05 <1H, dd, J =
14.9 Hz, 5.0 Hz, CHCH2), 2.72 (3H, s, NCHs), 1.90 (1H, bs, NH), 0.79 (9H, s, CHb); 13C NMR (125 
MHz, CDCI3) 6c 176.0 (C), 137.7 (C), 136.6 (C), 128.8 (CH), 128.8 (C), 127.6 (CH), 127.3 (CH),
126.8 (CH), 121.9 (CH), 119.4 (CH), 119.2 (CH), 110.1 (C), 109.7 (CH), 83.4 (CH), 59.3 (CH),
49.9 (CH2), 31.3 (CH3), 27.4 (CH2), 25.7 (CH3); LRMS m/z (ES+) [M+H]+ = 376.2; HRMS m/z (ES+) 
[M + H f = 376.2384; HRMS m/z calc. [M+H]+ = 376.2389; [a ]D30 -48.0 (c 0.1, CH3OH).
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11 Appendix A
11.1 X-ray data fo r 82
Identification code nct0809
Empirical formula C28 H30 Br N2 02 P
Formula weight 537.42
Temperature 150(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P21
Unit cell dimensions a = 9.1420(3) A a = 90°. 
b = 14.8200(5) A 8= 113.0440(10)°. 
c = 10.7260(4) A r  = 90°.
Volume 1337.25(8) A 3
Z 2
Density (calculated) 1.335 Mg/m3
Absorption coefficient 1.623 m m 'l
F(000) 556
Crystal size 0.36x0.22x0.11 mm3
Theta range for data collection 2.48 to 27.55°.
Index ranges -ll< = h < = ll, -18<=k<=19, -13<=l<=13
Reflections collected 5237
Independent reflections 5237 [R(int) = 0.0000]
Completeness to theta = 27.55° 99.2 %
Max. and min. transmission 0.8416 and 0.5926
Refinement method Full-matrix least-squares on F2
Data /  restraints /  parameters 5 2 3 7 / 4 / 3 1 6
Goodness-of-fit on F2 1.079
Final R indices [l>2sigma(l)] R1 = 0.0472, wR2 = 0.0846
R indices (all data) R1 = 0.0629, wR2 = 0.0913
Absolute structure parameter 0.010(9)
Largest diff. peak and hole 0.318 and -0.379 e.A'3
£
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Table 2. Atom ic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x 
103)
for nct0809. U(eq) is defined as one third of the trace of the orthogonalized U'J tensor.
X y z U(eq)
C(1) 4589(4) 7024(2) 6616(4) 23(1)
C(2) 4151(6) 7856(3) 6005(5) 36(1)
C(3) 4384(6) 8633(3) 6784(5) 51(1)
C(4) 5057(6) 8574(4) 8189(4) 44(1)
C(5) 5509(6) 7747(3) 8803(4) 38(1)
C(6) 5281(5) 6968(3) 8037(4) 29(1)
C(7) 5511(4) 5128(2) 6523(4) 22(1)
C(8) 5245(5) 4568(3) 7451(4) 26(1)
C(9) 6342(5) 3901(3) 8101(4) 32(1)
C(10) 7699(5) 3802(3) 7862(4) 35(1)
C ( l l) 7981(6) 4363(3) 6962(5) 43(1)
C(12) 6895(5) 5028(3) 6287(4) 32(1)
C(13) 4158(4) 6175(2) 4025(4) 22(1)
C(14) 5298(5) 6722(3) 3844(4) 27(1)
C(15) 5369(5) 6781(3) 2582(5) 37(1)
C(16) 4312(5) 6294(3) 1511(4) 39(1)
C(17) 3172(5) 5767(3) 1672(4) 38(1)
C(18) 3096(5) 5692(3) 2938(4) 31(1)
C(19) 1136(4) 6265(3) 5591(4) 24(1)
C(20) -500(4) 5893(3) 4682(4) 26(1)
C(21) -754(4) 5833(3) 3203(4) 30(1)
C(22) -711(5) 6607(3) 2492(4) 28(1)
C(23) -979(5) 6555(3) 1124(4) 36(1)
C(24) -1281(6) 5729(3) 471(5) 51(1)
C(25) -1309(7) 4972(4) 1170(5) 62(2)
C(26) -1058(6) 5017(3) 2538(5) 47(1)
C(27) 1248(5) 6370(3) 7052(4) 28(1)
C(28) 450(8) 7324(4) 8544(6) 67(2)
N (l) 2385(3) 5651(2) 5566(3) 22(1)
N(2) 571(5) 7120(3) 7253(4) 41(1)
0(1) 1875(4) 5814(2) 7940(3) 40(1)
0(2) 2170(5) 3938(2) 8632(4) 53(1)
P(l) 4118(1) 5998(1) 5669(1) 19(1)
B r(l) 1376(1) 3477(1) 5363(1) 40(1)
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Table 3. Bond lengths [A] and angles [°] for nct0809.
C(l)-C(2) 1.380(5)
C(l)-C(6) 1.406(5)
C (l)-P (l) 1.785(4)
C(2)-C(3) 1.390(6)
C(3)-C(4) 1.389(6)
C(4)-C(5) 1.376(7)
C(5)-C(6) 1.385(6)
C(7)-C(8) 1.389(5)
C(7)-C(12) 1.392(5)
C(7)-P(l) 1.792(4)
C(8)-C(9) 1.386(6)
C(9)-C(10) 1.369(6)
C(10)-C (ll) 1.373(6)
C (ll)-C (12) 1.385(6)
C(13)-C(18) 1.389(5)
C(13)-C(14) 1.392(5)
C(13)-P(l) 1.797(4)
C(14)-C(15) 1.383(6)
C(15)-C(16) 1.380(6)
C(16)-C(17) 1.366(6)
C(17)-C(18) 1.391(6)
C(19)-N(l) 1.469(5)
C(19)-C(20) 1.533(5)
C(19)-C(27) 1.537(6)
C(20)-C(21) 1.513(6)
C(21)-C(26) 1.376(6)
C(21)-C(22) 1.386(6)
C(22)-C(23) 1.392(6)
C(23)-C(24) 1.382(6)
C(24)-C(25) 1.356(7)
C(25)-C(26) 1.395(7)
C(27)-0(l) 1.220(5)
C(27)-N(2) 1.330(5)
C(28)-N(2) 1.463(6)
N (l)-P (l) 1.628(3)
C(2)-C(l)-C(6) 119.5(4)
C(2)-C(l)-P(l) 122.0(3)
C(6)-C(l)-P(l) 118.2(3)
C(l)-C(2)-C(3) 120.5(4)
C(4)-C(3)-C(2) 119.9(5)
C(5)-C(4)-C(3) 119.9(4)
C(4)-C(5)-C(6) 120.8(4)
C(5)-C(6)-C(l) 119.5(4)
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C(8)-C(7)-C( 12) 119.5(4)
C(8)-C(7)-P(l) 120.5(3)
C(12)-C(7)-P(l) 119.9(3)
C(9)-C(8)-C(7) 119.5(4)
C(10)-C(9)-C(8) 120.8(4)
C(9)-C(10)-C(ll) 120.0(4)
C(10)-C(ll)-C(12) 120.3(4)
C(ll)-C(12)-C(7) 119.9(4)
C(18)-C(13)-C(14) 119.8(4)
C(18)-C(13)-P(l) 118.2(3)
C(14)-C(13)-P(l) 121.7(3)
C(15)-C(14)-C(13) 119.9(4)
C(16)-C(15)-C(14) 119.7(4)
C(17)-C(16)-C(15) 120.9(4)
C(16)-C(17)-C(18) 120.1(4)
C(13)-C(18)-C(17) 119.6(4)
N(l)-C(19)-C(20) 109.8(3)
N(l)-C(19)-C(27) 109.8(3)
C(20)-C(19)-C(27) 110.1(3)
C(21)-C(20)-C(19) 113.5(3)
C(26)-C(21)-C(22) 119.0(4)
C(26)-C(21)-C(20) 120.8(4)
C(22)-C(21)-C(20) 120.2(4)
C(21)-C(22)-C(23) 120.2(4)
C(24)-C(23)-C(22) 120.0(4)
C(25)-C(24)-C(23) 119.7(4)
C(24)-C(25)-C(26) 120.7(5)
C(21)-C(26)-C(25) 120.2(5)
0(1)-C(27)-N(2) 123.0(4)
0(1)-C(27)-C(19) 123.4(4)
N(2)-C(27)-C(19) 113.6(4)
C(19)-N(l)-P(l) 123.1(3)
C(27)-N(2)-C(28) 122.6(4)
N (l)-P (l)-C (l) 108.62(17)
N(l)-P(l)-C(7) 106.58(17)
C(l)-P(l)-C(7) 110.91(18)
N(l)-P(l)-C(13) 111.90(16)
C(l)-P(l)-C(13) 109.92(17)
C(7)-P(l)-C(13) 108.88(17)
Symmetry transform ations used to  generate equivalent atoms:
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Table 4. Anisotropic displacement parameters (A2x 10^)for nct0809. The anisotropic 
displacement factor exponent takes the form: -2I12[ h2a*2l ) l l  + ... + 2 h k a* b* U^2 ]
u i i U22 U33 1(23 U l3 U l2
C(1) 23(2) 18(2) 25(2) -3(2) 7(2) -3(2)
C(2) 55(3) 22(2) 30(2) 1(2) 14(2) -1(2)
C(3) 84(4) 18(3) 49(3) 1(2) 24(3) -4(2)
C(4) 65(3) 28(3) 39(2) -12(3) 18(2) -13(3)
C(5) 46(3) 35(2) 27(2) -5(2) 8(2) -6(2)
C(6) 32(2) 24(2) 30(2) -2(2) 12(2) 0(2)
C(7) 23(2) 18(2) 21(2) -3(2) 5(2) 1(2)
C(8) 24(2) 27(2) 26(2) -2(2) 8(2) -6(2)
C(9) 37(3) 26(2) 24(2) 4(2) 1(2) -4(2)
C(10) 39(3) 31(2) 26(2) 3(2) 2(2) 12(2)
C ( l l) 35(3) 53(3) 39(3) 7(2) 13(2) 22(2)
C(12) 29(2) 36(2) 34(2) 11(2) 17(2) 8(2)
C(13) 19(2) 22(2) 24(2) 1(2) 9(2) 7(2)
C(14) 22(2) 29(2) 31(2) 6(2) 13(2) 7(2)
C(1S) 39(3) 39(3) 41(3) 17(2) 25(2) 14(2)
C(16) 42(3) 52(3) 30(2) 11(2) 21(2) 19(2)
C(17) 40(3) 48(3) 24(2) 0(2) 10(2) 14(2)
C(18) 24(2) 38(3) 27(2) -5(2) 7(2) 1(2)
C(19) 24(2) 21(2) 29(2) 5(2) 14(2) 2(2)
C(20) 20(2) 27(2) 33(2) 5(2) 12(2) 5(2)
C(21) 13(2) 35(2) 33(2) 8(2) 0(2) 4(2)
C(22) 24(2) 28(2) 31(2) 1(2) 11(2) 4(2)
C(23) 36(3) 41(3) 29(2) 3(2) 11(2) 4(2)
C(24) 58(3) 53(3) 24(2) -7(2) -3(2) 10(3)
C(25) 85(4) 37(3) 35(3) -11(2) -9(3) -6(3)
C(26) 44(3) 36(3) 34(3) 1(2) -12(2) -5(2)
C(27) 32(2) 26(2) 31(2) 2(2) 18(2) 5(2)
C(28) 118(6) 54(3) 49(3) 2(3) 52(4) 27(4)
N (l) 20(2) 16(1) 32(2) 0(1) 12(1) 0(1)
N(2) 67(3) 35(2) 29(2) 10(2) 28(2) 21(2)
0(1) 58(2) 32(2) 30(2) 9(2) 18(2) 13(2)
0(2) 68(3) 39(2) 48(2) 16(2) 20(2) 9(2)
P(l) 17(1) 19(1) 21(1) 0(1) 7(1) -K D
Br(l) 47(1) 21(1) 39(1) 1(1) 2(1) -7(1)
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Table 5. Hydrogen coordinates ( x 10^) and isotropic displacement parameters (A^x 10^) 
fo r nct0809.
X y z U(eq)
H(2) 3688 7898 5045 44
H(3) 4082 9204 6357 61
H(4) 5206 9103 8724 53
H(5) 5983 7710 9763 45
H(6) 5591 6399 8469 35
H(8) 4319 4641 7638 32
H(9) 6150 3508 8720 39
H(10) 8445 3345 8319 42
H ( l l) 8926 4295 6801 51
H(12) 7094 5415 5665 38
H(14) 6027 7053 4585 32
H(15) 6142 7155 2453 44
H(16) 4377 6326 650 47
H(17) 2431 5451 919 46
H(18) 2324 5313 3058 37
H(19) 1286 6869 5242 29
H(20A) -626 5284 5006 32
H(20B) -1332 6286 4768 32
H(22) -498 7174 2940 33
H(23) -954 7087 639 43
H(24) -1468 5693 -463 61
H(25) -1502 4404 724 75
H(26) -1097 4482 3013 56
H(28A) 158 6776 8903 101
H(28B) -364 7788 8403 101
H(28C) 1477 7546 9191 101
H (l) 2188 5068 5492 27
H(2A) 180 7508 6583 49
H(10) 2180(50) 4536(7) 8540(40) 26(11)
H(20) 1830(80) 3710(30) 7790(20) 110(30)
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Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated)
Absorption coefficient 
F(000)
Crystal size
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 27.48° 
Max. and min. transmission 
Refinement method 
Data /  restraints /  parameters
Goodness-of-fit on F2 
Final R indices [l>2sigma(l)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole
nct0807
C18 H20CI N3 03
361.82 
200(2) K 
0.71073 A 
Orthorhombic 
P212121
a = 7.5840(2) A ct = 90°.
b = 10.4830(3) A 8 = 90°.
c = 23.1960(6) A r  = 90°.
1844.15(9) A 3 
4
1.303 Mg/m3 
0.229 mm"1 
760
0.40 x 0.15 x 0.04 mm3
3.21 to 27.48°.
-9<=h<=9, -13<=k<=13, -29<=l<=30 
4216
4216 [R(int) = 0.0000]
99.6 %
0.9909 and 0.9141 
Full-matrix least-squares on F2 
4 2 1 6 / 0 / 2 2 8  
1.044
Rl = 0.0601, wR2 = 0.1054 
Rl = 0.0992, wR2 = 0.1198 
0.06(9)
0.229 and -0.255 e.A"3
Table 2. Atom ic coordinates ( x 10^) and equivalent isotropic displacement parameters (A^x 
103 )
fo r nct0807. U(eq) is defined as one third of the trace of the orthogonalized U'J tensor.
X y z U(eq)
C(l) 4602(4) 10336(3) -746(1) 25(1)
C(2) 5718(4) 9455(3) 143(1) 24(1)
C(3) 3980(4) 8826(3) -29(1) 25(1)
C(4) 5848(4) 9684(3) -1182(1) 26(1)
C(5) 7021(4) 10424(3) -1499(1) 32(1)
C(6) 8244(4) 9849(4) -1857(1) 37(1)
C(7) 8237(5) 8553(4) -1903(1) 42(1)
C(8) 7065(5) 7789(4) -1609(1) 49(1)
C(9) 5859(5) 8378(3) -1243(1) 38(1)
C(10) 3707(4) 11521(3) -984(1) 34(1)
c ( i i ) 1731(4) 9074(3) -798(1) 37(1)
C(12) 5878(4) 9655(3) 787(1) 29(1)
C(13) 7705(4) 9940(3) 1020(1) 29(1)
C(14) 7891(5) 10143(4) 1609(1) 48(1)
C(15) 9512(5) 10443(4) 1844(2) 56(1)
C(16) 10973(5) 10552(3) 1504(2) 43(1)
C(17) 10810(5) 10334(3) 922(1) 37(1)
C(18) 9191(4) 10023(3) 685(1) 31(1)
0(1) 3300(3) 7928(2) 220(1) 34(1)
0(2) 10692(5) 8552(4) -2491(2) 96(1)
0(3) 9393(8) 6789(4) -2357(2) 160(3)
N (l) 5666(3) 10657(2) -212(1) 23(1)
N(2) 3343(3) 9439(2) -497(1) 26(1)
N(3) 9553(6) 7925(5) -2273(2) 74(1)
C l(l) 9070(1) 12173(1) -509(1) 32(1)
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N(1)-H(1A) 0.9200
N(1)-H(1B) 0.9200
N (2)-C (l)-N (l) 99.6(2)
N(2)-C(l)-C(10) 112.2(2)
N(l)-C(l)-C(10) 110.6(2)
N(2)-C(l)-C(4) 112.0(2)
N(l)-C(l)-C (4) 107.9(2)
C(10)-C(l)-C(4) 113.5(2)
N(l)-C(2)-C(12) 115.2(2)
N(l)-C(2)-C(3) 101.4(2)
C(12)-C(2)-C(3) 112.7(3)
N(l)-C(2)-H(2) 109.1
C(12)-C(2)-H(2) 109.1
C(3)-C(2)-H(2) 109.1
0(1)-C(3)-N(2) 126.7(3)
0(1)-C(3)-C(2) 125.1(3)
N(2)-C(3)-C(2) 108.2(2)
C(9)-C(4)-C(5) 119.8(3)
C(9)-C(4)-C(l) 120.8(3)
C(5)-C(4)-C(l) 119.4(3)
C(6)-C(5)-C(4) 120.3(3)
C(6)-C(5)-H(5) 119.9
C(4)-C(5)-H(5) 119.9
C(7)-C(6)-C(5) 118.6(3)
C(7)-C(6)-H(6) 120.7
C(5)-C(6)-H(6) 120.7
C(6)-C(7)-C(8) 123.0(3)
C(6)-C(7)-N(3) 119.2(4)
C(8)-C(7)-N(3) 117.7(4)
C(7)-C(8)-C(9) 117.8(4)
C(7)-C(8)-H(8) 121.1
C(9)-C(8)-H(8) 121.1
C(4)-C(9)-C(8) 120.5(3)
C(4)-C(9)-H(9) 119.8
C(8)-C(9)-H(9) 119.8
C(1)-C(10)-H(10A) 109.5
C(1)-C(10)-H(10B) 109.5
H(10A)-C(10)-H(10B) 109.5
C(1)-C(10)-H(10C) 109.5
H(10A)-C(10)-H(10C) 109.5
H(10B)-C(10)-H(10C) 109.5
N(2)-C(11)-H(11A) 109.5
N(2)-C(11)-H(11B) 109.5
H(11A)-C(11)-H(11B) 109.5
N(2)-C(11)-H(11C) 109.5
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H(11A)-C(11)-H(11C) 109.5
H(11B)-C(11)-H(11C) 109.5
C(2)-C(12)-C(13) 116.9(3)
C(2)-C(12)-H(12A) 108.1
C(13)-C(12)-H(12A) 108.1
C(2)-C(12)-H(12B) 108.1
C(13)-C(12)-H(12B) 108.1
H(12A)-C(12)-H(12B) 107.3
C(18)-C(13)-C(14) 117.6(3)
C(18)-C(13)-C(12) 124.1(3)
C(14)-C(13)-C(12) 118.2(3)
C(15)-C(14)-C(13) 120.9(3)
C(15)-C(14)-H(14) 119.6
C(13)-C(14)-H(14) 119.6
C(16)-C(15)-C(14) 120.8(3)
C(16)-C(15)-H(15) 119.6
C(14)-C(15)-H(15) 119.6
C(15)-C(16)-C(17) 118.8(4)
C(15)-C(16)-H(16) 120.6
C(17)-C(16)-H(16) 120.6
C(16)-C(17)-C(18) 120.7(3)
C(16)-C(17)-H(17) 119.7
C(18)-C(17)-H(17) 119.7
C(13)-C(18)-C(17) 121.1(3)
C(13)-C(18)-H(18) 119.4
C(17)-C(18)-H(18) 119.4
C(2)-N(l)-C(l) 105.9(2)
C(2)-N(1)-H(1A) 110.5
C(1)-N(1)-H(1A) 110.5
C(2)-N(1)-H(1B) 110.5
C(1)-N(1)-H(1B) 110.5
H(1A)-N(1)-H(1B) 108.7
C(3)-N(2)-C(ll) 124.0(3)
C(3)-N(2)-C(l) 113.0(2)
C (ll)-N (2 )-C (l) 121.8(2)
0(2)-N(3)-0(3) 123.0(4)
0(2)-N(3)-C(7) 119.3(4)
0(3)-N(3)-C(7) 117.7(4)
Symmetry transform ations used to  generate equivalent atoms:
Table 4. Anisotropic displacement parameters (A2x lO^Jfor nct0807. The anisotropic 
displacement factor exponent takes the form: -202[ h2a*2U^1 + ... + 2 h k a* b* U12 ]
U H U22 1)33 L)23 U13 U l2
C(l) 21(2) 23(2) 29(2) -2(1) -1(1) -1(1)
C(2) 23(2) 19(2) 31(2) K D 2(1) 1(1)
0(3) 26(2) 20(2) 29(2) -3(1) 4(1) 0(1)
C(4) 26(2) 26(2) 26(1) K D -4(1) 1(1)
C(5) 32(2) 33(2) 31(2) K D 3(1) -8(2)
0(6) 28(2) 54(2) 28(2) 4(2) 2(2) -7(2)
C(7) 42(2) 51(2) 33(2) 4(2) 10(2) 17(2)
C(8) 68(3) 33(2) 47(2) 3(2) 22(2) 12(2)
C(9) 44(2) 30(2) 40(2) 3(1) 14(2) 2(2)
C(10) 30(2) 26(2) 44(2) 0(1) -2(2) 1(1)
C ( l l) 26(2) 41(2) 44(2) -5(2) -6(2) -7(2)
C(12) 27(2) 26(2) 33(2) 2(1) 2(2) 1(2)
C(13) 29(2) 26(2) 32(2) -K D 0(1) 0(1)
C(14) 36(2) 76(3) 32(2) -2(2) 1(2) -3(2)
C(15) 47(3) 85(3) 36(2) -1(2) -7(2) -6(2)
C(16) 34(2) 42(2) 52(2) -3(2) -14(2) 2(2)
C(17) 25(2) 37(2) 48(2) -1(2) 1(2) 5(2)
C(18) 27(2) 31(2) 37(2) -2(1) -1(2) 3(2)
0(1) 34(1) 29(1) 40(1) 2(1) 3(1) -11(1)
0(2) 74(2) 123(3) 93(2) 4(2) 54(2) 21(2)
0(3) 225(6) 70(3) 184(5) -1(3) 153(4) 44(3)
N (l) 17(1) 22(1) 30(1) -2(1) 2(1) -K D
N(2) 20(1) 26(1) 33(1) -1(1) K D -6(1)
N(3) 84(3) 79(3) 60(2) 11(2) 37(2) 37(3)
C l(l) 26(1) 30(1) 39(1) -5(1) 1(1) -7(1)
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Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 10^)
for nct0807.
X y z U(eq)
H(2) 6718 8911 8 29
H(5) 6982 11327 -1470 38
H(6) 9071 10347 -2067 44
H(8) 7078 6888 -1656 59
H(9) 5038 7875 -1033 46
H(10A) 3110 11310 -1346 50
H(10B) 4593 12183 -1054 50
H(10C) 2840 11834 -704 50
H(11A) 1113 8416 -576 55
H(11B) 2030 8738 -1180 55
H(11C) 968 9822 -841 55
H(12A) 5433 8879 982 34
H(12B) 5092 10368 897 34
H(14) 6890 10075 1853 57
H(15) 9612 10575 2248 67
H(16) 12081 10774 1666 51
H(17) 11818 10396 681 44
H(18) 9108 9864 282 38
H(1A) 6788 10908 -311 27
H(1B) 5137 11307 -9 27
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11.3 X-ray data fo r 119-HCI
C
Identification code nctl008
Empirical formula C19 H23 Cl N2 02
Formula weight 346.84
Temperature 150(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P21
Unit cell dimensions a = 11.7339(14) A a = 90°.
Volume
b = 7.1391(6) A 8 = 116.538(4)°. 
c= 12.4541(14) A r = 90°.
933.35(17) A3
Z 2
Density (calculated) 1.234 Mg/m3
Absorption coefficient 0.218 mm"1
F(000) 368
Crystal size 0.20 x 0.20 x 0.04 mm3
Theta range for data collection 3.21 to 23.00°.
Index ranges -12<=h<=12, -7<=k<=7, -13<=l<=13
Reflections collected 2341
Independent reflections 2341 [R(int) = 0.0000]
Completeness to theta = 23.00° 99.4 %
Max. and min. transmission 0.9914 and 0.9578
Refinement method Full-matrix least-squares on F2
Data /  restraints /  parameters 2 3 4 1 /1 /2 2 0
Goodness-of-fit on F2 1.051
Final R indices [l>2sigma(l)] Rl = 0.0659, wR2 = 0.1401
R indices (all data) R1 = 0.1003, wR2 = 0.1603
Absolute structure parameter -0.22(15)
Largest diff. peak and hole 0.308 and -0.323 e.A"3
1
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Table 2. A tom ic coordinates ( x 10^) and equivalent isotropic displacement parameters (A^x 
103 )
fo r nctl008 . U(eq) is defined as one th ird of the trace of the orthogonalized U'J tensor.
X y z U(eq)
C(l) 3256(6) 5136(9) 7679(5) 29(2)
C(2) 1825(6) 5074(10) 6923(5) 34(2)
C(3) 2280(6) 2356(9) 8139(6) 34(2)
C(4) 3999(6) 4804(9) 6939(6) 33(2)
C(5) 4033(5) 6569(11) 6286(5) 33(2)
C(6) 4895(7) 7999(10) 6914(7) 43(2)
C(7) 4926(8) 9646(11) 6342(7) 49(2)
C(8) 4143(8) 9884(13) 5152(9) 60(2)
C(9) 3296(7) 8488(14) 4508(7) 57(2)
C(10) 3244(6) 6808(12) 5082(6) 48(2)
C ( ll) 18(6) 3003(11) 6555(6) 47(2)
C(12) 2504(6) 555(9) 7601(6) 37(2)
C(13) 1932(6) 2064(9) 9186(6) 30(2)
C(14) 1373(6) 3472(9) 9526(6) 36(2)
C(15) 1137(6) 3298(10) 10516(6) 38(2)
C(16) 1503(6) 1679(10) 11190(6) 41(2)
C( 17) 2084(6) 250(10) 10873(6) 38(2)
C(18) 2297(6) 447(9) 9875(6) 34(2)
C(19) 814(9) 2884(12) 12606(8) 67(3)
N (l) 1355(5) 3568(8) 7221(5) 34(1)
N (2) 3456(5) 3590(7) 8572(4) 28(1)
0(1) 1215(4) 6259(8) 6161(4) 45(1)
0(2) 1303(4) 1367(9) 12188(4) 47(1)
c i(i) 4083(2) 6328(2) 10627(1) 38(1)
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Table 3. Bond lengths [A] and angles [°] for nctl008.
C(l)-N(2) 1.508(8)
C(l)-C(2) 1.514(9)
C(l)-C(4) 1.544(9)
C (2)-0(l) 1.234(7)
C(2)-N(l) 1.334(9)
C(3)-N(l) 1.458(8)
C(3)-N(2) 1.519(8)
C(3)-C(12) 1.526(9)
C(3)-C(13) 1.544(9)
C(4)-C(5) 1.510(9)
C(5)-C(10) 1.377(9)
C(5)-C(6) 1.403(10)
C(6)-C(7) 1.384(10)
C(7)-C(8) 1.362(11)
C(8)-C(9) 1.382(12)
C(9)-C(10) 1.411(11)
C ( ll) -N ( l) 1.466(8)
C(13)-C(14) 1.367(9)
C(13)-C(18) 1.387(8)
C(14)-C(15) 1.384(9)
C(15)-C(16) 1.380(9)
C(16)-C(17) 1.379(9)
C(16)-0(2) 1.382(7)
C(17)-C(18) 1.381(9)
C(19)-0(2) 1.428(9)
N(2)-C(l)-C(2) 101.6(5)
N(2)-C(l)-C(4) 112.6(5)
C(2)-C(l)-C(4) 112.9(5)
0(1)-C(2)-N(1) 126.6(6)
0(1)-C(2)-C(1) 124.0(6)
N(l)-C(2)-C(l) 109.4(6)
N(l)-C(3)-N(2) 100.0(5)
N(l)-C(3)-C(12) 111.7(5)
N(2)-C(3)-C(12) 109.7(5)
N(l)-C(3)-C(13) 110.9(5)
N(2)-C(3)-C(13) 108.6(5)
C(12)-C(3)-C(13) 114.8(5)
C(5)-C(4)-C(l) 110.6(5)
C(10)-C(5)-C(6) 118.9(7)
C(10)-C(5)-C(4) 121.6(7)
C(6)-C(5)-C(4) 119.5(5)
C(7)-C(6)-C(5) 120.6(7)
C(8)-C(7)-C(6) 120.4(8)
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C(7)-C(8)-C(9) 120.1(7)
C(8)-C(9)-C(10) 120.1(7)
C(5)-C(10)-C(9) 119.8(8)
C(14)-C(13)-C(18) 118.6(6)
C(14)-C(13)-C(3) 120.5(6)
C(18)-C(13)-C(3) 120.6(5)
C(13)-C(14)-C(15) 121.7(6)
C(16)-C(15)-C(14) 119.1(6)
C(17)-C(16)-C(15) 120.3(6)
C(17)-C(16)-0(2) 116.3(6)
C(15)-C(16)-0(2) 123.4(6)
C(16)-C(17)-C(18) 119.6(6)
C(17)-C(18)-C(13) 120.8(6)
C(2)-N(l)-C(3) 116.2(5)
C (2 )-N (l)-C (ll) 122.4(6)
C (3 )-N (l)-C (ll) 120.9(5)
C(l)-N(2)-C(3) 110.2(4)
C(16)-0(2)-C(19) 117.6(6)
Symmetry transform ations used to  generate equivalent atoms:
Table 4. Anisotropic displacement parameters (A2x 103)for nctl008. The anisotropic 
displacement factor exponent takes the form: -2e2[ h2a * 2 u l l  + ... + 2 h k a* b* 11 -^2 ]
U H  U22 U33 U23 U13 U12
C(l)
C(2)
C(3)
C(4)
C(5)
C(6)
C(7)
C(8)
C(9)
C(10)
C ( l l)
cd2)
C(1B)
C(14)
C(15)
C(16)
C(17)
C(18)
C(19)
N (l)
N(2)
0(1)
0(2)
CI(1)
35(4)
35(4)
24(4)
35(4)
26(3)
47(4)
59(5)
54(5)
38(5)
33(4)
35(4)
36(4)
29(4)
40(4)
37(4)
37(4)
44(4)
29(4)
98(7)
29(3)
30(3)
36(2)
50(3)
36(1)
23(4)
46(5)
35(4)
31(4)
49(5)
48(5)
41(5)
66(6)
94(7)
75(7)
59(5)
32(4)
29(4)
30(4)
42(4)
54(6)
32(4)
35(4)
65(6)
37(3)
28(3)
60(3)
58(3)
34(1)
30(4)
23(4)
38(4)
37(4)
30(4)
43(4)
61(6)
85(7)
44(5)
41(5)
40(4)
45(4)
29(4)
38(4)
38(4)
31(4)
40(4)
42(4)
61(6)
32(3)
30(3)
42(3)
39(3)
42(1)
0(3)
4(3)
-2(3)
0(3)
3(4)
-2(4)
12(4)
38(5)
35(5)
11(4)
-3(4)
-9(3)
3(3)
8(3)
8(4)
3(4)
7(3)
-3(3)
2(4)
2(3)
-1(2)
16(3)
3(3)
-5(1)
14(3)
15(3)
8(3)
19(3)
18(3)
28(4)
41(5)
54(5)
24(4)
20(4)
11(3)
21(3)
10(3)
19(4)
19(3)
14(3)
21(4)
18(3)
56(5)
10(3)
17(2)
19(2)
25(2)
16(1)
4(3)
8(4)
0(3)
4(3)
8(4)
10(4)
-1(4)
25(5)
15(5)
2(4)
-11(4)
-6(3)
4(3)
3(3)
11(4)
-2(4)
3(4)
3(3)
-1(5)
0(3)
2(3)
13(3)
-3(3)
-3(1)
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Table 5. Hydrogen coordinates ( x 10^) and isotropic displacement parameters (A^x 10^)
for nct!008.
X y z U(eq)
H (l) 3508 6365 8106 35
H(4A) 4880 4407 7480 40
H(4B) 3586 3788 6351 40
H(6) 5463 7833 7739 51
H(7) 5496 10617 6783 59
H(8) 4179 11011 4762 72
H(9) 2749 8659 3678 68
H(10) 2666 5845 4638 58
H(11A) -434 3907 5911 71
H(11B) -378 2968 7101 71
H(11C) -27 1757 6208 71
H(12A) 1723 -196 7269 55
H(12B) 3193 -162 8227 55
H(12C) 2741 867 6960 55
H(14) 1141 4598 9072 43
H(15) 729 4280 10727 46
H(17) 2336 -864 11339 46
H(18) 2698 -537 9657 41
H(19A) 1397 3953 12803 100
H(19B) 735 2492 13324 100
H(19C) -25 3247 11977 100
H(2A) 3619 4102 9304 34
H(2B) 4148 2879 8666 34
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11.4 X-ray data fo r 121-HCI
(
Identification code nctl007
Empirical formula C18 H21 Cl N2 0
Formula weight 316.82
Temperature 150(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P21
Unit cell dimensions a = 10.5272(4) A a = 90°.
Volume
b = 7.5333(3) A 8 = 105.028(2)°. 
c = 10.6980(5) A r  = 90°.
819.38(6) A 3
Z 2
Density (calculated) 1.284 Mg/m3
Absorption coefficient 0.237 mm'1
F(000) 336
Crystal size 0.25 x 0.15 x 0.02 mm3
Theta range for data collection 3.15 to 27.46°.
Index ranges -13<=h<=13, -9<=k<=8, -13<=l<=13
Reflections collected 3113
Independent reflections 3113 [R(int) = 0.0000]
Completeness to theta = 27.46° 99.2 %
Max. and min. transmission 0.9953 and 0.9432
Refinement method Full-matrix least-squares on F^
Data /  restraints /  parameters 3 1 1 3 /1 /2 0 2
Goodness-of-fit on F3 1.050
Final R indices [l>2sigma(l)] Rl = 0.0522, wR2 = 0.1082
R indices (all data) R1 = 0.0696, wR2 = 0.1183
Absolute structure parameter 0.04(9)
Extinction coefficient 0.077(7)
Largest diff. peak and hole 0.321 and -0.260 e.A"3
$
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Table 2. Atom ic coordinates ( x 10^) and equivalent isotropic displacement parameters (A^x 
103 )
fo r nctl007 . U(eq) is defined as one third of the trace of the orthogonalized U'J tensor.
X y z U(eq)
C(1) 7965(3) 4503(4) -297(3) 20(1)
C(2) 8697(3) 6234(5) 111(3) 20(1)
C(3) 7595(3) 5582(4) 1701(3) 21(1)
C(4) 7389(3) 4379(5) -1756(3) 23(1)
C(5) 6964(3) 2553(5) -2299(3) 23(1)
C(6) 7070(3) 1041(6) -1546(3) 27(1)
C(7) 6638(3) -600(5) -2118(4) 32(1)
C(8) 6116(4) -729(5) -3433(4) 35(1)
C(9) 6025(4) 769(5) -4194(4) 35(1)
C(10) 6439(4) 2395(6) -3632(4) 31(1)
C ( ll) 8929(4) 8444(5) 1868(4) 28(1)
C(12) 6537(3) 6476(5) 2195(3) 28(1)
C(13) 8470(3) 4311(5) 2673(3) 21(1)
C(14) 9806(3) 4135(5) 2742(3) 25(1)
C(15) 10577(4) 2914(5) 3583(3) 29(1)
C(16) 10031(4) 1861(5) 4370(3) 31(1)
C(17) 8709(3) 2049(5) 4315(3) 30(1)
C(18) 7935(3) 3262(5) 3478(3) 25(1)
N (l) 8357(3) 6850(4) 1161(3) 21(1)
N(2) 6965(2) 4539(4) 479(2) 19(1)
0(1) 9457(2) 6915(3) -438(2) 29(1)
C l(l) 5615(1) 1152(1) 1198(1) 28(1)
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Table 3. Bond lengths [A] and angles [°] for nctl007.
C(l)-N(2) 1.501(4)
C(l)-C(2) 1.520(5)
C(l)-C(4) 1.524(5)
C (2)-0(l) 1.221(4)
C(2)-N(l) 1.347(4)
C(3)-N(l) 1.460(4)
C(3)-C(12) 1.509(4)
C(3)-N(2) 1.522(4)
C(3)-C(13) 1.533(4)
C(4)-C(5) 1.515(5)
C(5)-C(6) 1.382(5)
C(5)-C(10) 1.395(5)
C(6)-C(7) 1.402(6)
C(7)-C(8) 1.374(5)
C(8)-C(9) 1.380(6)
C(9)-C(10) 1.384(5)
C ( ll) -N ( l) 1.463(4)
C(13)-C(18) 1.390(5)
C(13)-C(14) 1.396(5)
C(14)-C(15) 1.391(5)
C(15)-C(16) 1.385(5)
C(16)-C(17) 1.385(5)
C(17)-C(18) 1.386(5)
N(2)-C(l)-C(2) 101.7(2)
N(2)-C(l)-C(4) 114.7(3)
C(2)-C(l)-C(4) 112.6(3)
0(1)-C(2)-N(1) 127.3(3)
0(1)-C(2)-C(1) 124.7(3)
N(l)-C(2)-C(l) 108.1(3)
N(l)-C(3)-C(12) 112.2(3)
N(l)-C(3)-N(2) 99.2(2)
C(12)-C(3)-N(2) 109.6(3)
N(l)-C(3)-C(13) 112.5(3)
C(12)-C(3)-C( 13) 114.1(3)
N(2)-C(3)-C(13) 108.2(3)
C(5)-C(4)-C(l) 116.6(3)
C(6)-C(5)-C(10) 118.4(3)
C(6)-C(5)-C(4) 123.6(3)
C(10)-C(5)-C(4) 117.9(3)
C(5)-C(6)-C(7) 120.3(3)
C(8)-C(7)-C(6) 120.5(4)
C(7)-C(8)-C(9) 119.6(4)
C(8)-C(9)-C(10) 120.1(3)
232
C(9)-C(10)-C(5) 121.1(4)
C(18)-C(13)-C(14) 118.5(3)
C(18)-C(13)-C(3) 120.4(3)
C(14)-C(13)-C(3) 121.0(3)
C(15)-C(14)-C(13) 120.5(3)
C(16)-C(15)-C(14) 120.5(3)
C(15)-C(16)-C(17) 119.1(3)
C(16)-C(17)-C(18) 120.7(3)
C(17)-C(18)-C(13) 120.7(3)
C(2)-N(l)-C(3) 113.4(3)
C (2 )-N (l)-C (ll) 123.4(3)
C (3 )-N (l)-C (ll) 121.8(3)
C(l)-N(2)-C(3) 105.8(2)
Symmetry transform ations used to  generate equivalent atoms:
Table 4. Anisotropic displacement parameters (A2x 10^)for nctl007. The anisotropic 
displacement factor exponent takes the form: -2I?I2[ h2a*2U11 + ... + 2 h k a* b* U12 ]
U H U22 1)33 1)23 1)13 U l2
C(1) 20(2) 16(2) 26(2) 0(1) 7(1) K D
C(2) 20(1) 16(2) 23(1) 3(2) K D -1(2)
C(3) 21(2) 20(2) 19(2) -1(1) 3(1) -4(1)
C(4) 28(2) 19(2) 24(2) 3(2) 8(1) 0(1)
C(5) 20(2) 21(2) 27(2) -4(2) 5(1) 3(1)
C(6) 24(2) 26(2) 29(2) 0(2) 4(1) 4(2)
C(7) 28(2) 22(2) 44(2) -2(2) 7(2) 2(2)
C(8) 26(2) 27(2) 47(2) -15(2) 0(2) 4(2)
C(9) 38(2) 36(3) 28(2) -13(2) 2(2) 3(2)
C(10) 32(2) 31(2) 29(2) 4(2) 5(2) 3(2)
C ( l l) 33(2) 18(2) 32(2) -5(2) 8(2) -8(2)
C(12) 26(2) 29(2) 30(2) -1(2) 10(1) 2(1)
C(13) 23(2) 19(2) 19(2) -3(1) 4(1) -3(1)
C(14) 25(2) 24(2) 24(2) 2(2) 6(1) KD
C(15) 26(2) 32(2) 30(2) 1(2) 7(2) 5(2)
C(16) 37(2) 27(2) 24(2) 4(2) 1(2) 9(2)
C(17) 36(2) 29(2) 26(2) 5(2) 9(2) -5(2)
C(18) 22(2) 26(2) 25(2) -3(2) 6(1) -3(1)
N (l) 24(1) 15(1) 25(1) -2(1) 6(1) -5(1)
N(2) 18(1) 16(2) 23(1) 2(1) 3(1) K D
0(1) 28(1) 30(1) 31(1) 4(1) 9(1) -7(1)
C l(l) 25(1) 22(1) 33(1) 2(1) 3(1) -5(1)
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Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A^x 10^)
for nctl007.
X y z U(eq)
H (l) 8580 3485 -2 24
H(4A) 6617 5178 -1997 28
H(4B) 8051 4835 -2184 28
H(6) 7438 1114 -638 32
H(7) 6706 -1630 -1593 38
H(8) 5819 -1843 -3816 42
H(9) 5679 684 -5105 42
H(10) 6364 3421 -4163 37
H(11A) 9569 8099 2671 42
H(11B) 8231 9156 2074 42
H(11C) 9370 9144 1332 42
H(12A) 6938 7074 3016 42
H(12B) 5908 5584 2330 42
H(12C) 6078 7352 1560 42
H(14) 10193 4855 2210 30
H(15) 11484 2801 3618 35
H(16) 10557 1021 4939 37
H(17) 8328 1340 4857 36
H(18) 7031 3377 3453 30
H(2A) 6765 3404 683 23
H(2B) 6205 5085 21 23
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11.5 X-ray data fo r 158
05=
Identification code nctl004
Empirical formula C16 H20 N4 06
Formula weight 364.36
Temperature 150(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P21
Unit cell dimensions a = 11.6652(16) A a = 90°.
Volume
b = 6.0708(7) A R = 104.760(7)°. 
c = 12.7801(15) A r = 90°. 
875.18(19) A3
Z 2
Density (calculated) 1.383 Mg/m3
Absorption coefficient 0.107 mm'1
F(OOO) 384
Crystal size 0.35 x 0.06 x 0.02 mm3
Theta range for data collection 2.74 to 27.48°.
Index ranges -14<=h<=14, -7<=k<=7, -16<=l<=16
Reflections collected 3631
Independent reflections 3631 [R(int) = 0.0000]
Completeness to theta = 27.48° 97.3 %
Max. and min. transmission 0.9979 and 0.9634
Refinement method Full-matrix least-squares on F2
Data /  restraints /  parameters 3 6 3 1 /1 /2 4 0
Goodness-of-fit on F2 1.068
Final R indices [l>2sigma(l)] R1 = 0.0952, wR2 = 0.1635
R indices (all data) R1 = 0.1954, wR2 = 0.2009
Absolute structure parameter -1(3)
Largest diff. peak and hole 0.248 and -0.259 e.A'3
f
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Table 2. A tom ic coordinates ( x 104) and equivalent isotropic displacement parameters (A^x 
103 )
fo r nctl004 . U(eq) is defined as one third of the trace of the orthogonalized U'J tensor.
X y z U(eq)
C(1) 2958(5) 8133(8) 6104(4) 36(2)
C(2) 3072(5) 4987(9) 5066(4) 36(1)
C(3) 4032(5) 4672(9) 6120(4) 33(1)
C(4) 2032(6) 8227(9) 6770(5) 42(2)
C(5) 1657(6) 5900(9) 7019(5) 49(2)
C(6) 2553(6) 9430(9) 7833(5) 49(2)
C(7) 932(6) 9495(11) 6150(5) 56(2)
C(8) 1832(5) 7961(9) 4076(4) 43(2)
C(9) 5194(5) 3993(8) 5882(4) 38(2)
C(10) 4978(5) 7899(9) 7282(4) 34(1)
C ( l l) 5944(5) 6458(8) 7951(4) 32(1)
C(12) 5692(5) 4617(9) 8481(4) 32(1)
C(13) 6606(5) 3393(8) 9102(4) 33(1)
C(14) 7788(6) 3940(10) 9227(4) 41(2)
C(15) 8000(6) 5810(10) 8696(5) 41(2)
C(16) 7115(5) 7101(10) 8069(4) 40(2)
N (1) 4022(4) 6834(6) 6642(3) 31(1)
N(2) 2566(4) 6959(7) 5071(3) 35(1)
N(3) 6307(6) 1427(7) 9673(4) 43(1)
N(4) 9256(5) 6483(12) 8807(5) 60(2)
0(1) 2865(4) 3652(7) 4322(3) 48(1)
0(2) 5056(3) 9899(6) 7360(3) 41(1)
0(3) 5274(5) 1186(7) 9695(3) 53(1)
0(4) 7128(4) 192(7) 10095(4) 62(1)
0(5) 9443(4) 8188(10) 8364(4) 75(2)
0(6) 10041(4) 5293(10) 9320(5) 85(2)
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Table 3. Bond lengths [A] and angles [°] for nctl004.
C(l)-N(2) 1.467(6)
C (l)-N (l) 1.483(6)
C(l)-C(4) 1.538(9)
C (2)-0(l) 1.225(6)
C(2)-N(2) 1.335(7)
C(2)-C(3) 1.529(7)
C(3)-N(l) 1.474(7)
C(3)-C(9) 1.519(8)
C(4)-C(6) 1.525(8)
C(4)-C(7) 1.533(8)
C(4)-C(5) 1.536(8)
C(8)-N(2) 1.472(6)
C(10)-O(2) 1.219(6)
C(10)-N(l) 1.366(6)
C(10)-C (ll) 1.508(8)
C (ll)-C (12) 1.376(7)
C (ll)-C (16) 1.391(8)
C(12)-C(13) 1.374(7)
C(13)-C(14) 1.387(8)
C(13)-N(3) 1.487(7)
C(14)-C(15) 1.377(8)
C(15)-C(16) 1.379(8)
C(15)-N(4) 1.493(8)
N(3)-0(3) 1.221(6)
N(3)-0(4) 1.228(6)
N(4)-0(6) 1.219(7)
N(4)-0(5) 1.225(7)
N(2)-C (l)-N (l) 101.0(4)
N(2)-C(l)-C(4) 114.5(5)
N(l)-C(l)-C (4) 112.7(4)
0(1)-C(2)-N(2) 126.6(5)
0(1)-C(2)-C(3) 123.8(5)
N(2)-C(2)-C(3) 109.5(4)
N(l)-C(3)-C(9) 116.3(4)
N(l)-C(3)-C(2) 101.4(4)
C(9)-C(3)-C(2) 110.4(5)
C(6)-C(4)-C(7) 108.2(5)
C(6)-C(4)-C(5) 109.0(5)
C(7)-C(4)-C(5) 108.9(6)
C(6)-C(4)-C(l) 109.5(5)
C(7)-C(4)-C(l) 110.2(5)
C(5)-C(4)-C(l) 111.0(5)
0(2)-C(10)-N(1) 123.5(5)
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0(2)-C( lO )-C (ll) 120.1(5)
N (l)-C (10)-C (ll) 116.3(4)
C(12)-C(ll)-C(16) 120.1(5)
C(12)-C(ll)-C(10) 121.9(5)
C(16)-C(ll)-C(10) 118.0(5)
C(13)-C(12)-C(ll) 119.5(5)
C(12)-C(13)-C(14) 122.6(5)
C(12)-C(13)-N(3) 118.3(5)
C(14)-C(13)-N(3) 119.1(5)
C(15)-C(14)-C(13) 116.0(5)
C(14)-C(15)-C(16) 123.6(6)
C(14)-C(15)-N(4) 118.3(6)
C(16)-C(15)-N(4) 118.1(6)
C(15)-C(16)-C(ll) 118.2(5)
C(10)-N(l)-C(3) 126.4(4)
C(10)-N (l)-C(l) 119.0(4)
C(3)-N(l)-C (l) 111.5(4)
C(2)-N(2)-C(l) 113.8(4)
C(2)-N(2)-C(8) 121.8(4)
C(l)-N(2)-C(8) 123.8(4)
0(3)-N(3)-0(4) 125.5(5)
0(3)-N (3)-C( 13) 117.6(5)
0(4)-N(3)-C(13) 116.9(6)
0(6)-N(4)-0(5) 123.5(7)
0(6)-N(4)-C(15) 118.3(6)
0(5)-N(4)-C(15) 118.2(6)
Symmetry transform ations used to generate equivalent atoms:
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Table 4. Anisotropic displacement parameters (A2x lO^Jfor nctl004. The anisotropic 
displacement factor exponent takes the form: -2t?l2[ h2a*2l | l l  + ... + 2 h k a* b* U12 ]
u i i U22 l|33 U23 l|13 U l2
C(l) 42(4) 19(3) 43(3) 4(3) 1(3) 3(3)
C(2) 46(4) 20(3) 42(3) 0(3) 15(3) -4(3)
C(3) 39(4) 25(3) 37(3) -1(3) 16(3) -6(3)
C(4) 43(4) 31(3) 51(4) -2(3) 10(3) 6(3)
C(5) 56(4) 32(3) 63(4) 3(3) 22(4) 0(3)
C(6) 61(4) 41(4) 46(3) 3(3) 17(3) 3(3)
C(7) 49(4) 54(4) 62(4) 1(4) 11(3) 18(3)
C(8) 40(4) 36(3) 49(4) 12(3) 7(3) 1(3)
C(9) 50(4) 21(3) 41(3) -8(3) 11(3) -2(3)
C(10) 45(4) 26(3) 32(3) -2(3) 11(3) 2(3)
C(11) 42(4) 21(3) 32(3) -6(2) 7(3) 0(3)
C(12) 36(3) 22(3) 35(3) -7(2) 5(3) -3(3)
C(13) 44(4) 19(3) 36(3) 1(2) 8(3) 2(3)
C(14) 42(4) 37(3) 37(3) -4(3) -1(3) 10(3)
C(15) 38(4) 44(4) 37(3) -1(3) 2(3) -4(3)
C(16) 52(4) 34(3) 33(3) 2(3) 12(3) -8(3)
N (l) 38(3) 16(2) 37(2) -1(2) 9(2) 0(2)
N(2) 43(3) 23(2) 35(3) -3(2) 2(2) -3(2)
N(3) 61(4) 24(3) 36(3) 0(2) 0(3) 3(3)
N(4) 40(4) 88(5) 49(3) -3(4) 8(3) -3(4)
0(1) 55(3) 36(2) 47(2) -12(2) 4(2) -2(2)
0(2) 51(3) 20(2) 49(2) -5(2) 7(2) -7(2)
0(3) 68(4) 38(2) 58(3) 12(2) 24(3) 2(2)
0(4) 73(3) 39(2) 61(3) U (2) -6(3) 2(3)
0(5) 55(3) 93(4) 74(3) 12(3) 13(2) -23(3)
0(6) 42(3) 98(4) 105(4) 25(4) 1(3) 3(3)
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Table 5. Hydrogen coordinates ( x 10^) and isotropic displacement parameters (A^x 10^) 
fo r nctl004.
X y z U(eq)
H (l) 3202 9664 5968 44
H(3) 3777 3508 6567 39
H(5A) 1339 5104 6340 73
H(5B) 1046 6002 7421 73
H(5C) 2346 5108 7456 73
H(6A) 1948 9568 8237 73
H(6B) 2818 10900 7680 73
H(6C) 3230 8595 8263 73
H(7A) 1174 10907 5902 84
H(7B) 409 9762 6627 84
H(7C) 509 8627 5524 84
H(8A) 1996 7237 3444 64
H(8B) 2019 9533 4064 64
H(8C) 992 7782 4057 64
H(9A) 5684 3206 6508 56
H(9B) 5617 5308 5739 56
H(9C) 5031 3026 5247 56
H(12) 4893 4196 8417 38
H(14) 8413 3075 9653 49
H(16) 7299 8395 7726 48
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